TW209213B - - Google Patents

Download PDF

Info

Publication number
TW209213B
TW209213B TW81106539A TW81106539A TW209213B TW 209213 B TW209213 B TW 209213B TW 81106539 A TW81106539 A TW 81106539A TW 81106539 A TW81106539 A TW 81106539A TW 209213 B TW209213 B TW 209213B
Authority
TW
Taiwan
Prior art keywords
methyl
group
ministry
paper
economic affairs
Prior art date
Application number
TW81106539A
Other languages
Chinese (zh)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of TW209213B publication Critical patent/TW209213B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Description

itr 〇α,.ΐ3 Λ 6 η 6 五、發明説明(1 技術領域 本發明為有關具有血管緊縮素[I (以下簡稱A i I )拮抗 作用之新穎4 -醯胺基眯唑衍生物或其鹽 背景技術 己知A I I為具有强力昇壓作用之生理活性胜肽,而視為 種種哺乳類之高血壓原因物質。在生體内生成Λ II之途 徑雖已知有兩三個,但代表性途徑為由於腎酵素之作用 而從血管緊縮素原生成血管緊縮素I,此受血管緊缩素 轉換酶(ACE)之作用而轉變為All。本發明化合物乃作用 於All受體,而抑制All之人作用之呈現,故可當作All 拮抗藥》 藥 抗 拮 先 叫 背 而 之 注 意 事 項 本 頁一 裝 素 鹵 有 。 位物 4 生 唑衍 AI咪唑 於在眯 至之代 載取 第 諳 申 利 專 洲 歐 如 知 已 基 基 硝 記 4 號之 1 等 3’基 53烯 rsu 代 取 線- 示 掲 之 明 發 學 化AI 之抗 物異 合優 化有 知具 習鹽 與其 現或 發物 們生 者衍 明唑 發眯 本基 胺 醯 I 4 之 同 不 造 構 活 本 成 完 而itr 〇α ,. l3 Λ 6 η 6 V. Description of the invention (1 Technical field The present invention relates to a novel 4-amidoamino azole derivative or angiotensin [I (hereinafter referred to as A i I) antagonism Background Art AII is known to be a physiologically active peptide with a strong boosting effect, and is regarded as a variety of mammalian hypertensive causative substances. Although there are two or three ways to produce Λ II in the body, the representative way is In order to produce angiotensin I from angiotensinogen due to the action of renal enzymes, this is converted to All by the action of angiotensin converting enzyme (ACE). The compound of the present invention acts on the All receptor and inhibits All The role of human beings, so it can be regarded as "All antagonists". The anti-antagonism of the medicine is called first. Note that this page contains a halogen. The bit 4 is azole derivative AI imidazole. Lizhuzhou Ou Ruzhi has the base of the nitrate 4 No. 4 and other 3'-based 53-ene rsu substitution line Spermidine The difference between the I 4 and the construction cost is not completed.

經濟部屮央標準局员工消伢合作社印$L 式 下 如 為 物 合 化 明(I 。發式 明本下 發 如 之 穎 新 物 生 衍 唑 咪 基物 胺生 醛衍 4-唑 I)眯 &lt;基 胺 酸 本紙張尺度遑用中《«家«毕(CNS) T4規怙(2丨0X297公货) 81. 7. 20,U00i(c (II) 五、發明説明(2)The Ministry of Economic Affairs, Bureau of Standards, Employee Consumer Cooperatives printed $ L under the formula as a compound chemical compound (I. The model version is issued as a new bio-derivative imidazole amine-derived 4-azole I)术 <Using Amino Acid on the paper standard "《家« 毕 (CNS) T4 regulation (2 丨 0X297 public goods) 81. 7. 20, U00i (c (II) V. Description of the invention (2)

經濟部屮央櫺準局β工消费合作社印^ (式中R 1為低烷基 R2 : R6 〇 ,〇 | 11 或 一 V 一 s -N - C - R5 l^_AiJ R5為可被羧基,胺基,低烷胺基,低烷氣羰基或芳基 任意取代之低烯基;被低烷氧基或芳氣基任一取代之低 烷基;低烷氣羰基,或 —CH 〉 R 6為氫或低烷基, A1為可被低烷基取代之C2 - 6伸烷基, 0 II 7 R 3為氰基或 一C —0 — R7 R 7為氫或酯殘基, R 4為氫或芳烷基^ Η詳述上式(I)之化合物。 在式(I)之定義中,除另行規定者外,「低j乃指 (請先閲請背而之注意事項洱項寫本f. 裝- 訂 線· 本紙張尺度逍用中困國家«準(CNS)甲4規格(210X297公t) 81. 7. 20.000¾ (II) 經濟部屮央榣準局cs:工消费合作杜印製 - 五、發明説明(3 ) Cl— 6直或分枝鐽β 故低烷基可為例如甲基,乙基,丙基,異丙基,丁基 ,異丁基,第二丁基,第三丁基,戊基,異戊基,新戊 基,第三戊基,1-甲基丁基,2 -甲基丁基,1,2-二甲基 丙基,己基,異己基,1-甲基戊基,2 -甲基戊基,3 -甲 基戊基,1,1-二甲基丁基,1,2 -二甲基丁基,2, 2 -二甲 基丁基,1,3-二甲基丁基,2, 3-二甲基丁基,3, 3-二甲 基丁基,卜乙基丁基,2-乙基丁基,1,1, 2-三甲基丙基 ,1,2,2-三甲基丙基,1-乙基-1-甲基丙基,1-乙基- 2-甲基丙基等。 低烯基為〇2_ s直或分枝鏈烯基,例如乙烯基,烯 丙基,卜丙烯基,2-丙烯基,卜丁烯基,2-丁烯基,3-丁烯基,2-甲基-1-丙烯基,2-甲基烯丙基,1-甲基-1 -丙烯基,1-甲基烯丙基,1,1-二甲基乙烯基,1-戊烯基 ,2 -戊鋪基,3 -戊燦基,4 -戊嫌基,3 -甲基-1-丁铺基 ,3-甲基-2-丁烯基,3-甲基-3-丁烯基,2-甲基-1-丁 烯基,2-甲基-2-丁烯基,2-甲基-3-丁烯基,1-甲基-卜 丁烯基,1-甲基-2-丁烯基,1-甲基-3-丁烯基,1,1-二 甲基烯丙基,1,2-二甲基-卜丙烯基,1,2-二甲基-2-丙 烯基,1-乙基-1-丙烯基,1-乙基-2-丙烯基,1-己烯基, 2-己烯基,3-己烯基,4-己烯基,5-己烯基,1,1-二甲 基-卜丁烯基,1,1-二甲基-2-丁烯基,1,卜二甲基- 3-丁烯基,3,3-二甲基-1-丁烯基,1-甲基-1-戊烯基,1- 本紙»尺度遑用中《國家準(CNS)甲4規怙(210X297公Λ) 81. 7. 2U,000ik(ll) 五、發明説明(4 Λ 6 Π 6 甲基-2 -戊烯基,1 -甲基-3 -戊烯基,4 -甲基-1 -戊烯基, 4 -甲基-2 -戊烯基,4 -甲基-3 -戊烯 經濟部屮央橾準局只工消费合作社印製 這些低烯可被羧基,胺基 芳基取代。 低烷胺基可為例如甲胺基 ,戊胺基,己胺基,二甲胺 乙基甲胺基等。 低烷氣羰基可為甲氣羰基 氧羰基,戊氧羰基等。 除另行規定外,芳基乃指 基,二甲苯基,聯苯基,桊 氣苯基,氣苯基,硝苯基等 至於被低烷氣基或芳氣基 氣基,乙氧基,丙氧基,異 ,第二丁氣基,第三丁氧基 戊氣基,新戊氧基,2 -甲基 ,1-乙基丙氣基,己氧基等 甲氣基,聯苯氧基或萘氣基 A 1 「可被低烷基取代之C 乙基,伸丙基,四亞甲基, 基,五亞甲基,1,2 -二乙基 基等。 ,低烷胺基, ,乙胺 基,二 基,丙 乙胺基 低烷氣羰基, 胺基,丁胺基 ,二丙胺基, ,乙氣羰基,丙氣羰基,丁 磺環芳基,例如苯基,甲苯 基,饈基,菲基等,或低烷 0 任意取代之低烷基可為被甲 丙氧基,丁氣基,異丁氣基 ,戊氣基,異戊氣基,第三 丁氣基,1,2 -二甲基丙氧基 低烷氣基或如苯氣基,三苯 等芳氣基取代之上述低烷基 2 - s伸烷基」可為例如伸 2 -甲基三亞甲基,乙基伸乙 伸乙基,二甲基伸己基等。Printed by the β-Consumer Cooperative Society of the Central Bureau of Economics and Development of the Ministry of Economic Affairs ^ (where R 1 is a lower alkyl group R 2: R 6 〇, 〇 | 11 or a V s -N-C-R5 l ^ _AiJ R5 is a carboxyl group, Amino group, low alkylamino group, low alkyl carbonyl group or aryl group optionally substituted lower alkenyl group; lower alkyl group substituted by either lower alkoxy group or aryl group; low alkyl carbonyl group, or —CH> R 6 Is hydrogen or lower alkyl, A1 is C2-6 alkylene which may be substituted by lower alkyl, 0 II 7 R 3 is cyano or a C — 0 — R7 R 7 is hydrogen or ester residue, R 4 is Hydrogen or aralkyl ^ Η Detailed description of the compound of formula (I) above. In the definition of formula (I), unless otherwise specified, "low j means (please read the notes on the back-end notes first f. Binding-Thread · This paper standard is used in the troubled country «quasi (CNS) A 4 specifications (210X297 g) 81. 7. 20.000¾ (II) Department of Economics, Ministry of Economic Affairs, Census Bureau cs: industrial and consumer cooperation Printing-V. Description of the invention (3) Cl-6 straight or branched β so the lower alkyl can be, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, second butyl , Tert-butyl, pentyl, isopentyl, neopentyl, tertiary pentyl, 1-methyl Butyl, 2-methylbutyl, 1,2-dimethylpropyl, hexyl, isohexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 1,1- Dimethylbutyl, 1,2-Dimethylbutyl, 2,2-Dimethylbutyl, 1,3-Dimethylbutyl, 2,3-Dimethylbutyl, 3,3- Dimethylbutyl, ethylbutyl, 2-ethylbutyl, 1,1, 2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methyl Propyl, 1-ethyl-2-methylpropyl, etc. Lower alkenyl is 〇2_ s straight or branched alkenyl, such as vinyl, allyl, propenyl, 2-propenyl, propylene Alkenyl, 2-butenyl, 3-butenyl, 2-methyl-1-propenyl, 2-methylallyl, 1-methyl-1-propenyl, 1-methylallyl , 1,1-dimethylvinyl, 1-pentenyl, 2-pentyl, 3-pentanyl, 4-pentyl, 3-methyl-1-butyl, 3-methyl -2-butenyl, 3-methyl-3-butenyl, 2-methyl-1-butenyl, 2-methyl-2-butenyl, 2-methyl-3-butenyl , 1-methyl-butenyl, 1-methyl-2-butenyl, 1-methyl-3-butenyl, 1,1-dimethylallyl, 1,2-dimethyl Base-propenyl, 1,2-dimethyl -2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1,1-dimethyl-bubutenyl, 1,1-dimethyl-2-butenyl, 1, budimethyl-3-butenyl, 3,3- Dimethyl-1-butenyl, 1-methyl-1-pentenyl, 1-base paper »Standard use of" National Standard (CNS) A 4 regulations (210X297 public Λ) 81. 7. 2U, 000ik (ll) V. Description of the invention (4 Λ 6 Π 6 methyl-2-pentenyl, 1-methyl-3-pentenyl, 4-methyl-1-pentenyl, 4-methyl- 2-Pentenyl, 4-Methyl-3-Pentene, Ministry of Economic Affairs, Pyongyang Bureau of Industry and Commerce Printed by the Consumer Cooperative, these lower olefins can be replaced by carboxyl groups and aminoaryl groups. The lower alkylamino group may be, for example, methylamino group, pentylamino group, hexylamino group, dimethylamine ethylmethylamino group and the like. The low-alkane carbonyl group may be methyloxycarbonyloxycarbonyl, pentyloxycarbonyl and the like. Unless otherwise specified, aryl refers to a group, xylyl, biphenyl, phenyl, phenyl, nitrophenyl, etc. As for the lower alkyl gas or aromatic gas, ethoxy, propylene Oxygen, iso, second butanyl, third butoxypentyl, neopentyloxy, 2-methyl, 1-ethylpropanyl, hexyloxy and other methyl groups, biphenoxy Or naphthalene group A 1 "C ethyl group, propyl group, tetramethylene group, alkyl group, pentamethylene group, 1,2-diethyl group, etc. which may be substituted by lower alkyl group, lower alkylamino group, , Ethylamino, diyl, propylethylamino lower alkyl carbonyl, amino, butylamino, dipropylamino,, ethyl carbonyl, propyl carbonyl, butanesulfonyl aryl, such as phenyl, tolyl, Phenyl, phenanthrenyl, etc., or lower alkyl 0. The lower alkyl optionally substituted may be methylpropoxy, butyl, isobutyl, pentyl, isopentyl, third butyl, 1 , The above-mentioned lower alkyl 2-s alkylene group substituted with a 2-alkylpropoxy lower alkyl gas group or an aromatic gas group such as benzene gas group, tribenzene, etc. may be, for example, 2-methyltrimethylene, Ethylene extends ethyl, ethyl extends dimethyl and so on.

之「酯殘基」乃指低烷基,呈式-A 2 - 0 - - X - R 本紙張尺度遑用中《«家楳準(CNS)甲4規怙(210X297公;》) 81. 7. 20,000¾ (II) 先 WI 背 而 之 注 意 事 項 填 % 本 頁 五、發明説明(5 之取代低烷基,如下式基: CH2 R8 V 0 或 Λ 6η 6The "ester residue" refers to the lower alkyl group, which is of the formula -A 2-0--X-R. This paper uses the "《楳 楳 准 (CNS) A 4 regulation (210X297 Gong;") 81. 7. 20,000¾ (II) The precautions for WI are filled in%. Page 5 5. Description of the invention (Substituted lower alkyl group of 5 is as follows: CH2 R8 V 0 or Λ 6η 6

上述A2之「低伸烷基」乃指直或分枝碩鍵,可為亞 甲基,伸乙基,伸丙基,二甲基亞甲基,四亞甲基,五 亞甲基,六亞甲基等。 R8之「環烷基」可為如環丙基,環丁基,環戊基, 環己基,環庚基,環辛基,環癸基等。 故式- A2 -OCO-X-R8中X為單鍵之基可為例如乙醯氧 甲基,1-乙醯氣乙基,2 -乙醯氧乙基,待戊醯氣甲基, 2,2-二甲基丙醯氧甲基,1-(特戊醯氣基)乙基,1-(待 戊醯氧基)丙基,2-(特戊醯氣基)乙基,2-(特戊醯氣基 )丙基,特戊醯氧基)丙-2-基,2 -二乙基丁醯氧甲基, 2, 2-二丙基戊醯氣甲基,環丙羰氣甲基,環丁羰氣甲基 ,環戊羰氣基,環己羰氧甲基等 另The "low alkylene" in A2 above refers to straight or branched main bonds, which may be methylene, ethylidene, propylidene, dimethylmethylene, tetramethylene, pentamethylene, hexamethylene Methylene and so on. The "cycloalkyl" of R8 may be, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and the like. Therefore, in the formula-A2 -OCO-X-R8, the group where X is a single bond may be, for example, acetyloxymethyl, 1-ethoxyethyl, 2-ethylacetoxyethyl, or pentyloxymethyl, 2 , 2-Dimethylpropionyloxymethyl, 1- (terpentylamino) ethyl, 1- (topentyloxy) propyl, 2- (terpentylamino) ethyl, 2- (Pivaloyl) propyl, pivaloyloxy) propan-2-yl, 2-diethylbutaneoxymethyl, 2, 2-dipropylpentylaminomethyl, cyclopropylcarbonyl Methyl, cyclobutanyl methyl, cyclopentyl carbonyl, cyclohexyloxymethyl, etc.

Th 先 間 讀 背 而 之 注 意 事 項 填 寫 Λ. 个 經濟部屮央標準局员工消&amp;合作社印製 基 乙 基 基 甲 氣 欺 氣 甲 如基 例氧 為羰 可氣 基甲 之T 氣2 為’ 基 乙 氧 羰 氧 乙 氣K 羰1-氣 ’ 甲基 /V 甲 基基 乙氣 }羰 基..¾ 氧 2 乙 , T基 2 乙 基基 乙氣 }羰 基 氧 羰 氧 氣 丙 基 甲 氣 羰 氣 羰 氣 丙 環 基 乙 羧羰 氣氣 丁 己 環環 基基 甲乙 氣氣 羰羰 氣氣 丁戊 環環 基基 乙甲 氧氣 羰羰 氧氣 丙戊 環環 基基 甲乙 氧氣 本紙»尺度遑用中《«家«準(CNS)肀4規格(210父297公龙) 8!. 7. 20.000¾ (!1) 五、發明説明(6 Λ 6 η 6 氧甲基,環己氣羰氣乙基,環庚氣羰氣甲基等。 式 CH, R8 W V 0 之代表基如下 -ch2^,ch3V 〇 CH2 CH3 ~CH2v/CH2CH2CH3 J \ / *\0 V , 〇 γ CH, -CH2 CH - CH3 ch2 ch2ch2ch2ch3 V 〇 V o 經濟部屮央標準局C3:工消&quot;合作杜印製 芳烷基為上迷低烷基之任意氫被芳基取代之基。 例如苄基,二苯甲基,苯乙基或三苯甲基等α 本發明化合物(I)可與酸及鹼形成鹽。與酸之鹽可如 鹽酸,氫溴酸,氫碘酸,硫酸,硝酸,磷酸等礦酸,或 如甲酸,乙酸,丙酸,草酸,丙二酸,丁二酸,反丁烯 二酸,順丁烯二酸,乳酸,蘋果酸,檸檬酸,酒石酸, 磺酸,苦酸,甲磺酸,乙磺酸,麩胺酸等有機酸之酸加 成鹽。 與鹺之鹽可為與如鈉,鉀,鎂,鈣,鋁等無機齡,如甲 胺,乙胺,乙醇胺等有機鹼,或如離胺酸,鳥胺酸等鹼 性胺基酸之鹽,或銨鹽。 8 - 本紙張尺度遑用中困《家標準(CNS)〒4規格(210X297公Α) 81. 7. 2U.000ik (H) 經濟部中央櫺準局A工消件合作杜印3i _Λ]_ 五、發明説明(7) 本發明化合物中有雙鍵之存在,又依取代基之種類而 含不對稱磺原子之情形。故本發明化物也包括幾何異構物 ,光學異構物等各種異構物之混合物或其單離者。 製法 本發明化合物可用種種合成法來製造。下面例示其代 表性製法。 第1製法Th Read the notes for the first time and fill in Λ. An employee of the Ministry of Economic Affairs Bureau of Standards and Public Security Co., Ltd. prints a base ethyl methyl gas and a gas. For example, the oxygen is carbonyl gas. The T gas 2 is 'Base ethoxycarbonyloxyethane gas K carbonyl 1-gas' Methyl / V methyl ethyl ethane} carbonyl .. ¾ Oxygen 2 ethyl, T ethyl 2 ethyl ethyl ethane} carbonyloxycarbonyl oxygen propyl methyl carbonyl Gas carbonyl gas propionyl ethyl carboxy carbonyl gas gas butyl hexyl cyclyl methyl acetyl gas carbonyl carbonyl gas butyl pentyl cyclyl ethyl oxo carbonyl carbonyl oxygen propyl pentyl cyclyl methyl ethoxygen paper »Standard to use "« Home «Quasi (CNS) Xuan 4 specifications (210 father 297 male dragon) 8 !. 7. 20.000¾ (! 1) V. Description of the invention (6 Λ 6 η 6 oxymethyl, cyclohexane gas carbonyl gas ethyl , Cycloheptane carbonyl methyl, etc. The representative groups of the formula CH, R8 WV 0 are as follows -ch2 ^, ch3V 〇CH2 CH3 ~ CH2v / CH2CH2CH3 J \ / * \ 0 V, 〇γ CH, -CH2 CH-CH3 ch2 ch2ch2ch2ch3 V 〇V o Ministry of Economic Affairs, Central Bureau of Standards C3: Gongxin &quot; Cooperative Du-printed aralkyl group is a group in which any hydrogen in the lower alkyl group is replaced by an aryl group. For example Benzyl, benzhydryl, phenethyl or trityl α The compound (I) of the present invention can form salts with acids and bases. Salts with acids can be hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, Mineral acids such as nitric acid, phosphoric acid, or such as formic acid, acetic acid, propionic acid, oxalic acid, malonic acid, succinic acid, fumaric acid, maleic acid, lactic acid, malic acid, citric acid, tartaric acid, sulfonic acid , Acid addition salts of organic acids such as picric acid, methanesulfonic acid, ethanesulfonic acid, glutamic acid, etc. The salt with the salt can be combined with inorganic ages such as sodium, potassium, magnesium, calcium, aluminum, etc., such as methylamine, ethyl Organic bases such as amines, ethanolamines, etc., or salts of basic amino acids such as lysine, ornithine, or ammonium salts. 8-This paper is not suitable for the use of "Household Standards (CNS) 〒 4 specifications (210X297 Α) 81. 7. 2U.000ik (H) The Ministry of Economic Affairs, Central Bureau of Trade and Industry A, cooperation and cooperation Du Yin 3i _Λ] _ V. Description of the invention (7) The compound of the present invention has the presence of a double bond, depending on the substituent The type contains asymmetric sulfon atoms. Therefore, the compounds of the present invention also include mixtures of geometric isomers, optical isomers and other various isomers or their isolated ones. The compounds can be used to manufacture a variety of synthesis methods. The following illustrates representative of the production method thereof. Process 1

Re R«Re R «

(式中 R1 ,R3 ,R4 ,RS 及 Re 同前)。 本發明化合物Ua)可令呈式(Ila)胺與呈式(III)羧酸 或其反應性衍生物反應來製造。 反應乃令化合物UII)或其反應性衍生物與化合物(Ila) 用約等莫耳或一方用過量,在對反應為惰性之有機溶劑 ,如吡啶,四氫呋喃,二枵烷,乙_,苯,甲苯,二甲 苯,二氯甲烷,二氣乙烯,氮仿,二甲基甲醯胺,乙酸 乙酯,乙腈等溶劑中進行。 將化合物(ΙΗ)以游離羧酸反應時,宜在二環己基碩 本紙Λ尺度逍用中《«家tt準(CNS) Ή規怙(210x297公;¢) 81. 7. 20.000ik(li) Λ 6 II 6 五、發明説明(8 ) 化二亞胺或〖,1 '-羰基二眯唑等縮合劑之存在下進行。 至於化合物(111)之反應性衍生物可為如醯氮,醯溴 等醛鹵;醯基叠氮;與Ν -羥基苯駢三唑或Ν -羥基丁二醯 亞胺等之活性酯;對稱酐;與烷基磺酸或對甲苯磺酸之 混合酐等。 依反應性衍生物之種類而在反應時宜加如三乙胺.吡 啶,甲基吡啶,二甲基吡啶,Ν,Ν’-二甲基苯胺等有機 鹼,或如磺酸鉀,N a Ο Η等無機鹼,俾反應順利進行。吡 啶也可兼當溶劑。 反應溫度也依反應性衍生物之種類而異,並無特別限 定。 第二製法 (請先閲讀背而之注*市項再填寫本頁^ 裝- 經濟部中央標準局员工消赀合作社印製(Where R1, R3, R4, RS and Re are the same as above). The compound Ua) of the present invention can be produced by reacting an amine of formula (Ila) with a carboxylic acid of formula (III) or a reactive derivative thereof. The reaction is to make the compound UII) or its reactive derivative and the compound (Ila) with an equivalent molar amount or one side in excess, in an organic solvent inert to the reaction, such as pyridine, tetrahydrofuran, dioxane, ethyl, benzene, Toluene, xylene, methylene chloride, difluoroethylene, nitroform, dimethylformamide, ethyl acetate, acetonitrile and other solvents. When the compound (ΙΗ) is reacted with free carboxylic acid, it should be used in the dicyclohexyl master paper Λ scale for ease of use «Home tt quasi (CNS) Ή regulations (210x297 public; ¢) 81. 7. 20.000ik (li) Λ 6 II 6 V. Description of the invention (8) Carried out in the presence of a condensing agent such as diimine or 〖, 1'-carbonyl dibenzozole. As for the reactive derivative of compound (111), it can be aldehyde halide such as amide nitrogen, amide bromide; amide azide; active ester with N-hydroxybenzotriazole or N-hydroxysuccinimide; etc. Anhydride; mixed anhydride with alkylsulfonic acid or p-toluenesulfonic acid. Depending on the type of reactive derivative, organic bases such as triethylamine, pyridine, picoline, lutidine, Ν, Ν'-dimethylaniline, or potassium sulfonate, Na a Inorganic bases such as Η will react smoothly. Pyridine can also be used as a solvent. The reaction temperature also depends on the type of reactive derivative, and is not particularly limited. The second system method (please read the back-note * market item before filling in this page ^ Outfit-Printed by the Cooperative Society of the Ministry of Economic Affairs, Central Standards Bureau

-10- 本紙ft尺度遑用中Β Β家楳準(CHS) T4規怙(210X297公《) 81. 7. 20.000¾ (H) 五、發明説明(9-10- The ft scale of this paper is used in the middle of the family. The family standard (CHS) T4 regulation (210X297) "81. 7. 20.000¾ (H) V. Description of the invention (9

第2製程 Μ (V) Λ 6 Π 62nd process Μ (V) Λ 6 Π 6

R&quot; (式中Y為鹵素或磺酸殘基,R1 ,R3 ,R4及A1同前)。 本製法乃式(I)中R2為如下式醯胺基之目的物之製法R &quot; (where Y is a halogen or sulfonic acid residue, R1, R3, R4 and A1 are the same as above). This preparation method is a preparation method in which R2 in formula (I) is the target compound of the following formula amide group

OHC - N AJ _一 鹵 之 \)/ V I /(\ 式 里 與 胺 ih 先 閲 背 而 之 注 意 事 項 塡 裝· 訂_ 基基 醯胺 磺醯 或之 (應 對 造 製 來 應 反 物 生 lb衍 (I性 式應 呈反 令其 乃或 法酸 製羧 此基 烷 第法 )(方 C (V之行 物物進 合的法 程 製 程 製 2 第 物 合 化 將 次 製 發第 本仿 得可 而化 化基 環醯 V)之 ί程 化目製 經濟部屮央梂準局员工消费合作杜印製 物 合 化 基 胺 醯 將 。 可行 化進 環易 之容 程就 製理 2 處 第鹺 以 中 劑 溶 性 惰 在 , 叶 基 甲 喃,二 呋0H, 氫Na啶 四 ,吡 如鉀基 用酸甲 可碩 , 劑,胺 溶鉀乙 性醇三 惰丁 , 於用啶 至可吡 0, 本紙張尺度遑用中II困家楳準(CNS) T4規格(210X297公釐) 苯 Η a 納 屬 等 苯 甲 納 醇 甲 胺 甲 81. 7. 2U.U0Uik(l!) Λ 6 Π 6 五、發明説明(10) 等。此反應在冷卻 第3製法 室溫下容易進行OHC-N AJ _Monohalide \) / VI / (\ The formula and the amine ih first read the notes and instructions for installation and ordering _ the base amide sulfonamide or it (The formula of I should be reversed, or the method of preparing the carboxyl alkane by the method of acid) (Square C (the process of the process of the combination of the objects of the V It can be converted into a base ring (V)). The project of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Central Bureau of Employee Consumption Cooperation will print the compound of the base amine. The process of making it possible to enter the environment is based on the 2nd place. It is soluble in inertia in Chinese medicine, erythromethan, difuran 0H, hydrogen pyridine, tetrapyridine, potassium, acid, formic acid. 0, the paper size is used in the middle II sleepy family standard (CNS) T4 specification (210X297 mm) benzene Η a Na genus benzalkonol methylamine methyl 81. 7. 2U.U0Uik (l!) Λ 6 Π 6 V. Description of the invention (10) etc. This reaction is easy to proceed at room temperature after cooling the third production method

R8 I M /NC0 - R5 R'-/ ΊR8 I M / NC0-R5 R '-/ Ί

IT (請先閲讀背而之注意事項#填寫本^ (式中 R1 ,R3 ,R4 ,R5 ,R6 ,Y 同前。) 本發明化合物(Ic)可令呈式(VI)醯胺化合物與呈式 (VII)烷基鹵(或磺酸烷酯)化合物反應來製造。 此反應可令化合物(VI)與反應對應量化合物(VII)在 前述惰性溶劑中,於室溫〜加溫下反應,為促進反應, 宜加前述鹼。 第4製法 装, 線· 經濟部屮央榣準局C3:工消许合作杜印製IT (please read the back-end notes first # fill in this ^ (where R1, R3, R4, R5, R6, Y are the same as above.) The compound (Ic) of the present invention can make the amide compound of formula (VI) and The alkyl halide (or alkyl sulfonate) compound of formula (VII) is reacted to produce. This reaction can make the compound (VI) react with the corresponding amount of compound (VII) in the aforementioned inert solvent at room temperature ~ heating, In order to promote the reaction, it is advisable to add the aforesaid alkali. The fourth method is installed, the line · Ministry of Economic Affairs, Bureau of Biology and Censorship C3: the work of consumer cooperation permit Du Du

本紙Λ尺度遑用中國围家楳爭(CHS) T4規格(210X297公《) 81. 7. 20,000¾ (II) 經濟部屮央橾準局兵工消伢合作杜印!u 五、發明説明(11) (式中R4 1為芳烷基,其他符號同前)。 在本發明之化合物U )中,R 4為氫者可將R 4為芳烷 基之化合物以觸媒還原,液氨還原等常法之還原反應或 以酸處理而得。 觸媒還原可在如Pd-C,氣化鉑等貴金屬觸媒之存在下 ,在如甲醇,乙醇,乙酸乙酯等習用於觸媒還原之溶劑 中於常壓〜加壓下進行。 液氨還原乃將液態氨單獨或以醚類為共溶劑,加鈉, 鉀,鋰,於-3 3 °C以下反應。 酸處理時,用乙酸,三氟乙酸,三氣乙酸,鹽酸,硫 酸,氫溴酸乙酸等。此反應通常在如甲醇,乙醇,丙_ 等有機溶劑中或在水中。於室溫〜加溫下(或回流下)進 行〇 第5製法 本發明化合物中,R3為游離羧酸者可令R 3被酯化之 化合物以酸或齡處理而得。至於酸可為如鹽酸,硫酸, 氫溴酸,三氟乙酸等,鹼則可為如苛性納,苛性鉀,硬 酸鉀,重磺酸鈉,甲醇鈉,乙醇納等。 産業上之利用可能性 因本發明化合物具有血管緊縮素ΙΙ(ΑΙΙ)拮抗作用, 故可供治療起因於All生理作用之種種疾病(如高血壓, 慢性心臓衮竭,心臓肥大,動脈硬化,糖尿病性腎症, 糖尿病性視網膜症,慢性错小球醫炎,增飱性腎小球晋 -1 3 - A 6 Π 6 (請先閲讀背而之注意事項ΛΛ?窍本 本紙»尺度遑用中《困家樣毕(CNS) 1M規格(210父297公4) 81. 7. 20,000¾ (II) 五、發明説明(12) Λ 6 Π 6 隨素 其性 及雄 大高 肥性 腺次 列二 前及 性性 良發 ,原 症-慮良 焦不 ,環 症循 忘梢 健末 障難 内因 綠尿 uhr, 32¾ 炎伴 症 用 作 抗 0 士口 X—^ If 等有 礙也 障II 管\ 血 腦 之 成 生 及及 素藥 酵制 腎抑 E 介 C \ 不 對 物 合 化 明 發 本 又 bb 待 期 可 故 體抗 受拮 I , I 之 A 涫 之縮 5收 物 I J I 合 A 化之 明脈 發動 本主 。子 譜兔 壓出 降摘 之對 廣乃 更力 藥效 抗之 拮用 素作 酵斷 腎遮 作用 用 生 作 制 抑 之 應 反 壓 昇 I I A 之 鼠 壊 破 髓 脊 。 對者 及定 2測 夕} 體内 生體 S 關 eb相 K 量 在用 掛起 懸本 ,標 本該 標則 I Η I ti 旋 螺 成 作 而 出 摘 脈 8&lt;|^ 驗主 試子 外兔 體將 生 加 添 中 液 該 0 中 液 ,與 側前 度加 濃添 高藥 往驗 移被 線算 曲計 用以 作 , 量降 用下 之力 縮縮 收收 II大 5 B取 此Q w I 令 A 〇依 縮令 收或 加 添 線 曲 幅:之 之 罾性ΡΛ elffi® BU 用t濃 作M高 斷 3遮 砠體2二 a &quot;後1¾移 最 或 度 以 乃 力 用} 。作值 率童數 制用對 抑使負 縮1(之 收ί度 大Α2濃 (請先間讀背而之注意事項丹填寫本 裝- 訂 線· 值 2 數 P 對 或負 之 度 濃 0 斷 遮 之 需 所 % ο 5 制 抑 力 縮 收 大 最 使 /IV 值 示 表 經濟部屮央櫺準局β工消費合作社印製 導 入 CU 插 脈 .靜 及 脈 動 之 鼠 老 m 破 錢 脊 於 下 吸 驗呼 試 Η 内人 髏在 生 驗 試 内 體 ri 生 o A 行10對 進1(。 而AI昇 管予上 投壓 鑲血 持續 内持 脈之 ( 8 靜 Η 在mill 鼠 7 老)-壞 5 破現 is呈 -SJ πυ 本 , 於 由 制 抑 量 用 隨 因 物 之 丨 用 «Μη 作 ),斷 分遮 /有 8 t k 體 / 受 本紙ft尺度遑用中國國家楳準(CNS) 1»4規格(210X297公址) 81. 7. 20.000ik (II)This paper uses the Chinese Weijia Zheng (CHS) T4 specification (210X297). 81. 7. 20,000¾ (II) The Ministry of Economic Affairs, the Central Bureau of War Industry, the Military Industry Consumers Cooperation and Du Du! U 5. The description of the invention ( 11) (where R4 1 is aralkyl, other symbols are the same as above). In the compound U) of the present invention, where R 4 is hydrogen, a compound in which R 4 is an aralkyl group can be obtained by a conventional reduction reaction such as catalyst reduction, liquid ammonia reduction, or acid treatment. The catalyst reduction can be carried out in the presence of precious metal catalysts such as Pd-C, vaporized platinum, etc., in solvents such as methanol, ethanol, ethyl acetate, etc., which are conventionally used for catalyst reduction, under normal pressure ~ pressurized. Liquid ammonia reduction is the reaction of liquid ammonia alone or with ether as a co-solvent, adding sodium, potassium, and lithium at -3 3 ° C. For acid treatment, use acetic acid, trifluoroacetic acid, trigas acetic acid, hydrochloric acid, sulfuric acid, hydrobromic acid acetic acid, etc. This reaction is usually in organic solvents such as methanol, ethanol, propylene, etc. or in water. Perform at room temperature ~ under heating (or under reflux). Fifth production method In the compound of the present invention, the compound in which R3 is a free carboxylic acid can be obtained by treating the compound in which R3 is esterified with acid or age. As for the acid, it can be, for example, hydrochloric acid, sulfuric acid, hydrobromic acid, trifluoroacetic acid, etc., and the base can be, for example, caustic soda, caustic potash, potassium stearate, sodium disulfonate, sodium methoxide, sodium ethanol, etc. INDUSTRIAL APPLICABILITY Since the compound of the present invention has angiotensin ΙΙ (ΑΙΙ) antagonistic effect, it can be used to treat various diseases caused by All physiological effects (such as hypertension, chronic heart exhaustion, heart hypertrophy, arteriosclerosis, diabetes mellitus) Nephropathy, Diabetic Retinopathy, Chronic Miscellaneous Globules, Inflammatory Glomerulus Jin-1 3-A 6 Π 6 (Please read the precautions first ΛΛ? Tips for this paper »Standards in use "Sleepy Home Sample (CNS) 1M Specification (210 father, 297 male 4) 81. 7. 20,000¾ (II) V. Description of the invention (12) Λ 6 Π 6 The second highest in terms of its nature and the hypertrophic gland Sexual benign hair, the original symptom-consider good focus, not circulatory symptoms, forgetfulness of the end, obstacles due to green urine uhr, 32¾ inflammation with symptoms used as anti-0 Shikou X- ^ If and other obstacles also hinder II tube \ The formation of blood brain and the production of renal inhibitory enzymes through the fermentation of ketones E-C The Mingmai mobilizes the principal. The sub-spectrum rabbit presses down and extracts the antagonists that are more potent against Guangnai as enzymes for fermentation The kidney covering effect is used to suppress the spinal ridge of the rat that should counteract the rise of IIA. The opponent and the Ding 2 test evening} In vivo organism S related eb phase K amount is used to suspend the suspension, the specimen is the standard I Η I ti spins the snail into the body and extracts the veins. 8 &lt; | ^ The main body of the tester will be added with the middle liquid and the middle liquid will be added to the front side to increase the concentration of the high drug. Calculate for the purpose of reducing the amount of force used to shrink the collection II big 5 B take this Q w I so that A 〇According to the contraction order or add a line of curvature: the characteristics of the ΛΛ elffi® BU with t concentrated work M high break 3 cover the tortoise 2 two a &quot; after 1¾ shift the most or the degree is to use force}. As the value of the number of children's system is used to inhibit the negative shrinkage 1 (the degree of harvest is large Α2 thick (please read first Contrary precautions: Dan fills in this book-Stranding · Value 2 Number P Pair or negative degree of concentration 0 Need for breaking off% ο 5 Inhibition force shrinks most greatly / IV value shows the Ministry of Economic Affairs Printed and introduced by quasi-bureau β industry consumer cooperatives to insert CU veins. Static and pulsating rat old m Broken money ridge under the suction test call test Η The human skeleton is in the life test The test body risheng o A line 10 pairs into 1 (. And the AI ascending tube is put on the blood pressure to continue the internal holding of the vein (8 静 Η in the mill rat 7 old)-bad 5 broken is is -SJ πυ , In order to suppress the amount of use of dependent factors, use «Μη as a), cut off the cover / have 8 tk body / accept the paper ft scale to use the Chinese National Standard (CNS) 1» 4 specifications (210X297 public address) 81 . 7. 20.000ik (II)

C .-9 ··'· 66 ΛΒ 五、發明説明(13) A [[之持缠血壓上舁,故從被驗藥投予後之血壓下降幅 度檢討A I I拮抗作用。A I I受體遮斷作用之效力乃以I C 30 值(A I I投予後之使血壓下降3 G b m H g之用量)表示。 以上實驗之結果如表 1。 表 1本發明化合物之A I I受體遮斷作用 實施例 In vitro (pA2値)ipD/ 値) In vivo (IC3 〇mmHg(mg/kg, iv)) D u p 7 5 3 EP 253310 置施例8 9 E β載之化合物 8 . 2 0.1 f施例3 7 (本發明化合物) 9.67 0 . 0 0 7 實施例4 4 發明化合物) 8.76 0 . 0 3 贯施例4 7 發明化合物j 8 . 1 7 0.03 (請先閲讀背而之注意亊項再墦窍本頁} 裝· 訂_ 線. 經濟部屮央楳準局员工消伢合作社印製 此外,本發明化合物毒性低而適用為醫藥品。 以化合物(I)或其鹽之一種或二種以上為有效成分之 製劑可用習用以製劑化之載體或賦形劑及其他添加劑來 調製。 製劑用之載體或賦形劑可為固體或液體,例如乳糖, 硬脂酸镁,澱粉,滑石,明膠,洋菜,果膠,阿拉伯膠 ,橄欖油,胡麻油,可可脂,乙二醇等及其他常用者。 投予可以錠劑,九劑,膠囊劑,顆粒劑,散劑,液劑 等之口服,或以靜脈及肌肉等注射劑,坐劑,經皮等之 -1 5 - 本紙張尺度遑用中明國家楳华(CNS) T4規格(210x297公Λ) 81. 7. 20,()00ik (II) 五、發明説明(1句 非口服之任何形態。投予量可參考症狀,投予對象之年 龄及性別等,隨値別情形而適當地決定,惟通常口服時 ,成人每日1 0〜1 0 0 0 in g,作一次或分2〜4次投予。 實施發明之最佳形態 以上説明本發明之化合物及其製法,下面更舉例詳細 説明之。實施例所用原料化合物中新穎者其製法例示於 參考例。參考例 1 Γ P ηC .-9 ···· 66 ΛΒ V. Description of the invention (13) A [[The blood pressure is held up, so the A I I antagonism is examined from the blood pressure drop after the drug is administered. The effectiveness of the blocking effect of the A I I receptor is expressed as the I C 30 value (the amount by which the blood pressure decreases by 3 G b m H g after A I I administration). The results of the above experiments are shown in Table 1. Table 1 Examples of AII receptor blocking effect of the compounds of the present invention In vitro (pA2 value) ipD / value) In vivo (IC3 〇mmHg (mg / kg, iv)) D up 7 5 3 EP 253310 Example 8 9 E β-compound 8. 2 0.1 f Example 3 7 (compound of the present invention) 9.67 0. 0 0 7 Example 4 4 inventive compound) 8.76 0. 0 3 through Example 4 7 inventive compound j 8. 1 7 0.03 (Please read the back-to-back notes first and then the page on this page) Binding · Order _ Line. Printed by the Employee Consumer Cooperative of the Department of Economics, Ministry of Economic Affairs. In addition, the compounds of the present invention are low in toxicity and suitable for use as pharmaceuticals. (I) One or two or more of its salts as active ingredients can be prepared with conventional carriers or excipients and other additives. The carriers or excipients used in the formulation can be solid or liquid, such as lactose , Magnesium stearate, starch, talc, gelatin, lettuce, pectin, gum arabic, olive oil, flax oil, cocoa butter, ethylene glycol, etc. and other commonly used ones. Administration can be tablets, nine doses, capsules, Granules, powders, liquids, etc. are taken orally, or intravenous and intramuscular injections, etc. Agents, transdermal, etc. -1 5-This paper uses the Zhongming National Huahua (CNS) T4 specification (210x297 g) 81. 7. 20, () 00ik (II) V. Description of the invention (1 sentence not included) Any form of oral administration. The dosage can be determined according to the symptoms, the age and sex of the subject, and it can be appropriately determined according to the situation. However, when it is taken orally, the adult takes 10 to 1 0 0 in g daily. Or it can be administered in 2 to 4 times. Best Mode for Carrying Out the Invention The compounds of the present invention and their preparation methods have been described above, and more detailed explanations will be given below by way of example. Among the raw material compounds used in the examples, their preparation methods are shown in Reference Examples. Reference Example 1 Γ P η

二笨甲基 經濟部屮央楳準局员工消费合作社印製 a) 在丁腈159克於氬縈氣下加無水乙醇5QQinl,而冷卻至 〇 °C後,冷卻3 0°C以下而吹入乾H C 1氣體2小時3在5 °C 放置一夜後,減壓蒸除溶劑,而加乙醚1公升。收集白 色結晶而以多量乙醚洗淨,得丁基亞胺酸乙酯鹽酸鹽260 克,吸濕性白色結晶。 理化學的性狀 Ή-NMR (CDC13) δ (ppm): 4. 6 5 (2 H, q) , 2. 7 3 (2 H, t), 1. 6 6-1. 91 (2 H, m) f 1 . 4 9 ( 3 H, t ) , 1 · 0 2 ( 3 H, t ) b) 將此丁基亞胺酸乙酯鹽酸鹽30克溶在無水乙醇60ml -1 6 _ 本紙張尺度遑用中《國家《準(CNS)甲4規怙(210X297公;»:) 81. 7. 2U.000ik(ll) Λ 6 It 6 經濟部屮央楳準局Α工消费合作社印製 五、發明説明(15) ,而在室溫加氰醯胺8 . 3克。在室溫攪拌一夜後,濾除 氛化銨沈澱,減壓Μ除溶劑,加乙酸乙酯2 0 0 m 1 ,以水 5 0 m 1洗2次。乙酸乙酯層以無水硫酸鎂乾燥後,減壓蒸 發,得N -氰基-丁基亞胺酸乙酯2 5 . 7克,無色油狀物。 理化學的性狀 'H-NMR (CDC13) δ (ppm): 4. 29 (2 H, q) , 2. 67 (2 H, t ), 1.54—1.96(2H, m), 1. 35 ( 3 H, t) , 1. 00 ( 3 H, t ) 質譜 (GC—MS) :m/z 1 4 0 (M+) c)將此氣基丁基亞胺酸乙酯18. 6克溶在無水乙醇150 in 1 ,而在室溫加甘胺酸乙酯鹽酸鹽2 0克後,於U °C滴加 三乙胺30克。俟徐徐舁至室溫後,攪拌一夜。減壓蒸除 溶劑後,於殘渣加乙酸乙酯1 5 0 οι 1 ,依序以飽和檸樣酸 溶液及飽和食鹽水洗濯,以無水硫酸請乾燥,減壓蒸除 溶劑。殘渣在矽膠柱層析(乙酸乙酯:正己烷=1: 1), 得Ν' -氰基-N-(羰乙氧基)丁基亞胺酸甲酯11. 9克,黃色 油狀。 理化學的性狀 'H-NMR (CDC13) δ (ppm): 6· 38 C 1 H, b r ) , 4. 30 (2 H, q ) - - « &lt; « « «4······ · · · (請先閲讀背而之注意事項#填寫本一^ 裝- 訂 本紙張尺度遑用中國B家«準(CNS)T4規怙(210X297公*) 81. 7. 20,000^(11) Λ 6 Η6Printed by the Employee Consumer Cooperative of the Department of Economics, Biyangmiao, Ministry of Economics, abenben methyl a) 159 g of butyronitrile was added with anhydrous ethanol 5QQinl under argon gas, and after cooling to 0 ° C, it was cooled below 30 ° C and blown in Dry the HC 1 gas for 2 hours and 3 at 5 ° C. After overnight, the solvent was distilled off under reduced pressure, and 1 liter of ether was added. The white crystals were collected and washed with a large amount of ether to obtain 260 g of ethyl butylimidate hydrochloride, hygroscopic white crystals. Physical and chemical properties Ή-NMR (CDC13) δ (ppm): 4. 6 5 (2 H, q), 2. 7 3 (2 H, t), 1. 6 6-1. 91 (2 H, m ) f 1. 4 9 (3 H, t), 1 · 0 2 (3 H, t) b) Dissolve 30 g of ethyl butylimidate hydrochloride in absolute ethanol 60ml -1 6 _ this paper The standard is used in the "National Standards (CNS) A4 Regulations (210X297);» :) 81. 7. 2U.000ik (ll) Λ 6 It 6 Printed by the Ministry of Economic Affairs, the Central Bureau of Industry and Commerce, A Industrial and Consumer Cooperative 3. Description of the invention (15), and 8.3 g of cyanamide is added at room temperature. After stirring at room temperature overnight, the ammonium oxychloride precipitate was filtered off, the solvent was removed under reduced pressure, ethyl acetate 200 m 1 was added, and washed twice with water 50 m 1. The ethyl acetate layer was dried over anhydrous magnesium sulfate, and evaporated under reduced pressure to obtain 25.7 g of ethyl N-cyano-butylimidate, as a colorless oil. Physical and chemical properties' H-NMR (CDC13) δ (ppm): 4. 29 (2 H, q), 2. 67 (2 H, t), 1.54-1.96 (2H, m), 1. 35 (3 H, t), 1. 00 (3 H, t) mass spectrometry (GC-MS): m / z 1 4 0 (M +) c) 18.6 g of this gas-based ethyl butylimidate was dissolved in anhydrous Ethanol 150 in 1, and after adding 20 g of ethyl glycinate hydrochloride at room temperature, 30 g of triethylamine was added dropwise at U ° C. After slowly reaching room temperature, stir overnight. After evaporating the solvent under reduced pressure, add ethyl acetate 1 5 0 οι 1 to the residue, wash with saturated citric acid solution and saturated brine in this order, dry with anhydrous sulfuric acid, and evaporate the solvent under reduced pressure. The residue was chromatographed on a silica gel column (ethyl acetate: n-hexane = 1: 1) to obtain 11.9 g of methyl N′-cyano-N- (carbonylethoxy) butylimidate, as a yellow oil. Physicochemical properties' H-NMR (CDC13) δ (ppm): 6.38 C 1 H, br), 4. 30 (2 H, q)--«&lt;« «« 4 ······ · · · (Please read the notes on the back # fill in this one ^ Binding-the paper size of the book is not to use the Chinese B home «quasi (CNS) T4 regulation (210X297 public *) 81. 7. 20,000 ^ (11) Λ 6 Η6

五、發明説明(lb) 4. 0 7 ( 2 H, d) , 2. 6 4 (2 H, t ), 1. 66-1. 9 2 ( 2 Η, m), 1. 31 (3 Η, t ) , 1 . 05 ( 3 Η. t ) 質譜 (GC—MS): m/z 1 9 7 (M*) d)將Ν' -氣基-N-(羰乙氧基)丁基亞胺酸乙酯9克在二 甲基甲醯胺5 0 m 1 ,而在冰冷下加N a Η (含量6 0 % ) 1 · 9克。 在室溫攪拌20分後,冰冷下加Ν-三苯甲基-5- ( 4 溴甲 基聯苯-2-基)四唑30.5克,徐徐昇至室溫而觸伴5小時 。冰冷後,加N a Η ( 6 0 % ) 1 . 0克,在室溫jf拌2小時。減 壓蒸除溶劑後,於殘渣加乙酸乙酯/正己烷(2 : 1 )而依 序以水及飽和食鹽水洗淨,以無水硫酸鎂乾燥,減壓蒸 除溶劑,殘渣在矽膠柱層析(乙酸乙酯:正己烷=1: 1) ,得4 -胺基-2-正丙基- l-〔 〔2-(N -三苯甲基-四唑- 5-基)聯苯-4-基〕甲基〕-1H-眯唑-5-羧酸乙酯9.8克,黃 色油狀。 理化學的性狀 1 Η - NMR (C D C 1 3) δ (ppm): 經濟部屮央榣準局员工消费合作杜印51 6. 79 — 7. 89 (23H, m), 5. 32 (2 H, s ) , 4. 94 ( 1 H, s , b r ), 4 . 16 ( 2 Η, q), 2 . 4 0 ( 2 Η,, q ), 1. 59-1. 69 (2Η, m), 1. 20 (3 Η, b r ) , 〇. 8 7 (3 Η, t ) 質譜 (FAB) : τη/ ζ 6 7 4 (ΜΗ&quot;) -1 8 - 81. 7. 20,000^(11) 本紙5艮尺度遑用中β Β家楳準(CNS) Τ4規格(210x297公;«:&gt; 五、發明説明(17) 參考例5. Description of the invention (lb) 4. 0 7 (2 H, d), 2. 6 4 (2 H, t), 1. 66-1. 9 2 (2 Η, m), 1. 31 (3 Η , t), 1. 05 (3 Η. t) mass spectrometry (GC-MS): m / z 1 9 7 (M *) d) the Ν '-amino-N- (carbonylethoxy) butylene 9 g of ethyl amine acid in dimethylformamide 50 m 1, and Na a H (content 60%) 1.9 g under ice cooling. After stirring at room temperature for 20 minutes, 30.5 g of N-trityl-5- (4-bromomethylbiphenyl-2-yl) tetrazole was added under ice-cooling, and the temperature was gradually raised to room temperature for 5 hours. After ice cooling, 1.0 g of NaH (60%) was added, and the mixture was stirred at room temperature for 2 hours. After the solvent was distilled off under reduced pressure, ethyl acetate / n-hexane (2: 1) was added to the residue, washed with water and saturated brine in sequence, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was deposited on the silica gel column layer Analysis (ethyl acetate: n-hexane = 1: 1) to give 4-amino-2-n-propyl-1-(〔2- (N-trityl-tetrazol-5-yl) biphenyl- 4-yl] methyl] -1H-quinazole-5-carboxylic acid ethyl ester 9.8 g, yellow oil. Physical and chemical properties 1 Η-NMR (CDC 1 3) δ (ppm): Employee consumption cooperation of the Central Bureau of Economics and Trade of the Ministry of Economic Affairs Du Yin 51 6. 79 — 7. 89 (23H, m), 5. 32 (2 H , s), 4. 94 (1 H, s, br), 4. 16 (2 Η, q), 2. 4 0 (2 Η ,, q), 1. 59-1. 69 (2Η, m) , 1. 20 (3 Η, br), 0.8 7 (3 Η, t) mass spectrometry (FAB): τη / ζ 6 7 4 (ΜΗ &quot;) -1 8-81. 7. 20,000 ^ (11) paper 5 Burst Standard Use Medium Beta Beta Family (CNS) Τ4 Specification (210x297 g; «: &gt; V. Description of the Invention (17) Reference Example

Ξ苯甲基 仿參考例1得如下化合物。 生成物:ν'-氰基- N-m甲基-丁胖 理化學的性狀 A 6 It 6 (請先閱讀背而之注意事項•再塡寫木一k; 經濟部屮央櫺準局ΚΙ:工消&quot;合作社印製 'H - NMR (C D C 1 3) &lt;5 ( p p m): 4. 18 (2 H, d) , 2. 6 3 (2 H, t), 1.5 0 - 2. 02 (2H, m). 1 . 0 4 ( 3 H, t ) 質譜 (El) :m/z 150( M*) 生成物:N 1 -氛基-N -氛甲基-N -〔〔 2…(N -三苯甲基四 唑-5-基〉聯苯-4-基〕甲基]丁脒 理化學的性狀 Ή-NMR (CDC13) &lt;5 (ppm): 6. 84 — 8. 02 (23H, m), 4. 56 ( 2 H, s), 3. 99 (2 H, s ),2. 70-2. 90(2 H. m), 1. 6 0 - 1. 7 8 ( 2 H, m), 1 . 0 8 ( 3 H, t )^ 譜 (FAB) : m/ z 6 2 7 ( Μ H+ ) -1 9 - 本紙Λ尺度遑用中因Β家《準(CNS) &lt;P4規怙(210x297公*) 81. 7. 20.000ik(!l) % Λ 6 η 6 五、發明説明(丄8) 生成物:4 -胺基-5-氣基-2-丙基-1-〔 〔2- (Ν -三苯甲基 -四唑-5-基)聯苯-4-基〕甲基〕-1Η -咪唑 理化學的性狀 Ή-NMR (CDC13) δ (ppm): 6. 8 0 - 8. 02 (23 H,m). 4. 89 (2 H, s) 4. 16-4. 23 (2 H, m), 2. 41 (2H, t ) 1. 5 0 - 1. 7 8 ( 2 H, m). 1. 18-1. 33 ( 2 H, m) , 0 . 88 ( 3 H, t (請先閲讀背而之注意苹碩洱填荩本i,』 質譜 實施例 (FAB) : m/ zΞBenzyl group Following Reference Example 1, the following compounds were obtained. Product: ν'-cyano-Nm-methyl-Dingfa physical properties A 6 It 6 (please read the precautions first • write the wood one k; the Ministry of Economic Affairs Bureau of the Central Government Bureau ΙΙ: Consumer &quot; printed by cooperatives ’H-NMR (CDC 1 3) &lt; 5 (ppm): 4. 18 (2 H, d), 2. 6 3 (2 H, t), 1.5 0-2. 02 ( 2H, m). 1. 0 4 (3 H, t) Mass spectrometry (El): m / z 150 (M *) Product: N 1 -Amino-N -Aminomethyl-N-[〔2… ( N-Trityltetrazol-5-yl> biphenyl-4-yl] methyl] butamidine physical and chemical properties Ή-NMR (CDC13) &lt; 5 (ppm): 6. 84 — 8. 02 (23H, m), 4. 56 (2 H, s), 3. 99 (2 H, s), 2. 70-2. 90 (2 H. m), 1. 6 0-1. 7 8 (2 H, m), 1.08 (3 H, t) ^ Spectrum (FAB): m / z 6 2 7 (Μ H +) -1 9-This paper uses Λ scale to use Zhongyin B's quasi (CNS) &lt; P4 Regulation (210x297 g *) 81. 7. 20.000ik (! L)% Λ 6 η 6 V. Description of the invention (丄 8) Product: 4-amino-5-amino-2-propyl-1- [[2- (Ν-Trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-imidazole physical and chemical properties Ή-NMR (CDC13) δ (ppm): 6. 8 0-8. 02 (23 H, m). 4. 89 (2 H, s) 4. 16-4. 23 (2 H, m), 2. 41 (2H, t) 1. 5 0-1. 7 8 (2 H, m). 1. 18-1. 33 (2 H, m), 0. 88 (3 H, t (please read back to note first, Ping Shuo Er fills the book i, "Mass Spectrometry Example (FAB): m / z

2 7 (MHO2 7 (MHO

MeMe

苯甲基 裝· - 經濟部屮央榣準局負工消#合作杜印^ 將4 -胺基-2-正丙基-1-〔 〔2'-(N -三苯甲基-四唑- 5- 基)聯苯-4 -基〕甲基〕咪唑-5 -羧酸乙酯1 . 0克溶在吡啶 1 0 m 1 ,在冰冷下滴加甲基甲丙烯醯氣1 7 ϋ m g。在1 5 °C }1 拌一夜後,減壓蒸除溶劑。殘渣溶在四氣仿2 0 m 1 ,而以 水及飽和食鹽水洗濯,以硫酸鎂乾燥,減壓蒸除溶劑。 2 ϋ - 本紙張尺度逍用中_ B家楳準(CNS) Ή規格(210X297公釐) 81. 7. 20,000i|c (II)Benzyl group ·-Ministry of Economic Affairs, Bureau of Biology and Biology, Nonggongxiao # Cooperation Du Yin ^ 4-amino-2-n-propyl-1- [〔2 ′-(N -trityl-tetrazole -5-yl) biphenyl-4-yl] methyl] imidazole-5-carboxylic acid ethyl ester 1.0 g dissolved in pyridine 10 m 1, methyl methacrylic acid gas was added dropwise under ice cooling 1 7 ϋ mg . After stirring overnight at 15 ° C} 1, the solvent was distilled off under reduced pressure. The residue was dissolved in SiQi 20 m 1, washed with water and saturated brine, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. 2 ϋ-This paper is used in standard _ B Jiayu standard (CNS) Ή specification (210X297 mm) 81. 7. 20,000i | c (II)

Vju’0 Λ 6 It 6 五、發明説明(19) 殘渣在矽膠柱層析(正己烷:乙酸乙酯=1 : 2 ),得4 -N - U -甲基丙烯醯基)胺基〕-2 -正丙基-1 -〔 〔 2 1 - ( PJ -] 苯甲基-四唑-5 -基)聯苯-4 -基〕甲基]-1H -眯脞-5-羧 酸乙酯5 1 ϋ m g ,泡狀。 理化學的性狀^-NMR (CDC13): δ (ppm) 9 . 43 — 9. 5 6 ( 1 H, m),Vju'0 Λ 6 It 6 V. Description of the invention (19) The residue is chromatographed on a silica gel column (n-hexane: ethyl acetate = 1: 2) to obtain 4 -N-U-methacryloylamino)]- 2 -n-propyl-1-[[2 1-(PJ-] benzyl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-squint-5-carboxylic acid ethyl ester 5 1 ϋ mg, blister. Physical and chemical properties ^ -NMR (CDC13): δ (ppm) 9. 43 — 9. 5 6 (1 H, m),

C 先 閲 背 而 之 意 事 項 再 填 % 米 .6 . 7 0 —7 . 9 5 (2 3 H ,m) 5 . 8 9 -5 . 9 5 (1 H, m), 5 . 4 2 -5 . 5 1 (1 H, m), k 5 . 3 6 (2 Η t s ), 4 . 17 (2 H, d d), 2 . 6 2 (2 Η t t ), 2 . 0 8 (3 H, s ), 訂 1 . 5 8 -1 . 9 0 (2 H, m), 1 . 1 4 (3 Η » t ), 0 . 8 9 (3 H, t ) k (FAB) : m/ z 7 4 2 (Μ Η+) 質譜 實施例 經濟部屮央榣準局A工消伢合作杜印製C Read the contradictions first and then fill in% meters. 6. 7 0 — 7. 9 5 (2 3 H, m) 5. 8 9 -5. 9 5 (1 H, m), 5. 4 2- 5. 5 1 (1 H, m), k 5. 3 6 (2 Η ts), 4. 17 (2 H, dd), 2. 6 2 (2 Η tt), 2. 0 8 (3 H, s), order 1. 5 8 -1. 9 0 (2 H, m), 1. 1 4 (3 Η »t), 0. 8 9 (3 H, t) k (FAB): m / z 7 4 2 (Μ Η +) Example of Mass Spectrometry Co-production by the Ministry of Economic Affairs

苯甲基 仿實施例1製得4 -〔 Ν - ( 3 -甲基丁烯醯基)胺i〕- 2 - -2 1 本紙ft尺度遑用中β國家楳準(CNS) T4規格(210x297公釐) 81. 7. 20.000¾ (II) 3 ,fJοο ,ο 6 ΛΠ 五、發明説明(20) 正丙基-1 -〔〔 2 ' - ( N -三苯甲基-四唑-5 -基)聯苯-4 -基 甲基〕-1 H -眯唑-5 -羧酸乙_ 理化學的性狀 1 H-NMR (CDC13): δ (ppm) 8. 86 ( 1 Η, s ), 6. 7 2 - 7. 93 (23 Η, m), 6. 06 ( 1 Η, s ) , 5. 35 ( 2 Η, s ) 4 . 11 (2 Η, dd), 2. 58 ( 2 Η, t ), 2. 25 (2 Η, d), 1 . 91 (2 Η, d), 1 . 5 9 - 1. 8 4 ( 2 Η, m), 1. 1 7 ( 3 Η, t ) , 0 . 89 ( 3 Η, t ) 質譜 (FAB) : m/ z 7 5 6 (MH+) 實施例 3 η —The benzyl imitation example 1 produced 4- [N- (3-methylbutenyl) amine i]-2--2 1 in paper ft scale and used in China National Beta Standard (CNS) T4 specification (210x297 Mm) 81. 7. 20.000¾ (II) 3, fJοο, ο 6 ΛΠ V. Description of the invention (20) n-propyl-1-[〔2 '-(N -trityl-tetrazole-5- Group) biphenyl-4-ylmethyl] -1 H-quinazol-5 -carboxylic acid ethyl physicochemical properties 1 H-NMR (CDC13): δ (ppm) 8. 86 (1 Η, s), 6. 7 2-7. 93 (23 Η, m), 6. 06 (1 Η, s), 5. 35 (2 Η, s) 4.11 (2 Η, dd), 2. 58 (2 Η , t), 2. 25 (2 Η, d), 1.91 (2 Η, d), 1.59-1. 8 4 (2 Η, m), 1. 1 7 (3 Η, t) , 0.89 (3 Η, t) mass spectrometry (FAB): m / z 7 5 6 (MH +) Example 3 η —

仿實施例1製得4 - ( Ν -甲氧乙醯基)胺基-2 -正丙基-i-〔〔2 ' - ( Ν -三苯甲基-四唑-5 -基)聯苯-4 -基〕甲基〕-1 Η -眯唑-5 -羧酸乙酯 理化學的性狀 苯甲基 先 閲 讀 背 而 之 意 事 項 孙 塡 % 本 頁 裝 線 經濟部屮央梂準局CX工消#合作杜印Μ 2 2- 本紙》尺度边用中β »家《準(CNS) 規怙(210X297公龙) 81. 7. 20,000^(11)4-(Ν -methoxyethoxy) amino-2 -n-propyl-i-[〔2 '-(Ν -trityl-tetrazol-5-yl) biphenyl was prepared by imitating Example 1 -4 -yl] methyl] -1 Η -Penazole-5 -ethyl carboxylate physicochemical properties benzyl first read the meaning of the matter Sun 塡%工 消 # Cooperation Du Yin Μ 2 2- This paper is used in the scale of β »home" quasi (CNS) regulations (210X297 male dragon) 81. 7. 20,000 ^ (11)

C 00 3ι, ··&gt;&gt; β ,ο Λπ 五、發明説明(21) ah-nmr (CDClg): δ (ppm) 6. 7 1 - 7. 94 (23 H, m), 5. 39 (2H, s). 4. 19 (2 H, d d) 4. 0 8 ( 2 H, s) , 3 · 51 (3 H, s ), 2. 6 0 (2 H, t ) , 1. 60 — 1. 79 (2 H, m), 1. 23 (3 H, t), 0. 88 (3H, t ) 質譜 (FAB) :m/z 7 4 6 (M H+) 實施例 4C 00 3ι, · &gt; β, ο Λπ 5. Description of the invention (21) ah-nmr (CDClg): δ (ppm) 6. 7 1-7. 94 (23 H, m), 5. 39 (2H, s). 4. 19 (2 H, dd) 4. 0 8 (2 H, s), 3.51 (3 H, s), 2. 6 0 (2 H, t), 1. 60 — 1. 79 (2 H, m), 1. 23 (3 H, t), 0.88 (3H, t) mass spectrometry (FAB): m / z 7 4 6 (M H +) Example 4

(請先閲讀背而之注意事項#構裒木頁) 裝- 線- 經濟部中央標準局CSC工消#合作杜印製 彷實施例1製得4 - ( N -乙氣草醯基)胺基-2 -正丙基-卜 〔〔2 1 - ( N -三苯甲基-四唑-5 -基)聯苯-4 -基]甲基〕-1 Η -眯唑-5 -羧酸乙酯 理化學的性狀 ^i-NMR (CDCI3): δ (ppm) 10. 45 C 1 Η, s), 6· 7 5 - 7. 9 0 (2 3 H, m) , 5. 41 (2 Η, s), 4. 4 2 (2 Η, q) , 4. 2 3 (2 Η, q), -2 3 - 本紙張尺度遑用中β國家楳準(CNS) T4規格(210X297公;¢) 81. 7. 20,000悵(Η) Γ, ο Λ 6 Β (; 五、發明説明ρ2) 2. 5 9 ( 2 H, t), 6 7 - 1. 7 3 ( 2 Η, m), 1 . 4 1 ( 3 Η, t ),1 . 0 . 2 9 ( 3 Η, t ) 質譜 (FAB) :m/z 實施例 5 29 (3 H, t: 7 7 4 (Μ Η+)(Please first read the back and attention matters # 建 裒 木 页) Installation-Line-Central Bureau of Economic Affairs CSC 工 消 # Cooperate with Du Yin to make imitation example 1 to prepare 4-(N-ethoxycaoyl) amine Yl-2 -n-propyl-bu [〔2 1-(N -trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1 Η-簯 azole-5 -carboxylic acid Physical and chemical properties of ethyl ester ^ i-NMR (CDCI3): δ (ppm) 10. 45 C 1 Η, s), 6.7 5-7. 9 0 (2 3 H, m), 5. 41 (2 Η, s), 4. 4 2 (2 Η, q), 4. 2 3 (2 Η, q), -2 3-The paper standard is used in the National Beta Standard (CNS) T4 specifications (210X297 public; ¢) 81. 7. 20,000 怅 (Η) Γ , ο Λ 6 Β (; 5. Description of invention ρ2) 2. 5 9 (2 H, t), 6 7-1. 7 3 (2 Η, m), 1. 4 1 (3 Η, t), 1.0. 2 9 (3 Η, t) mass spectrometry (FAB): m / z Example 5 29 (3 H, t: 7 7 4 (Μ Η +)

三苯甲基 仿實施例】製得4 - ( Ν -苯氣乙醯基)胺基-2 -正丙基-i -〔〔2'-(N-三苯甲基-四唑-5-基)聯苯-4-基]甲基〕 -1H-眯唑-5-羧酸乙酯 理化學的性狀 間 讀 背 而 之 it 意 事 項 % 木 頁一 裝 玎 線 經濟部中央櫺準局员工消#合作社印製 - NMR (C D C 1 3 ):δ (ppm) 9 · 9 9 ( 1 H, b r ), 6. 76-7. 89 (28 Η, m), 5. 39 (2 Η, s). 4· 67 ( 2 Η, s , b r ) , 4 . 16 ( 2 Η, q), 2. 6 0 (2 Η, t ) , 1. 68—1. 74 (2Η, m), 1 · 15 ( 3 Η, t ) , 0 . 8 9 ( 3 Η, t ) 質譜(FAB) : m/ z 8 0 8 (MH+ ) 實施例 6 -24 本紙Λ尺度遑用中_國家«毕(CNS)T4規格(210χ297ΑΑ) 81. 7. 20,000^ (II) 3 rl. 9nu_Example of trityl imitation] 4-(Ν-Benzene acetyl) amino-2-n-propyl-i-[〔2 '-(N-trityl-tetrazole-5- Group) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester physicochemical properties are read back and forth. It matters matters% wood page one decoration line staff of the Central Bureau of Economic Development of the Ministry of Economic Affairs Printed by Xiao # Cooperative Society-NMR (CDC 1 3): δ (ppm) 9 · 9 9 (1 H, br), 6. 76-7. 89 (28 Η, m), 5. 39 (2 Η, s ). 4.67 (2 Η, s, br), 4. 16 (2 Η, q), 2. 6 0 (2 Η, t), 1. 68-1. 74 (2Η, m), 1. 15 (3 Η, t), 0.8 9 (3 Η, t) Mass Spectrometry (FAB): m / z 8 0 8 (MH +) Example 6 -24 The paper Λ scale is used in China_Country «CN (CNS) T4 specification (210χ297ΑΑ) 81. 7. 20,000 ^ (II) 3 rl. 9nu_

An 五、發明説明(23)An 5. Description of the invention (23)

經濟部屮央標準局cx工消伢合作社印製 彷實施例1製得4-(N-苯丙烯醯胺基)-2-正丙基-1-〔 〔2'-(N -三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕-1H-眯唑-5 -羧酸乙酯 理化學的性狀 ^ - NMR (C D C 1 3 ): δ (ppm) 9. 0 6 - 9. 25 ( 1 H, br), 6. 45-7. 89 (30 H, m). 5. 3 8 (2 H, s), 4 . 20 ( 2 H, q) , 2. 5 7 ( 2 H, t ), 1. 74-1. 7 9 (2 H, m) , 1. 19 (3 H, t ), 0. 9 3 ( 3 H, t) 質譜(FAB) :m/z 804 (ΜΗ+) 實施例 ΊThe Ministry of Economic Affairs, Central Bureau of Standards, CX Industrial Consumer Cooperatives printed the imitation example 1 to prepare 4- (N-phenylacrylamino) -2-n-propyl-1- [[2 '-(N-tribenzone -Tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-ethyl carboxylate physical and chemical properties ^-NMR (CDC 1 3): δ (ppm) 9. 0 6-9. 25 (1 H, br), 6. 45-7. 89 (30 H, m). 5. 3 8 (2 H, s), 4. 20 (2 H, q), 2. 5 7 (2 H, t), 1. 74-1. 7 9 (2 H, m), 1. 19 (3 H, t), 0.9 3 (3 H, t) Mass Spectrometry (FAB): m / z 804 (ΜΗ +) Example Ί

本紙张尺度遑用中國國家楳毕(CNS) T4規格(210X297公4) 81. 7. 20,000¾ (II) Q ο £ Λιι 五、發明説明(24) 仿實施例1製得4 - ( H -亞環己基乙酷基)胺基-2 -正丙 基-1 -〔〔 2 1 - ( N -三苯甲基-四唑-5 -基)聯苯-.4 -基〕甲 基〕-1 Η -眯唑-5 -羧酸乙酯 理化學的性狀 ^-I-NMR (CDC13): δ (ppm) 8. 8 7 ( 1 H, s) , 6. 6 5 - 7. 9 3 (2 3 Η, m) 5. 8 5 - 6. 00 ( 1 Η, m). 5. 34 (2 Η, s ) 4. 15 (2 Η, d d) , 2. 81-3. 09 (2 Η, m) 2 . 5 7 ( 2 Η, t), 2 . 10-2. 35 ( 2 Η, m) 1. 48-1. 8 9 ( 6 Η, m) , 1 . 16 (3 Η, t ) ih 先 閲 背 而 之 意 事 項 % 本 1 0 . 質譜 實施例 8 9 (3 Η, t) (FAB) :m/z 7 9 6 (ΜΗ ΟThe size of this paper is based on the Chinese National Standard (CNS) T4 (210X297) 41.7. 20,000¾ (II) Q ο £ Λιι 5. Description of the invention (24) 4-(H- Cyclohexylethylidene) amino-2 -n-propyl-1-[[2 1-(N -trityl-tetrazol-5-yl) biphenyl-.4-yl] methyl]- 1 Physicochemical properties of Η- 篯 azole-5-ethyl carboxylate ^ -I-NMR (CDC13): δ (ppm) 8. 8 7 (1 H, s), 6. 6 5-7. 9 3 ( 2 3 Η, m) 5. 8 5-6. 00 (1 Η, m). 5. 34 (2 Η, s) 4. 15 (2 Η, dd), 2. 81-3. 09 (2 Η , m) 2. 5 7 (2 Η, t), 2. 10-2. 35 (2 Η, m) 1. 48-1. 8 9 (6 Η, m), 1. 16 (3 Η, t ) ih first read the meaning of the contrary% this 1 0. mass spectrometry example 8 9 (3 Η, t) (FAB): m / z 7 9 6 (ΜΗ Ο

苯甲基 N一N U)將4 -胺基-2-正丙基-卜〔〔2^(N-三苯甲基-四唑-5 -基)聯苯-4 -基〕甲基〕-1 Η -眯唑-5 -羧酸乙酷1 . 4 0克 溶在二氣甲烷1 5 m丨,而在室溫依序加三乙胺4 7丨】m g及4 -氛丁醯氣3 5 0 m g 在室溫攪拌1小時後,加水1 5 m 1來冼 經濟部中央棵準局A工消#合作社印3i 2 6 HI. 7. 20,000¾ (II) 本紙Λ尺度遑用中_ «家楳準(CNS) 規格(210X29V公*) IH) 五、發明説明(25) 經濟部中央找準^A工消费合作社印製 灌》有機層以硫酸鎂乾燥後,減壓蒸除溶劑。殘渣在矽 膠 柱 層析 (氣仿), 得 4 - ( 4 -氣丁· 基 )胺基-2 -正 丙基 -1 C C 2 '-( N -三 苯甲 基-四唑- 5 - •基)聯 苯-4 -基〕甲基〕 - -咪唑-5 - 羧酸 乙_ 1.17¾ , 泡 狀。 理 化 學的 性狀 1 Η -NMR (丨 C D C 1 3 ): &lt;5 ( ρ pm: 1 8. 9 1 (1 H, s ) , 6 . 7 0 - 1 8. 0 2 (2 3 Η. m), 5 . 3 7 (2 Η ,s ) , 4 • 14 (2 H, d d), 3 . 6 8 (2 Η, ,t) . 2. 1 3 - .2 .6 2 (6 Η, m), 1 . 5 8 - -1 . 8 5 (2 Η, m)( 1 .1 8 (3 Η, t), 0 . 8 7 (3 Η ,t ) 質 譜( FAB): m/ z 7 7 ! 9 (MH+) (b ) 將4- (4-氣丁醯基)胺基 -2 -正 丙 基-1 -C C 2 '-(N -二 苯 甲 基-四唑- .5 -基 )聯苯-4 - 基 〕甲基〕- 1 Η - B米唑-5 - 羧 酸 乙 酯1 · 17克 ,溶 在四氫呋 喃 1 0 IH 1 , 而在5 °C加 丁酯 鉀 18 5 m g。昇至室溫币 ί攪拌3小時後 &gt; 加甲 醇 2 m 1, 減壓蒸 除 溶 劑。 殘渣 在矽 膠柱層析 (氮仿 : 甲醇 = 10 0: 1 ), 得 4 - ( 2 -氣- 1 -吡 咯啶 基)-2 -正 丙 基- 1 - c r 2 ' - ( N - —-..._·» 甲 基 _四唑- 5 -基 )聯苯-4 -基〕 甲 基〕 - 1 Η - W ί 唑 _ 5 - 羧酸 乙 酯 750mg。 理化學的性狀 •*2 7·* 本紙ft尺度遑用中《Β家楳毕(CNS)Y4規tft(21〇X297公址) 81. 7. 20,000¾ (II) _ I? 6_ 五、發明説明(26) ^I-NMR (CDClg): δ (ppm) 6. 7 7 - 7. 9 4 (2 3 H, m) , 5. 4 3 (2 H, s) 4. 1 6 ( 2 H. d d) , 3. 89 (·2 H, t ), 2. 4 1-2. 60 ( 4 H, m), 2. 18-2. 28 ( 2 H, m), 1 . 5 3 - 1. 8 3 ( 2 H, m), 1 . 21 (3 H, t) , 0. 87 (3 H, t ) 質譜(FAB) : m/ z 7 4 2 (M H+) 實施例9 請 先 閲 ifi 背 而 之 注 意 事 項 再 m η 木Benzyl N-NU) 4-amino-2-n-propyl-Bu [〔2 ^ (N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl]- 1 Η-簯 azole-5 -carboxylic acid ethyl cool 1. 4 grams dissolved in two gas methane 15 m 丨, and at room temperature sequentially add triethylamine 4 7 丨] mg and 4-fenbutane gas 3 50 mg after stirring at room temperature for 1 hour, add water 1 5 m 1 to the Ministry of Economic Affairs Central Kezhun Bureau A Gongxiao # Cooperative Society Printing 3i 2 6 HI. 7. 20,000¾ (II) This paper is in use _ standard _ « CNS specifications (210X29V) *) IH) 5. Description of the invention (25) Central Ministry of Economic Affairs ^ A printed and irrigated ^ A industrial and consumer cooperative society. After the organic layer is dried with magnesium sulfate, the solvent is distilled off under reduced pressure. The residue was chromatographed on silica gel (gas imitation) to obtain 4-(4 -butanyl) amino-2 -n-propyl-1 CC 2 '-(N -trityl-tetrazole-5-• Group) biphenyl-4-yl] methyl]--imidazole-5-carboxylic acid ethyl _ 1.17¾, foam. Physical and chemical properties 1 Η -NMR (丨 CDC 1 3): &lt; 5 (ρ pm: 1 8. 9 1 (1 H, s), 6.7 0-1 8. 0 2 (2 3 Η. M ), 5. 3 7 (2 Η, s), 4 • 14 (2 H, dd), 3. 6 8 (2 Η,, t). 2. 1 3-.2 .6 2 (6 Η, m ), 1. 5 8--1. 8 5 (2 Η, m) (1.1 8 (3 Η, t), 0.8 7 (3 Η, t) Mass Spectrometry (FAB): m / z 7 7 ! 9 (MH +) (b) 4- (4-Gasobutylamino) amino-2 -n-propyl-1 -CC 2 '-(N -benzyl-tetrazole- .5-yl) biphenyl -4 -yl] methyl]-1 Η -B methazol-5 -carboxylate ethyl ester 1.17 g, dissolved in tetrahydrofuran 1 0 IH 1, and added potassium butyl ester 18 5 mg at 5 ° C. Increase to After stirring at room temperature for 3 hours> Add methanol 2 m 1 and evaporate the solvent under reduced pressure. The residue is chromatographed on a silica gel column (nitrogen: methanol = 10 0: 1) to obtain 4-(2 -gas-1- Pyrrolidinyl) -2 -n-propyl-1-cr 2 '-(N-—-..._ · »methyl_tetrazole-5 -yl) biphenyl-4 -yl] methyl]-1 Η-W ί azole_ 5-ethyl carboxylate 750mg. Physical and chemical properties • * 2 7 · * This paper ft遑 用 中 《B 家 戳 Bi (CNS) Y4 gauge tft (21〇X297 public address) 81. 7. 20,000¾ (II) _ I? 6_ V. Description of the invention (26) ^ I-NMR (CDClg): δ (ppm) 6. 7 7-7. 9 4 (2 3 H, m), 5. 4 3 (2 H, s) 4. 1 6 (2 H. dd), 3. 89 (· 2 H, t), 2. 4 1-2. 60 (4 H, m), 2. 18-2. 28 (2 H, m), 1. 5 3-1. 8 3 (2 H, m), 1. 21 (3 H, t), 0.87 (3 H, t) mass spectrometry (FAB): m / z 7 4 2 (M H +) Example 9 Please read ifi and then m η wood

苯甲基 經濟部屮央標準局A工消合作社印製 2 . 3 2-2 2 . 0 5-2 1 . 4 8-1 質譜(FAB) (a)仿實施例8之(a)處理,得4-(4 -氮丁醯基)胺基-5 氰基-2-正丙基-1-〔 -三苯甲基-四唑-5-基)聯 苯基]甲基〕-1H-眯唑。 理化學的性狀 1 Η - NMR (C D C 1 3 ): δ (ppm) 6. 7 8 - 8. 04 (23 H, m), 5. 05 ( 2 Η, s ) , 3 . 65 ( 2 Η, t ), 7 0 (4 Η, m), 3 1 ( 2 Η, m), 8 2 ( 2 Η, m) , 0. 8 7 ( 3 Η, t :m/ ζ 7 3 2 (Μ Η+) H___ 本紙張尺度遑用中鷗《家樣準(CNS)T4規格(2〗0χ297公A) 81. 7. 20,000^(11) ..X - G ο ΛΠ 五、發明説明(27) (b )仿實施例8之(b )處理,得5 -氣基-4 - ( 2 -氣-卜吡咯p$ 基)-2-正丙S-! -〔 〔2’-(N -三苯甲基-四唑-5-基)聯苯 基]甲基〕-1H-咪唑。 理化學的性狀 ^-NMR (CDClg): δ (ppm) 6 . 87 — 8. 02 (23 H, m), 5. 05 ( 2 Η, s ) , 3 . 97 ( 2 Η, t ), 2. 0 4 - 2. 72 ( 6 Η, m), 1· 47-1. 79 (2 Η, m) , 0. 87 (3 Η, t) 質譜(FAB) : m/ z 6 9 4 (MH+) 實施例 10 (請先閲-背而之注意苹項再碼忘本頁) nPrinted by the Industrial and Consumers Cooperative Society of the Central Standards Bureau of the Phenylmethyl Ministry of Economics 2. 3 2-2 2. 0 5-2 1. 4 8-1 Mass Spectrometry (FAB) (a) Processed as in Example 8 (a), 4- (4-Azetyl) amino-5 cyano-2-n-propyl-1-[-trityl-tetrazol-5-yl) biphenyl] methyl] -1H-quinazole . Physical and chemical properties 1 Η-NMR (CDC 1 3): δ (ppm) 6. 7 8-8. 04 (23 H, m), 5. 05 (2 Η, s), 3.65 (2 Η, t), 7 0 (4 Η, m), 3 1 (2 Η, m), 8 2 (2 Η, m), 0.8 7 (3 Η, t: m / ζ 7 3 2 (Μ Η + ) H___ This paper uses Zhongou's "CNS" T4 specification (2〗 0χ297 Gong A) 81. 7. 20,000 ^ (11) .. X-G ο ΛΠ V. Description of invention (27) (b ) Imitate the treatment of Example 8 (b) to obtain 5-amino-4-(2 -air-pyrrole p $ yl) -2-n-propyl S-!-[〔2 ′-(N -tribenzone -Tetrazol-5-yl) biphenyl] methyl] -1H-imidazole. Physical and chemical properties ^ -NMR (CDClg): δ (ppm) 6.87 — 8.02 (23 H, m), 5. 05 (2 Η, s), 3. 97 (2 Η, t), 2. 0 4-2. 72 (6 Η, m), 1.47-1.79 (2 Η, m), 0 . 87 (3 Η, t) mass spectrometry (FAB): m / z 6 9 4 (MH +) Example 10 (please read first-pay attention to the terms and forget the page) n

經濟部屮央櫺準局ΕΧ工消许合作杜印製 (a )將實施例8之(a )處理,得4 -〔 N - (5 -氮戊醯基〕胺 基〕-2 -正丙基-卜〔〔2 ’ - ( N -三苯甲基-四唑-Γ)-基)聯 苯-4 -基〕甲基〕-〖Η -眯唑-5 -羧酸乙酯。 理化學的性狀 本紙張尺度遑用中國β家櫺準(CNS)T4規怙(210x297公龙) HI. 7. 20,00()ife (II) 2〇如-'The Ministry of Economic Affairs, Ministry of Economic Affairs, Central Bureau of Examination and Cooperation permits the cooperation of Du Printing (a) to process Example 8 (a) to obtain 4-[N-(5-nitropentyl) amino] -2-n-propyl Yl-bu [[2 '-(N-trityl-tetrazole-Γ) -yl) biphenyl-4-yl] methyl]-〖Η- 眯 azole-5-carboxylic acid ethyl ester. Physical and chemical properties This paper uses the Chinese beta family standard (CNS) T4 regulation (210x297 male dragon) HI. 7. 20,00 () ife (II) 2〇 如-'

Λ G It G 五、發明説明(2ϋ) H-NMR (CDC13): δ (ppm) 6· 76-7. 9 0 ( 2 3 Η, m) , 5. 36 (2 Η, s ), 4· 18 ( 2 Η, q) , 3. 5 6 — 3. 59 ( 2 Η, m), 2 . 5 4 - 2. 58 ( 2 Η, b r ), 1 . 6 7-1. 91 (8 Η, m), 8 (3 Η, t) , 0 0 ( 3 Η, t) 質譜(FAB) : τη/ ζ 7 9 2 (Μ Η+) (b)仿實施例8之(b)處理,得4-(2 -氧-1-哌啶基)-2-正丙基-1-〔 〔2’-(Ν-三苯甲基-四唑-5-基)聯苯-4-基 甲基〕-1Η-咪唑-5-羧酸乙酯。 理化學的性狀 ^-NMR (CDCI3): δ (ppm) 6. 8 0 - 7. 90 (2 3 H, m) , 5. 45 (2Η, s), 4. 16 (2 Η, q) , 3 . 6 7 - 3. 7 0 (2 Η, m), 2 · 4 6 - 2.5 4 ( 4 Η, m), 9 2 — 1. 9 6 ( 4 Η, m, b r ), ] 先 閲 in 背 而 之 注 意 事 項 填 % 本一 頁 裝 π 經濟部屮央梂準局貝工消许合作社印製 1 ΙΑ 譜例 質施 實 Β 4 α 2 F 1 V „ 1 • Η ) ζ t \ m m b 8 Η Η ο Η t 7 Η Μ 本紙張尺度遑用中* »家標準(CNS) f 4規格(210父297公:《:)Λ G It G 5. Description of the invention (2ϋ) H-NMR (CDC13): δ (ppm) 6.76-7.90 (2 3 Η, m), 5. 36 (2 Η, s), 4. 18 (2 Η, q), 3. 5 6 — 3.59 (2 Η, m), 2.5 5 4-2. 58 (2 Η, br), 1.6 7-1. 91 (8 Η, m), 8 (3 Η, t), 0 0 (3 Η, t) Mass Spectrometry (FAB): τη / ζ 7 9 2 (Μ Η +) (b) Following the treatment of Example 8 (b), we get 4 -(2-oxo-1-piperidinyl) -2-n-propyl-1- [[2 '-(Ν-trityl-tetrazol-5-yl) biphenyl-4-ylmethyl] -1Η-imidazole-5-carboxylic acid ethyl ester. Physical and Chemical Properties ^ -NMR (CDCI3): δ (ppm) 6. 8 0-7. 90 (2 3 H, m), 5. 45 (2Η, s), 4. 16 (2 Η, q), 3. 6 7-3. 7 0 (2 Η, m), 2 · 4 6-2.5 4 (4 Η, m), 9 2 — 1. 9 6 (4 Η, m, br),] Read first in Contrary to note, fill in this page. This page contains π Printed by the Ministry of Economic Affairs, the Central Bureau of Industry and Economics, the Beigong Consumers ’Cooperative Society 1 ΙΑ Spectral Example B 4 α 2 F 1 V„ 1 • Η) ζ t \ mmb 8 Η Η ο Η t 7 Η Μ This paper standard is in use * »Home Standard (CNS) f 4 specifications (210 father 297 male:" :)

Bl. 7. 20,000i|c(ll) i 3 ο Γα 6 G Λ: 五、發明説明(2¾ ηBl. 7. 20,000i | c (ll) i 3 ο Γα 6 G Λ: 5. Description of the invention (2¾ η

經濟部中央橾準局员工消伢合作社印5i (a)仿實施例8之(a)處理,得4-〔Ν-(3 -氣-2, 2 -二甲 基-丙醯基)胺基〕-2 -正丙基- l-〔 〔2'-(N -三苯甲基-四唑-5 -基)聯苯-4-基〕甲基]-1H-眯唑-5 -錢酸乙酯。 理化學的性狀 ^-NMRCCDC^):δ (ppm) 9. 51 ( 1 H( s) , 6. 7 4 - 7. 90 (2 3 Η, m), 5. 3 4 (2 Η, s), 4. 17 (2 Η, q), 3. 74 (2 Η, s), 2. 60 (2 Η, t ), 1. 6 5 - 1. 7 6 (2 Η, m) , 1. 43 (6 Η, s), 1. 49 ( 3 Η, t ) , 0 . 88 ( 3 Η, t ) 質譜(FAB) :m/z 7 9 2, 7 9 3 (MH+) (b )仿實施例8之(b )處理,得4 - ( 3 , 3 -二甲基2 -氣-1 -吖丁啶基-2-正丙基-1-〔 〔 2'-(Ν -三苯甲基-四唑-5-基 )聯苯-4-基〕甲基〕-1Η -眯唑-5-羧酸乙酯。 理化$的性狀. -:i 1 - (請先閲請背而之注意事項#塡艿本頁} 裝- 線- 本紙Λ尺度遑用中家«準(CNS) T4規格(210X297公址) 81. 7. 20,000張(II) 五、發明説明(j0) lH-NMR (CDClg): δ (ppm) 6. 7 8 - 7. 91 ( 2 3 H, m) , 5. 42 (2 Η, s) 4. 19 ( 2 Η, q) , 3 . 6 7 ( 2 Η, s ), 1 . 6 0 - 1. 6 6 ( 2 Η, m) 1 . 2 3 ( 2 Η, t ), 2 . 5 1 ( 2 Η, t ) 1 . 4 3 ( 6 Η, s ) 0 . 8 7 ( 3 Η, t ) 質譜(FAB) : m/ z 實施例1 2 7 5 6 (Μ H+) η - PrThe Ministry of Economic Affairs, Central Bureau of Accreditation and Employee Consumer Cooperatives printed 5i (a) as in Example 8 (a), to obtain 4- [Ν- (3-gas-2,2-dimethyl-propionyl) amino 〕 -2 -n-propyl-1-(〔2 '-(N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-chanoic acid Ethyl ester. Physical and chemical properties ^ -NMRCCDC ^): δ (ppm) 9. 51 (1 H (s), 6. 7 4-7. 90 (2 3 Η, m), 5. 3 4 (2 Η, s) , 4. 17 (2 Η, q), 3. 74 (2 Η, s), 2. 60 (2 Η, t), 1. 6 5-1. 7 6 (2 Η, m), 1. 43 (6 Η, s), 1.49 (3 Η, t), 0.88 (3 Η, t) Mass spectrometry (FAB): m / z 7 9 2, 7 9 3 (MH +) (b) Example 8 (b) treatment, to obtain 4- (3,3-dimethyl-2-gas-1-acridinyl-2-n-propyl-1- [〔2 '-(Ν-trityl-tetrazole -5-yl) biphenyl-4-yl] methyl] -1Η-benzoxazole-5-carboxylic acid ethyl ester. Physical and chemical properties of $.-: I 1-(please read the notes on the back # 塡This page} Install-Line-This paper uses standard «quasi (CNS) T4 specifications (210X297 public address) 81. 7. 20,000 sheets (II) V. Description of invention (j0) lH-NMR (CDClg): δ (ppm) 6. 7 8-7. 91 (2 3 H, m), 5. 42 (2 Η, s) 4. 19 (2 Η, q), 3. 6 7 (2 Η, s), 1. 6 0-1. 6 6 (2 Η, m) 1. 2 3 (2 Η, t), 2.5 1 (2 Η, t) 1. 4 3 (6 Η, s) 0. 8 7 (3 Η, t) mass spectrometry (FAB): m / z Example 1 2 7 5 6 (Μ H +) η-Pr

三苯甲基 (請先間讀背而之注意身項洱项艿^.&gt;,) 裝· '1T_ 線- 經濟部中央標準局IS:工消费合作社印製 將4-〔 (2 -甲基丙烯醯基)胺基〕-2 -正丙基-1-〔 〔2'-(N -三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕-1H-昧唑-5-羧酸乙酯260mg溶在二甲基甲醯胺5ml,而在冰 冷下加N a Η 1 5 m g。攪拌2 ϋ分後,加溴化甲基55m g。昇至 室溫而邋拌一夜後,減壓蒸發。殘渣溶在氣仿1 0 m 1 ,而 以水及飽和食鹽水洗灌後,減壓蒸除溶劑。殘渣在矽膠 柱析(氮仿:甲醇=100: 1),得4-〔N -甲基-N-(2 -甲基丙 稀醯基)胺基〕-2-正丙基- l-〔 三苯甲基-四唑 -32- 本紙張尺度遑用中困《家楳準(CNS) 1Μ規怙(210x297公:it) 81. 7. 20,000¾^ (II) Λ β Π 6 五、發明説明(31) -5 -基)聯苯-4-基〕甲基〕-1H -眯睡-5-錢酸乙酯 140mg ,泡狀。 理化學的性狀 ^I-NMR (CDC13): δ (ppm) 6 . 6 5 — 7. 93 ( 2 3 Η, m), 5. 45 (2 Η, s ) . 4. 9 6-5. 11 ( 2 Η, m), 4. 17 (2 Η, d d) , 3. 2 7 (3 Η, s ), 2 . 4 8 (2 Η, t),1. 8 1 ( 3 Η, s), 1. 50-1. 72 (2 Η, m), 1. 2 6 (3 Η, t), 〇. 8 5 (3 Η. t) 質譜(F ΑΒ) : m/z 7 5 6 (ΜΗ+) 實施例 13 (請先閲讀背而之注意序項#项艿一 K)Trityl (please read back and pay attention to the item er item ^. &Gt;,) installed · '1T_ line-Central Bureau of Standards of the Ministry of Economic Affairs IS: printed by the industrial and consumer cooperatives will 4- ((2-A Propenyl acetyl) amino] -2 -n-propyl-1- [[2 '-(N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H- 260 mg of ethyl amidazole-5-carboxylate was dissolved in 5 ml of dimethylformamide, and Na 5 mg was added under ice cooling. After stirring for 2 minutes, 55 mg of methyl bromide was added. After warming to room temperature and stirring overnight, it was evaporated under reduced pressure. The residue was dissolved in gaseous 10 m 1, and after washing with water and saturated saline, the solvent was distilled off under reduced pressure. The residue was analyzed on a silica gel column (nitroform: methanol = 100: 1) to obtain 4- [N-methyl-N- (2-methylacryl) amino] -2-n-propyl-l- [ Trityl-tetrazole-32- This paper is not suitable for use on the paper, "Mexican Standard (CNS) 1M Standard (210x297 g: it) 81. 7. 20,000¾ ^ (II) Λ β Π 6 V. Invention Description (31) -5 -yl) biphenyl-4-yl] methyl] -1H-squint-5-ethyl hexanoate 140mg, foamy. Physical and chemical properties ^ I-NMR (CDC13): δ (ppm) 6. 6 5-7. 93 (2 3 Η, m), 5. 45 (2 Η, s). 4. 9 6-5. 11 (2 Η, m), 4. 17 (2 Η, dd), 3. 2 7 (3 Η, s), 2. 4 8 (2 Η, t), 1.8 1 (3 Η, s), 1. 50-1. 72 (2 Η, m), 1. 2 6 (3 Η, t), 0.8 5 (3 Η. T) mass spectrometry (F ΑΒ): m / z 7 5 6 (ΜΗ + ) Example 13 (please read back to note the sequence item # 项 艿 一 K)

經濟部中央梂準局β工消t合作杜印9i 仿基苯化 胺聯理 例 施 實 fmi 理 處 5 2 丙 基基 甲 正 3 2 基 狀 性 的 學 得 唑 咪 3 3 基} 醯基 嫌5-- 丁 基 甲 3-基酯 I 甲乙 -Ν苯酸 基三羧 甲 Ν 5 唑 四 m. 7. 'iOMmk (ii) 本紙張尺度遑用中a Η家«毕(CN5)f 4規格(210X297公放} 〇 A 6 Π 6 五、發明説明(32) ^-NMR (CDClg): δ (ppm) 6. 70 — 7. 90 ( 2 3 H, m) , 5 . 4 8 ( 3 H, s ) 4. 13 ( 2 H, d d ) , 3 · 24 ( 2 H, s ), 2 . 51 ( 2 H, t ) , 2. 06 (3 H, d), 1. 65 (3 H, d) , 1. 4 1-1. 82 (2 H, m) 1. 23 ( 3 H, t), 0. 95 ( 3 H, t ) 質譜(FAB) : m/ z 7 7 0 (MH+) 實施例1 4 (請先閲讀背而之注意^項洱项究^The Ministry of Economic Affairs, Central Bureau of Industry and Commerce, β-work, t-cooperation, Du Yin 9i, imitation-based benzylamine synergistic example, implementation of fmi treatment, 5 2 propylmethyl-methyl 3 2 morphological study, zomidazole 3 3 yl} amide 5-butyl butyl methyl 3-yl ester I methylethyl-N benzoic acid tricarboxymethyl N 5 azole tetram. 7. 'iOMmk (ii) This paper is used in a Η home «bi (CN5) f 4 specifications ( 210X297 public release} 〇A 6 Π 6 V. Description of the invention (32) ^ -NMR (CDClg): δ (ppm) 6. 70 — 7. 90 (2 3 H, m), 5. 4 8 (3 H, s) 4. 13 (2 H, dd), 3.24 (2 H, s), 2.51 (2 H, t), 2. 06 (3 H, d), 1. 65 (3 H, d ), 1. 4 1-1. 82 (2 H, m) 1. 23 (3 H, t), 0.95 (3 H, t) Mass Spectrometry (FAB): m / z 7 7 0 (MH +) Implementation Example 1 4 (please read the note ^ Xiang Er Xiang Research ^

MeMe

三苯甲基 裝. 訂_ 線, 經濟部屮央標準局β工消费合作社印製 仿實施例12處理,得4-(N -甲氧乙醯基-l-甲胺基)-2-正丙基-1-〔 〔2'-(N -三苯甲基-四唑-5-基)聯苯-4-基〕 甲基]-1 H-眯唑-5-羧酸乙酯。 理化學的性狀 ^i-NMR (CDClg): δ (ppm) 6. 7 0 - 7. 9 2 (2 3 H, m) , 5. 49 (2Η, s), 4. 19 (2 Η, d d) . 3. 9 0 (2 Η. s), -34- 本紙張尺度遑用中國國家標準(CNS) 1Μ規格(210x297公;《:)Trityl. Order _ line, imitation example 12 printed by the β-consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, to obtain 4- (N-methoxyethoxyl-l-methylamino) -2-positive Propyl-1- [[2 '-(N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1 H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties ^ i-NMR (CDClg): δ (ppm) 6. 7 0-7. 9 2 (2 3 H, m), 5. 49 (2Η, s), 4. 19 (2 Η, dd ). 3. 9 0 (2 Η. S), -34- This paper standard uses the Chinese National Standard (CNS) 1Μ specification (210x297 g; ":")

Hi. 7. 20,001)¾ (II) J- ό A 6 Π 6 五、發明説明(33) 3. 34 (3 H, s ) , 3 . 23 ( 3 Η, s ), 2. 52 (2 Η, t ) , 1. 5 8 — 1. 85 ( 2 Η, m) 1. 23 (3 Η, t ) , 0 . 88 (3 Η, t) 質譜(FAB) *:m/z 760 (ΜΗ+) 實施例15Hi. 7. 20,001) ¾ (II) J- ό A 6 Π 6 5. Description of the invention (33) 3. 34 (3 H, s), 3.23 (3 Η, s), 2. 52 (2 Η , t), 1. 5 8 — 1. 85 (2 Η, m) 1. 23 (3 Η, t), 0.88 (3 Η, t) mass spectrometry (FAB) *: m / z 760 (ΜΗ + ) Example 15

MeMe

苯甲基 (請先閲讀背而之注意卞.項再填_ 裝. 經濟部中央橾準扃β工消伢合作杜印3i 仿實施例12處理,得4-(N -乙草醯基-N-甲胺基)-2 -正 丙基-卜〔〔2’-(N -三苯甲基-四唑-5-基)聯苯-4-基〕 甲基〕-1H -眯唑-5-羧酸乙酯。 理化學的性狀^-NMR (CDC13): δ (ppm) 6· 7 4 - 7. 9 0 (2 3 Η, m) , 5. 44 (2 Η, s), 4. 21 (2 Η, q) , 4. 17 (2 Η, q), 3. 32 ( 3 Η, s ) , 2. 50 ( 2 Η. t ), 1 · 6 6-1. 71 (2 Η, m) , 1. 28 (3 Η, t ), 1 . 0 8 ( 3 Η, t ) , 0 . 8 7 ( 3 Η, t ) 質譜(FAB) :m/z 7 8 8 (MH+) 3 5- 本紙诔尺度遑用中«家楳準(CNS)T4規格(210X297公; 81. 7. 2(),(则伥(N) 線. ..3 Λ 6 η 6 五、發明説明(]4) 實施例 1 6Benzyl group (please read the note beforehand. Fill in the item _ pack. The central government of the Ministry of Economic Affairs β work consumer cooperation Du Yin 3i imitated in Example 12 processing, to obtain 4- (N-acetoacetyl- N-methylamino) -2 -n-propyl-bu [〔2 '-(N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol- 5-Carboxylic acid ethyl ester Physical and chemical properties ^ -NMR (CDC13): δ (ppm) 6 · 7 4-7. 9 0 (2 3 Η, m), 5. 44 (2 Η, s), 4 . 21 (2 Η, q), 4. 17 (2 Η, q), 3. 32 (3 Η, s), 2. 50 (2 Η. T), 1. 6 6-1. 71 (2 Η , m), 1. 28 (3 Η, t), 1.0 8 (3 Η, t), 0.8 7 (3 Η, t) mass spectrometry (FAB): m / z 7 8 8 (MH +) 3 5- This paper is used in the standard of 戳 楳 擳 (CNS) T4 specifications (210X297 male; 81. 7. 2 (), (the line (N) line ... 3 Λ 6 η 6 V. Description of invention () 4) Example 1 6

MeMe

仿實施例12處理,得4-〔 N -甲基-N-(苯氧乙醯基)胺 基〕-2 -正丙基- l-〔 〔2’-(M -三苯甲基-四唑-5-基)聯 苯-4-基〕甲基]-1H -咪唑-5 -羧酸乙酯。 (請先閲請背而之注意卞.項再塥耔^ 裝· 經濟部中央標準局只工消伢合作杜印製 理化學的性狀 - NMR (C D C 1 3 ): (5 (ppm) 6. 77-7. 91 (28 H, m), 5. 4 7 (2 H, s), 4· 5 3 ( 2 Η, s), 4. 12 (2 Η, q) 3. 2 6 ( 3 Η, s ) , 2. 51 ( 2 Η, t ) 1. 6 7 - 1. 7 2 ( 2 Η, m) , 1. 2 1 (3Η, t), Ο · 8 9 ( 3 Η, t ) 質譜(FAB) :m/z 8 2 2 (Μ H+) -36- 本紙張尺度逡+ 家4*準(CNS)f4規格(210X297公tf) HI. 7. 2(),000¾ (II) 線- Λ 6η 6 五、發明説明(35) 實施例1 7Following the treatment of Example 12, 4- [N-methyl-N- (phenoxyethanoyl) amino] -2-n-propyl-1-([2 '-(M-trityl-tetra Azole-5-yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester. (Please read the note to the back first. Xiang Zaicheng. ^ Installation · Central Bureau of Standards of the Ministry of Economic Affairs only cooperates with the consumer to print the properties of physical and chemical cooperation-NMR (CDC 1 3): (5 (ppm) 6. 77-7. 91 (28 H, m), 5. 4 7 (2 H, s), 4.55 3 (2 Η, s), 4. 12 (2 Η, q) 3. 2 6 (3 Η , s), 2. 51 (2 Η, t) 1. 6 7-1. 7 2 (2 Η, m), 1. 2 1 (3Η, t), Ο · 8 9 (3 Η, t) (FAB): m / z 8 2 2 (Μ H +) -36- The size of the paper + home 4 * standard (CNS) f4 specifications (210X297 male tf) HI. 7. 2 (), 000¾ (II) line- Λ 6η 6 V. Description of the invention (35) Example 1 7

MeMe

- 彷實施例12處理,得4-(N -苯丙烯醯基-N-甲胺基&gt;-2-正丙基-1-〔 〔 2'-(N-三苯甲基-四唑-5-基)聯苯-4-基〕 甲基〕-1H-咪脞-5-羧酸乙酯。 理化學的性狀 ^-NMR (CDC13): δ (ppm) 裝- 線· 經濟部屮央榣準局CX工消件合作杜印^ 6. 3 7-7. 9 4(3 OH, m) ,5. 50 (2 Η, S ) 4 · 1 3 (2 H, q), 3 . 3 4(3 Η, s), 2 . 5 6 (2 H, t ), 1 . 7 1 - 1 . 7 7 (2 Η, m) 1 . 2 0 (3 Η, t ). 0 . 9 1(3 Η, t ) 譜 (FAB) :να/ ζ 8 1 7, 8 1 8 (ΜΙ-Ι+) -37- HI. 7. 2(1,00(1¾ (Η) 本紙張尺度遑用中《國家«毕(CNS) Ή規怙(210X297公;it) Λ 6 η 6 五、發明説明(π) 實施例1 8-Following the treatment of Example 12, 4- (N-phenylacryloyl-N-methylamino) &gt; -2-n-propyl-1- [[2 '-(N-trityl-tetrazole- 5-yl) biphenyl-4-yl] methyl] -1H-imidazol-5-carboxylic acid ethyl ester. Physical and chemical properties ^ -NMR (CDC13): δ (ppm) Packing-Line · Ministry of Economic Affairs The cooperation between CX, CX, C & I and DuPont ^ 6. 3 7-7. 9 4 (3 OH, m), 5.50 (2 Η, S) 4 · 1 3 (2 H, q), 3.3 4 (3 Η, s), 2. 5 6 (2 H, t), 1. 7 1-1. 7 7 (2 Η, m) 1. 2 0 (3 Η, t). 0. 9 1 ( 3 Η, t) Spectrum (FAB): να / ζ 8 1 7, 8 1 8 (ΜΙ-Ι +) -37- HI. 7. 2 (1,00 (1¾ (Η) This paper scale is used in the " National «Bi (CNS) Ή Regulations (210X297; it) Λ 6 η 6 V. Description of the invention (π) Example 1 8

苯甲基 仿實施例12處理,得4-(Ν -環己叉乙醯基-Ν-甲胺基) -2 -正丙基-1-〔 〔2'-(Ν -三苯甲基-四唑-5-基)聯苯-4 基]甲基〕-1H-眯脞-5-羧酸乙酯。 理化學的性狀 1 Η - NMR (C D C 1 3 ): δ (ppm) 6. 7 0 - 7. 9 6 (2 3 H, m) , 5. 47 (2 Η, s) 5. 4 2 - 5. 4 3 ( 1 Η, m) r 4. 15 (2 Η, d d) 3. 2 4 (3 H, s) , 2. 5 3 - 2. 7 8 (2 H, m) 2. 50 ( 2 Η, t ) , 1. 8 9 — 2. 0 8 ( 2 Η, m) 裝- 線. 經濟部中央樑準局工消费合作杜印5i 1 ο 譜 質The benzyl imitation example 12 was treated to obtain 4- (Ν-cyclohexylidene-acetyl-N-methylamino) -2-n-propyl-1- [[2 '-(Ν-trityl- Tetrazol-5-yl) biphenyl-4yl] methyl] -1H-squint-5-carboxylic acid ethyl ester. Physical and chemical properties 1 Η-NMR (CDC 1 3): δ (ppm) 6. 7 0-7. 9 6 (2 3 H, m), 5. 47 (2 Η, s) 5. 4 2-5 . 4 3 (1 Η, m) r 4. 15 (2 Η, dd) 3. 2 4 (3 H, s), 2. 5 3-2. 7 8 (2 H, m) 2. 50 (2 Η, t), 1. 8 9 — 2. 0 8 (2 Η, m) installed-line. The Ministry of Economic Affairs Central Liangzhun Bureau Industrial and Consumer Cooperation Du Yin 5i 1 ο Spectrum quality

i Β 8 7α 3 8 F Λ—/ m Η’ 6 r\ ο 6 4 2 Η 3 Η 3 Η Μ /ι\ 6 9 7 ζ 8 3 81. 7. 20,000^(11) 本紙張尺度逍用中明《家楳準(CNS) T4規格(210X297公; 五、發明説明(37)i Β 8 7α 3 8 F Λ— / m Η '6 r \ ο 6 4 2 Η 3 Η 3 Η Μ / ι \ 6 9 7 ζ 8 3 81. 7. 20,000 ^ (11) The paper size is in use Ming Dynasty Standard "CNS" T4 (210X297); 5. Description of the invention (37)

經濟部屮央標準局只工消t合作社印51 將 4- C N- (2 -甲基 丙烯醯基)胺基〕-2 -正丙基 -1 _ [ 21 - (N-三 苯 甲 基-四 脞-5 - 基 )聯 苯 -4 -基 ]甲基〕 眯唑- -羧酸乙酯250 m g在5 %乙酸乙醇 混 液 1 ϋιη 1以外溫 9 0 °C 拌4 小時 後 » 減壓蒸除溶 劑 。殘渣在矽 膠柱層析(氣仿 :甲 醇= 2 0: 1 ),從乙腈 再 結晶, 得4- C N - ( 2 ~ 甲基丙 烯醯 基)胺基] -2-正丙基 -1 [ 2 -(四 唑-5-基 )聯苯- -基〕 甲基〕 - 1 H-眯 唑-5 - 羧 酸乙醋8 5 m g ,白色結晶。 理化 學的 性 狀 Hi- NMR (C D C 1 3 ): δ ( p P m) 9 . 6 2 (1 H, s ), 7 9 1 (1 Η, d), 7 . 5 5 (1 H, t), 7 4 9 (1 Η, t ), 7 . 3 6 (1 H, d), 7 1 2 (1 Η, d), 6 . 9 2 (1 H, d), 5 9 1 (1 Η, s ), 5 . 5 3 (1 H, s ), 5 5 0 (2 Η, S ), 4 . 2 8 (2 H, d d ) t 2 . 7 3 (2 Η, t ), -39- 裝· 訂' 線. 本紙5良尺度遑用中《圃家樣毕(CHS)〒4規格(2丨0X297公it) 81. 7. ^(Jf00(h'k (II) A 6 Π 6 五、發明説明(38) 2 . 0 0 (3 Η, S ), 1.60 —1 . 6 9( 2 H, 1 . 2 3 (3 Η, t), 0.9 1 (3 H, t ) 質譜(F A Β ) : m / ζ 5 0 0 (MH 熔點:1 3 3 -1 3 6 °C 元素分析値 (C 27H29 N7 °c I * 〇· 2 H2 0 ) C (°/〇) H (°/〇) N (°/〇) 計算値 6 4 , .45 5 . 8 9 19. 4 9 實測値 6 4 . 27 5 . 8 6 19. 4 7 實施例 2 0The Ministry of Economic Affairs's Bureau of Standards and Standards only works to eliminate 51 cooperatives. The 4-C N- (2-methacryloyl) amino group] -2 -n-propyl-1 _ [21-(N-trityl -Tetrazol-5-yl) biphenyl-4-yl] methyl] benzozole- -carboxylic acid ethyl ester 250 mg in 5% acetic acid-ethanol mixture 1 ϋιη 1 after mixing at an external temperature of 9 0 ° C for 4 hours »Reduced pressure Distill off the solvent. The residue was chromatographed on a silica gel column (aeroform: methanol = 2 0: 1) and recrystallized from acetonitrile to obtain 4- CN-(2 ~ methacryloyl) amino] -2-n-propyl-1 [2 -(Tetrazol-5-yl) biphenyl- -yl] methyl]-1 H-quinazol-5-carboxylic acid ethyl ester 85 mg, white crystals. Physical and chemical properties Hi-NMR (CDC 1 3): δ (p P m) 9.6 2 (1 H, s), 7 9 1 (1 Η, d), 7.5 5 (1 H, t) , 7 4 9 (1 Η, t), 7.3 6 (1 H, d), 7 1 2 (1 Η, d), 6.9 2 (1 H, d), 5 9 1 (1 Η, s), 5. 5 3 (1 H, s), 5 5 0 (2 Η, S), 4 2 8 (2 H, dd) t 2. 7 3 (2 Η, t), -39- · Set the line. The 5 good scales of this paper are used in "Public Samples (CHS) 〒 4 specifications (2 丨 0X297 public it) 81. 7. ^ (Jf00 (h'k (II) A 6 Π 6 5. Description of the invention (38) 2. 0 0 (3 Η, S), 1.60 — 1. 6 9 (2 H, 1.2 3 (3 Η, t), 0.9 1 (3 H, t) mass spectrometry (FA Β) : m / ζ 5 0 0 (MH melting point: 1 3 3 -1 3 6 ° C elemental analysis value (C 27H29 N7 ° c I * 〇 · 2 H2 0) C (° / 〇) H (° / 〇) N (° / 〇) Calculated value 6 4, .45 5. 8 9 19. 4 9 Measured value 6 4. 27 5. 8 6 19. 4 7 Example 2 0

Me 'MeMe 'Me

Η 仿實施例19處理,得4-〔 Ν -甲基- Μ- (3 -甲基丁烯醯基) 胺基〕-2-正丙基-卜〔〔2’-(四唑-5-基)聯苯-4-基〕甲 基〕-1H-咪唑-5-羧酸乙酯。 (諳先間讀背而之注意笊項洱项寫^ 裝&lt; 訂_ 線. 經濟部中央標準局A工消t合作杜印製 理化學的性狀 ^-NMR (CDClg):5 (ppm) 8. 0 2 ( 1 H, d) , 7. 5 9 ( 1 H, t ), 7. 5 3 (1 H, t) , 7. 4 0 (1 H, d), -4 ϋ - K紙ift尺度遑用中a S家楳率(CNS) Ή規格(210 &gt;: 297公;Μ:) HI. 7. 20,()()0ik (II) Λ 6 H 6 5 2 8 (ΜΗ+) 五、發明説明(39) 7 · 18 (2H, d). 6 . 9 7 (2 H, d), 5· 5 9 ( 2 Η, s ) , 5 . 4 2 ( 1 Η, s ). 4· 17 (2 Η, d d) , 3. 14 (3 Η, s ) 2. 65 ( 2 Η, t ) , 2. 〇 〇 ( 3 Η, s ) 1. 72-1. 78 (2Η, m), 1. 62 (3 Η, s), 1. 2 4 (3 Η. t ), Ο . 9 6 ( 3 Η, t ) 質譜(FAB) : m/ ζ 實施例 2 1 (請先閲讀背而之注意冰項再项i K) η — PrΗ Treated in Example 19 to give 4- [Ν-methyl-Μ- (3-methylbutenyl) amino] -2-n-propyl-Bu [[2 '-(tetrazole-5- Group) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester. (Be familiar with the first reading and pay attention to the writing of the erroneous item ^ Pack &lt; Order _ line. The Central Standards Bureau of the Ministry of Economic Affairs A industrial consumption t cooperation to print the physical and chemical properties of ^ -NMR (CDClg): 5 (ppm) 8. 0 2 (1 H, d), 7. 5 9 (1 H, t), 7. 5 3 (1 H, t), 7. 4 0 (1 H, d), -4 ϋ-K paper Ift scale is used, the median a S family rate (CNS) Ή specification (210 &gt;: 297 g; Μ :) HI. 7. 20, () () 0ik (II) Λ 6 H 6 5 2 8 (ΜΗ + ) 5. Description of the invention (39) 7.18 (2H, d). 6.9 7 (2H, d), 5.59 (2 Η, s), 5.4 2 (1 Η, s). 4.17 (2 Η, dd), 3. 14 (3 Η, s) 2. 65 (2 Η, t), 2. 〇〇 (3 Η, s) 1. 72-1. 78 (2Η, m ), 1. 62 (3 Η, s), 1. 2 4 (3 Η. T), Ο. 9 6 (3 Η, t) mass spectrometry (FAB): m / ζ Example 2 1 (please read the back And pay attention to the ice term again i K) η — Pr

Me Me I I NCOC = CH2 C02EtMe Me I I NCOC = CH2 C02Et

H 經濟部中央櫺準而员工消贤合作杜印製 仿實施例19處理,得4-〔N -甲基- N- (2 -甲基丙烯醯基) 胺基〕-2 -正丙基- l-〔 〔2’-( 四嗤 ° 5 -基 ) 聯苯-4-基〕甲基〕-1 Η -眯唑-5-羧酸乙酯。 理化學的性狀 ^I-NMR (CDClg): δ (ppm) 8 · UH,d) , 7. 6 0 ( 1 H, t ), 7 · 5 4 (1H, t ) , 7. 27 ( 2 H, d ) -4 1 - 本紙诋尺度遑用中《明家榣毕(CNS)T4規格(210X297公Λ) HI. 7. 2(),()()0¾ (II) 五、發明説明(40) 6. 9 4 ( 2 H, d). 5. 5 5 (2 H, s ), 4· 9 6 - 5. 0 0 ( 2 Η, m) , 4. 21 (2 Η, d), 3. 21 ( 3 Η, s) , 2. 62 (2 Η, t ), 1. 70-1. 75 (5 Η, m), 1 . 2 8 (3 Η, t ), 0· 9 4 ( 3 Η, t) 質譜(FAB) :m/z 514 (ΜΗ+) 熔點:1 5 2 - 1 5 4 °C 實施例 2 2 (諳先閲讀背而之注意事項再項駕一 K) n — PrH Central Ministry of Economic Affairs and employee Xiaoxian cooperated to produce the imitation example 19, 4- [N-methyl-N- (2-methacryloyl) amino] -2-n-propyl- l- [[2 '-(tetrazol ° 5-yl) biphenyl-4-yl] methyl] -1H-triazole-5-carboxylic acid ethyl ester. Physical and chemical properties ^ I-NMR (CDClg): δ (ppm) 8 · UH, d), 7. 6 0 (1 H, t), 7. 5 4 (1H, t), 7. 27 (2 H , d) -4 1-The standard of this paper is used in "Ming Jiayu Bi (CNS) T4 specification (210X297 g) HI. 7. 2 (), () () 0¾ (II) V. Description of invention (40 ) 6. 9 4 (2 H, d). 5. 5 5 (2 H, s), 4. 9 6-5. 0 0 (2 Η, m), 4. 21 (2 Η, d), 3 . 21 (3 Η, s), 2. 62 (2 Η, t), 1. 70-1. 75 (5 Η, m), 1.2 8 (3 Η, t), 0.94 (3 Η, t) Mass spectrometry (FAB): m / z 514 (ΜΗ +) Melting point: 1 5 2-1 5 4 ° C Example 2 2 (Be sure to read the precautions and then drive one K) n — Pr

Me NCOCH2OMe C〇2EtMe NCOCH2OMe C〇2Et

H 經濟部屮央榀準局员工消件合作杜印3i 仿實施例19處理,得4-(N -甲氧乙醯基-N-甲胺基)-2-正丙基- l-〔 〔2’-(四唑-5-基)聯苯-4-基〕甲基〕-1H- 眯唑-5 -羧酸乙酯。 理化學的性狀 lH - NMR (C D C 1 3 ): δ (ppm) 8. 0 1 (1 Η, d), 7 . 5 9 ( 1 Η, t ) 7 . 5 4 (1 Η. t ), 7 . 4 2 ( 1 Η, d) 7 . 19 (2 Η, d), 6 . 9 9 ( 2 Η, d) 4 2 本紙張尺度遑用中明《家«準(CNS)T4規格(210X297公;¢) 81. 7. (II) --. · 1 五、發明説明(41) 5 . 5 8 (2 H, S ) t 4. 2 3 ( 2 H, d d), 3 . 8 5 (2 H, S ), 3. 2 9 ( 3 H, s ), 3 . 1 8 (3 H, S ), 2. 6 7 ( 2 H, t ), 1 . 7 4 - -1 . 7 7 ( 2 Η, m) t 1 2 6 (3 H, 0 . 9 8 (3 H, t ) 質譜(FAB) : m/ z 5 1 8 (ΜΗ*) 實施例 2 3H The Ministry of Economic Affairs, Bureau of Accreditation, Employee, Consumers, Consumers, Du Yin, 3i, imitated in Example 19, and obtained 4- (N-methoxyethoxy-N-methylamino) -2-n-propyl-l- [[ 2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties lH-NMR (CDC 1 3): δ (ppm) 8. 0 1 (1 Η, d), 7.5 9 (1 Η, t) 7.5 4 (1 Η. T), 7 . 4 2 (1 Η, d) 7. 19 (2 Η, d), 6. 9 9 (2 Η, d) 4 2 The paper size is not in accordance with Zhongming's "Home" Standard (CNS) T4 specification (210X297 ; ¢) 81. 7. (II)-. · 1 V. Description of the invention (41) 5. 5 8 (2 H, S) t 4. 2 3 (2 H, dd), 3. 8 5 (2 H, S), 3. 2 9 (3 H, s), 3. 1 8 (3 H, S), 2. 6 7 (2 H, t), 1. 7 4--1. 7 7 (2 Η, m) t 1 2 6 (3 H, 0.98 (3 H, t) mass spectrometry (FAB): m / z 5 1 8 (ΜΗ *) Example 2 3

(請先閲讀背而之注意济項再项寫^ k) 裝- 線. 經濟部屮央標準局Μ工消件合作社印3i 仿實施例19處理,得4-(2 -氧-1-吡咯啶基)-2 -正丙基 -1-〔 〔2’-(四唑-5-基)聯苯-4-基〕甲基〕-1H -咪唑-5 -羧酸乙酯。 理化學的性狀^-NMR (CDClg):&lt;5 (ppm) 8. 00 ( 1 H, d), 7 . 58 ( 1 H, t ), 7 . 5 4 ( 1 H, t ) , 7 . 4 1 ( 1 H, d d ), 7. 09 ( 2 H, d), 6. 99 ( 2 H, d), -4 3 - 本紙張尺度遑用中《醸家標準(CNS) T4規格(210X297公龙) H1. 7. 20,000^(11) Ο 五、發明説明(42) 5 . 4 8 (2 H, s ) ,4 . 19 (2 Η, d d), 3 . 8 3 (2 H, t ), ,2. 6 2(2 Η, t ), 2 . 7 4 (2 H, t ), 2 . 14-2. 2 1 (2 H, m) 1. 6 9 - 1. 7 5 ( 2 H, m) , 1. 25 (3 H, t ), Ο . 9 6 ( 3 Η, t ) 質譜(FAB) :m/z 5 0 0 (MH+) 實施例 2 4 0(Please read the notes first and then write the item ^ k) Pack-line. Printed 3i by the Mongong Consumer Products Cooperative of the Bureau of Standards, Ministry of Economic Affairs, imitated in Example 19, and obtained 4- (2-oxo-1-pyrrole) Pyridyl) -2-n-propyl-1-[[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester. Physical and chemical properties ^ -NMR (CDClg): &lt; 5 (ppm) 8. 00 (1 H, d), 7. 58 (1 H, t), 7. 5 4 (1 H, t), 7. 4 1 (1 H, dd), 7. 09 (2 H, d), 6. 99 (2 H, d), -4 3-In this paper, the standard "CNS" T4 specification (210X297 Male dragon) H1. 7. 20,000 ^ (11) Ο V. Description of invention (42) 5. 4 8 (2 H, s), 4.19 (2 Η, dd), 3. 8 3 (2 H, t ),, 2. 6 2 (2 Η, t), 2. 7 4 (2 H, t), 2. 14-2. 2 1 (2 H, m) 1. 6 9-1. 7 5 (2 H, m), 1. 25 (3 H, t), Ο.96 (3 Η, t) mass spectrometry (FAB): m / z 5 0 0 (MH +) Example 2 4 0

仿實施例1 9處理,得5 -氣基-4 - ( 2 -氧-1 -吡咯啶基)-2 -正丙基-1-〔 〔2’-(四唑-5-基)聯苯-4-基〕甲基〕-1H-眯唑。 理化學的性狀 ^I-NMR (CDClg): δ (ppm)' (請先間讀背而之注意卞,項孙碭寫4-- 經濟部屮央標準局IS:工消费合作社印製 7 . 9 6 (1 Η, d ) t 7 . 5 9 (1 H, t ) 7 . 5 2 (1 Η, t ) t 7 . 4 2 (1 H, d) 7 . 1 3 (2 Η, d ) t 7 . 1 0 (2 H, d) 5 . 1 8 (2 Η, s ) t 3 . 9 7 (2 H, t ) 2 . 6 6 (2 Η, t ) t 2 . 5 6 (2 H, t ) 2 . 1 6 -2 .2 3 :2 H, m) 1 . 6 9 - 1. 78, Ο . 98 (3 Η, t ) -4 4 - 本紙張尺度遑用中B »家楳毕(CNS) 規格(210X297公:«:) Si, 7. 20,()00^ (II) ό Λ fi It 6 五、發明説明(43) 質譜(FAB) :m/z 453 (MH+) 兀素分析値(C25H24N8〇.〇. 8H2〇) C (%) Η (%) Ν (%) 計算値 64.30 5.5 3 2 4.0 0 貫测値 64.60 5 . 4 7 2 3 . 7 0 實施例 2 5Following the treatment of Example 19, 5-amino-4- (2-oxo-1-pyrrolidinyl) -2-n-propyl-1- [[2 '-(tetrazol-5-yl) biphenyl -4-yl] methyl] -1H-quinazole. Physical and chemical properties ^ I-NMR (CDClg): δ (ppm) '(please read back and forth and pay attention to Bian, Xiang Sun Dang writes 4--Ministry of Economics, Bureau of Standards IS: Printed by Industrial and Consumer Cooperative 7. 9 6 (1 Η, d) t 7. 5 9 (1 H, t) 7. 5 2 (1 Η, t) t 7. 4 2 (1 H, d) 7. 1 3 (2 Η, d) t 7. 1 0 (2 H, d) 5. 1 8 (2 Η, s) t 3. 9 7 (2 H, t) 2. 6 6 (2 Η, t) t 2. 5 6 (2 H , t) 2. 1 6 -2 .2 3: 2 H, m) 1. 6 9-1. 78, Ο. 98 (3 Η, t) -4 4-This paper is used in size B »Family 楳Bi (CNS) specifications (210X297 public: «:) Si, 7. 20, () 00 ^ (II) ό Λ fi It 6 5. Description of invention (43) Mass spectrometry (FAB): m / z 453 (MH +) Elemental analysis value (C25H24N8.0.0 8H2〇) C (%) Η (%) Ν (%) Calculation value 64.30 5.5 3 2 4.0 0 Continuous measurement value 64.60 5. 4 7 2 3. 7 0 Example 2 5

MeMe

仿實施例19處理,得4- (N -乙氣草醯基-N-甲胺基)-2-正丙基-1-〔 〔2’-(四脞-5-基)聯苯-4-基〕甲基〕-1H- 咪唑-5-羧酸乙酯。 (諳先閲讀背而之注意^項再蜞寫^一 裝· 線· 經濟部屮央標準局员工消费合作杜印製 理化學的性狀 lH - NMR (C D C 1 3 ): δ (p pm) 7. 9 9 (1 H, d) , 7. 59 ( 1 H, d d), 7 . 53 (1H. d d) , 7. 41 ( 1 H, d), 7. 18 ( 2 H, d) , 6. 96 (2 H, d), 5. 54 ( 2 H, s), 4. 21 (2 H, q), 4. 02 ( 2 H. q) . 3 . 25 ( 3 H, s ), 本紙ft尺度遑用中《«家樣準(CNS)肀4規格(210X297公Λ) η β_ 五、發明説明(44) 2. 61 ( 2 H, t ) , 1 . 7 Ο - 1 . 7 6 ( 2 Η, m), 1 . 28 (3 Η, t) , 0. 95 ( 3 Η, t ) 質譜(FAB) : m/ z 5 4 6 (ΜΗ+) 實施例 2 6Following the treatment of Example 19, 4- (N-ethoxypyranoyl-N-methylamino) -2-n-propyl-1- [[2 '-(tetralin-5-yl) biphenyl-4 -Yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester. (Be sure to read the notes before you ^ Items and then write ^ One outfit · line · The traits of the employee cooperation of the Ministry of Economic Affairs 'Bureau of Standards and Consumers' Du Printing and Physical Chemistry lH-NMR (CDC 1 3): δ (p pm) 7 . 9 9 (1 H, d), 7. 59 (1 H, dd), 7. 53 (1H. Dd), 7. 41 (1 H, d), 7. 18 (2 H, d), 6 . 96 (2 H, d), 5. 54 (2 H, s), 4. 21 (2 H, q), 4. 02 (2 H. q). 3. 25 (3 H, s), original paper In the ft scale, the Chinese Standard «Home Sample Standard (CNS) 4 specifications (210X297 g) η β_ V. Description of the invention (44) 2. 61 (2 H, t), 1. 7 Ο-1. 7 6 ( 2 Η, m), 1. 28 (3 Η, t), 0.95 (3 Η, t) mass spectrometry (FAB): m / z 5 4 6 (ΜΗ +) Example 2 6

彷實施例19處理,得4-(2 -氣- :1-哌啶基)-2 -正丙基-1-〔〔2'-(四唑-5-基)聯苯-4-基〕甲基〕-1H-咪唑-5-羧 酸乙酯。 理化學的性狀 - NMR (C D C I 3 ):5 (ppm) (請先閱-背而之注意*^項再项騖一 ,- 經濟部屮央標準局只工消费合作社印31 7 . 8 1 (1 Η d), 7 . 5 4 (1 Η, d d), 7 . 4 7 (1 Η » d d ) ,7 . 3 7 (1 H .d), 6 . 9 7 (2 Η I d ). 6 . 8 7 ( 2 H, d), 5 . 4 2 (2 Η t s ), 4 . 1 7 ( 2 H, q ). 3 . 5 4 -3 • 5 8 (2 Η, m r b r), 2 . 5 0 (2 Η » t), 2 . 3 8 -2 • 4 2 ( 2 Η, m, b r), 1 . 8 5 -1 8 9 ( 4 Η, m, 1 b r ), -46- 本紙張尺度遑用中《 β家樣準(CNS) TM規格(210X297公放) 81. 7. 20,0()0¾ (t!) Λ 6 Π 6 五、發明説明(45) 1. 64-1. 68 (2H. m), 1 . 23 ( 3 H, t ) , 0. 91 ( 3 H, t ) 質譜(FAB) : m/ z 5 1 4 (Μ H+) 實施例2 7 ηFollowing the treatment of Example 19, 4- (2-gas-: 1-piperidinyl) -2-n-propyl-1-[[2 '-(tetrazol-5-yl) biphenyl-4-yl] Methyl] -1H-imidazole-5-carboxylic acid ethyl ester. Physical and chemical properties-NMR (CDCI 3): 5 (ppm) (please read first-note to the contrary * ^ Item and then Item 鈛 一,-Ministry of Economic Affairs, Bureau of Standards, Industrial and Commercial Cooperative Printed 31 7. 8 1 ( 1 Η d), 7.5 4 (1 Η, dd), 7.4 7 (1 Η »dd), 7.3 7 (1 H .d), 6.9 7 (2 Η I d). 6 . 8 7 (2 H, d), 5. 4 2 (2 Η ts), 4. 1 7 (2 H, q). 3. 5 4 -3 • 5 8 (2 Η, mrbr), 2.5 0 (2 Η »t), 2. 3 8 -2 • 4 2 (2 Η, m, br), 1. 8 5 -1 8 9 (4 Η, m, 1 br), -46- this paper size遑 用 中 《β Family Sample Standard (CNS) TM Specification (210X297 public) 81. 7. 20,0 () 0¾ (t!) Λ 6 Π 6 V. Description of the invention (45) 1. 64-1. 68 (2H. M), 1.23 (3 H, t), 0.91 (3 H, t) Mass spectrometry (FAB): m / z 5 1 4 (Μ H +) Example 2 7 η

仿實施例1 9處理,得4 - ( 3 , 3 -二甲基-2 -氣-1 -吖丁啶 基)-2-正丙基-1-〔 〔2’-(四唑-5-基)聯苯-4-基〕甲基 - (請先閲讀背而之注意淨項洱艰 裝- 〕-1H -咪唑-5-羧酸乙酯。 理化學的性狀 ^ - NMR (C D C 1 3 ): 5 (ppm) 訂_ 線- 經濟部中央榀準局只工消费合作社印製 7 . 8 9 (1 Η, d). 7 . 5 6 (1 Η, d d), 7 . 5 0 (1 Η, d d) ,7 • 4 0 ( 1 Η .d), 7 . 0 4 (2 Η, d ), 6 . 9 0 (2 Η, d), 5 . 4 5 (2 Η, s ), 4 . 2 0 (2 Η, q ), 3 . 6 1 (2 Η, s ), 2 . 5 6 (2 Η, t ), 1 . 6 3 -1 .6 7(2 Η, m ) t 1 . 3 8 (6Ή, s), 1 . 2 4 (3 Η, t), 0 . 9 2 (2 Η, t ) 質譜(F AB) : m/ Z 5 1 4 (MH+) -4 7 - 本紙»尺度遑用中《家楳毕(CNS)T4規怙(210X297公龙) 81. 7. 20,()00^ (II) 3 9 ο 2 β 6 Λ: 五、發明説明(4b) 實施例 28Following the treatment of Example 19, 4- (3,3-dimethyl-2-gas-1-acridinyl) -2-n-propyl-1-[[2 '-(tetrazol-5-yl) Biphenyl-4-yl] methyl- (please read the net terms first and then the hard item-]-1H-imidazole-5-carboxylic acid ethyl ester. Physical and chemical properties ^-NMR (CDC 1 3): 5 (ppm) Order _ Line-Printed by the Ministry of Economic Affairs, Central Bureau of Industry and Commerce only cooperatives 7. 8 9 (1 Η, d). 7. 5 6 (1 Η, dd), 7. 5 0 (1 Η, dd), 7 • 4 0 (1 Η .d), 7.0 4 (2 Η, d), 6.9 0 (2 Η, d), 5. 4 5 (2 Η, s), 4.2 0 (2 Η, q), 3. 6 1 (2 Η, s), 2.5 6 (2 Η, t), 1. 6 3 -1 .6 7 (2 Η, m) t 1. 3 8 (6Ή, s), 1.2 4 (3 Η, t), 0.9 2 (2 Η, t) mass spectrometry (F AB): m / Z 5 1 4 (MH +) -4 7-Original paper »Scale In the use of "楳 戳 Bi (CNS) T4 regulation (210X297 male dragon) 81. 7. 20, () 00 ^ (II) 3 9 ο 2 β 6 Λ: V. Description of the invention (4b) Example 28

經濟部屮央標準局A工消t合作杜印製 仿實施例19處理,得4-〔 N -甲基-N-(苯氧乙醯基)胺 基〕-2-正丙基-卜〔〔2'-(四唑-5-基)聯苯-4-基〕甲 基〕-1H-咪唑-5-羧酸乙酯。 理化學的性狀 - NMR (C D C 1 3 ): δ (ppm) 7 . 9 7 ( 1 H, d), 7. 58 ( 1 Η, d d), 7. 51 ( 1 H. d d) , 7. 39 ( 1 H, d), 7. 10-7. 16 (4 Η, m) , 6. 9 4 (2 Η, d), 6. 87 ( 1 Η, d d) , 5. 55 ( 2 Η, s ), 4. 46 (2 Η, s), 4. 14 (2 Η, q), 3 . 21 ( 3 Η, s ) , 2 . 64 ( 2 Η, t ), 1 . 7 0 - 1. 7 9 ( 2 Η, m) , 1 . 2 1 (3 Η, t ), 0 . 9 7 ( 3 Η, t ) 質譜(FAB) :m/z 5 8 0 (MH+) (請先閲讀背而之注意涑項再埙%1,&gt;,) 裝- 線- 本紙張尺度遑用中明因家«毕(CNS)Τ4規格(210X297公:《:)A copy of the example 19 was processed in cooperation with the Industrial Standards Bureau of the Ministry of Economic Affairs and the Ministry of Economic Affairs to obtain 4- [N-methyl-N- (phenoxyethyl acetyl) amino] -2-n-propyl-bu [ [2 '-(Tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester. Physical and chemical properties-NMR (CDC 1 3): δ (ppm) 7.9 7 (1 H, d), 7. 58 (1 Η, dd), 7. 51 (1 H. dd), 7. 39 (1 H, d), 7. 10-7. 16 (4 Η, m), 6. 9 4 (2 Η, d), 6. 87 (1 Η, dd), 5. 55 (2 Η, s ), 4. 46 (2 Η, s), 4. 14 (2 Η, q), 3.21 (3 Η, s), 2.64 (2 Η, t), 1. 7 0-1. 7 9 (2 Η, m), 1.2 1 (3 Η, t), 0.97 (3 Η, t) mass spectrometry (FAB): m / z 5 8 0 (MH +) (please read the opposite first Pay attention to the re-entry% 1, &gt;,) Packing-Line-This paper scale uses Zhongming Yinjia «Bi (CNS) Τ4 specifications (210X297 :: :)

Mi. 7. 2〇(〇〇〇^ (μ) 209 L3 Λ 6 Π 6 五、發明説明(47) 實施例 2 9Mi. 7. 2〇 (〇〇〇 ^ (μ) 209 L3 Λ 6 Π 6 V. Description of the invention (47) Example 2 9

MeMe

仿實施例19處理,得4-(N -苯丙烯醯基-N-甲胺基)-2-正丙基-1 -〔 〔 2 ’ -(四唑-5 -基)聯苯-4 -基〕甲基〕-1 Η- 眯唑-5-羧酸乙酯。 理化學的性狀 ^I-NMRCCDClg): δ (ppm) (請先間請背而之注意淨項&gt;) 裝. •?τ_ 經濟部屮央標準局员工消合作社印^ 7 . 9 9 (1 Η, d), 7 . 4 9- 7 . 5 9 (3 H, m) 7 . 3 6 (1 Η, d), 7 . 19- 7 . 2 5 (5 H, m) 7 . 1 0 (2 Η, d) .6: 9 6 (2 H, d) r 6 . 3 0 (1 Η, d) ,5. 5 8 (2 H, s ), ► 4 . 1 4 (2 Η, q) .3. 2 5 (3 H, s ) r 2 . 6 9 (2 Η, t ), ,1 . 7 3- 1 . 8 1 (2 H, m) 1 . 1 9 (3 Η, t ) ,〇. 9 9 (3 H, t ) 質譜(F A ‘ B ):m. / z 5 7 6 (M H+; ) 線· 本紙張尺度遑用中國β家楳毕(CKS) f 4規怙(210x297公釐) 8!. 7. 20,0()i)i)c (II) ··0 ,‘上 9 ο 2 6 6 ΛΠ 五、發明説叫(48) 實施例 3 0Following the treatment of Example 19, 4- (N-phenylacryloyl-N-methylamino) -2-n-propyl-1-[[2 '-(tetrazol-5-yl) biphenyl-4- Group] methyl] -1 H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties ^ I-NMRCCDClg): δ (ppm) (please pay attention to the net items first>) installed. •? Τ_ Printed by the Employee Consumer Cooperative of the Bureau of Standards, Ministry of Economic Affairs ^ 7. 9 9 (1 Η, d), 7. 4 9- 7. 5 9 (3 H, m) 7. 3 6 (1 Η, d), 7. 19- 7. 2 5 (5 H, m) 7. 1 0 ( 2 Η, d) .6: 9 6 (2 H, d) r 6. 3 0 (1 Η, d), 5. 5 8 (2 H, s), ► 4. 1 4 (2 Η, q) .3. 2 5 (3 H, s) r 2. 6 9 (2 Η, t),, 1. 7 3- 1. 8 1 (2 H, m) 1. 1 9 (3 Η, t), 〇. 9 9 (3 H, t) mass spectrometry (FA 'B): m. / Z 5 7 6 (M H +;) line · This paper scale uses Chinese β- 漳 楳 Bi (CKS) f 4 regulations (210x297 Mm) 8 !. 7. 20,0 () i) i) c (II) ·· 0, 'Shang 9 ο 2 6 6 ΛΠ V. The invention is called (48) Example 3 0

仿實施例1 9處理,得4 - ( N -環己叉乙醯基-N -甲胺基) -2-正丙基-1-〔 〔2^(四脞-5-基)聯苯-4-基〕甲基〕 -1H-眯唑-5-羧酸乙酯。 理化學的性狀 元素分析値(C32H37N7 〇3 ) C {%) H (%) Ν (%) 計算値 67.70 6 . 5 7 17.27 實測値 67.65 6.4 9 17.2 7 焰點:2 1 3 - 2 1 5 °C 質譜(FAB) :m/z 5 6 8 (MH+) 實施例 31 Me Me (請先閲讀背而之注意苹.項#填穷k, 裝- 訂_ 線- 經濟部屮央榣準局IS:工消费合作杜印&quot;Following the treatment of Example 19, 4- (N-cyclohexylidene-acetyl-N-methylamino) -2-n-propyl-1- [[2 ^ (tetralin-5-yl) biphenyl- 4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties element analysis value (C32H37N7 〇3) C (%) H (%) Ν (%) Calculated value 67.70 6. 5 7 17.27 Measured value 67.65 6.4 9 17.2 7 Flame point: 2 1 3-2 1 5 ° C Mass Spectrometry (FAB): m / z 5 6 8 (MH +) Example 31 Me Me (please read first and pay attention to the apple. Item #fill the poor k, pack-book_line-Ministry of Economics and Social Security Bureau IS : Industry and consumer cooperation Du Yin &quot;

-50- 本紙Λ尺度遑用中《困家櫺準(CNS) 規格(210X297公:it) SI. 7. 2(),()()0^(11) C C Γ·‘ 6 t 五、發明説明(49) 於4 -〔 N -甲基-N - ( 2 -甲基丙烯醯基)胺基〕-2 -正丙基 -〔〔 2 · - ( N -三苯甲基-四唑-5 -基)聯苯-4 -基〕甲基〕 -1 Η -眯唑-5 -羧酸乙酯5㈣m g加甲酸8 m 1 ,而在室溫攪拌 4 8小時後,減壓蒸發。殘渣溶在乙醇5πι 1 ,而加1 N N a 0 H 水3 . 6 οι 1。在室溫下Μ拌3日後,減壓蒸除溶劑,殘渣 溶在水5ml而加1Ν鹽酸來調整為ΡΗ2後,以乙酸乙酯萃 取,而以硫酸鎂乾燥,減壓蒸除溶劑。殘渣在矽膠柱層 析(氯仿:甲醇:乙酸=1〇〇: 10: 1),得4-〔N -甲基- N- (2 -甲基丙烯醯基)胺基〕-2 -正丙基-1-〔 〔2'-(四唑-5 -基)聯苯-4-基〕甲基〕-1H-眯脞-5-羧酸,得lOOmg。 理化學的性狀 ^I-NMR (DMSO): δ (ppm) 7 . 5 7 (1 Η. d ), 7 . 5 1 (1 Η, t) 7 . 4 5 (1 Η, d), 7 . 4 1 (1 Η, d) 7 . 0 6 (1 Η, d), 6 . 8 0 (1 Η, d) 5 . 5 8 (2 Η, s ), 5 . 0 0 (1 Η, s ) 4 . 8 3 (1 Η, s )( 3 . 1 1 (3 Η, s ) 請 先 nil ύ 背 而 之 注 意 事 項 Λ 塡 % 本 頁 經濟部屮央標準局员工消份合作杜印製 2 · 47-2. 5 2 (2 H, m) , 1 . 7 4 (3 H, s), 1. 52-1. 59 (2Η, m), 0. 82 (3H, t ) 質譜(FAB) : m/ z 4 6 8 (MH+) 本紙张尺度逍用中國«家楳準(CNS)肀4規怙(2丨0X297公:it) 81. 7. 20,000i)t (II) 五、發明説明(50) 實施例3 2 Λ 6 U 6-50- This paper is used in the "Standard Family Standard (CNS) Specification (210X297): it) SI. 7. 2 (), () () 0 ^ (11) CC Γ · '6 t V. Invention Description (49) in 4-[N -methyl-N-(2 -methacryloyl) amino] -2 -n-propyl- [〔2 ·-(N -trityl-tetrazole- 5-yl) biphenyl-4-yl] methyl] -1 H-quinazol-5-ethyl carboxylate 5㈣m g plus formic acid 8 m 1, and after stirring at room temperature for 48 hours, it was evaporated under reduced pressure. The residue was dissolved in ethanol 5πι 1 and 1 N N a 0 H water was added 3.6 οι 1. After stirring at room temperature for 3 days, the solvent was distilled off under reduced pressure. The residue was dissolved in 5 ml of water and 1N hydrochloric acid was added to adjust to PH2. The mixture was extracted with ethyl acetate and dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel (chloroform: methanol: acetic acid = 100: 10: 1) to give 4- [N-methyl-N- (2-methacryloyl) amino] -2-n-propyl Yl-1- [[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-squinted-5-carboxylic acid, giving 100 mg. Physical and chemical properties ^ I-NMR (DMSO): δ (ppm) 7.5 7 (1 Η. D), 7.5 1 (1 Η, t) 7.4 5 (1 Η, d), 7. 4 1 (1 Η, d) 7. 0 6 (1 Η, d), 6. 8 0 (1 Η, d) 5. 5 8 (2 Η, s), 5. 0 0 (1 Η, s) 4. 8 3 (1 Η, s) (3. 1 1 (3 Η, s) Please nil ύ Back to the note Λ 塡% 47-2. 5 2 (2 H, m), 1. 7 4 (3 H, s), 1. 52-1. 59 (2Η, m), 0.82 (3H, t) mass spectrometry (FAB): m / z 4 6 8 (MH +) This paper scale is used in China «Homewood Standard (CNS) 悀 4 regulations (2 丨 0X297 public: it) 81. 7. 20,000i) t (II) V. Invention description ( 50) Example 3 2 Λ 6 U 6

Me ,MeMe, Me

Η 以4-〔N -甲基- N- (3 -甲基丁烯醛基)胺基〕-2 -正丙基 -1-〔 〔2,-(四唑-5-基)聯苯-4-基〕甲基〕-1H -咪唑-5 -羧酸乙酯為原料,彷實施例3 1處理,得4 -〔 N -甲基-N -(3-甲基丁烯醯基)胺基-2-正丙基-1-〔 〔2'-(四唑- 5- 基)聯苯-4-基〕甲基〕-1H -眯唑-5-羧酸。 理化學的性狀 'H-NMR(CDC13):&lt;5 (ppm) 先 Ml 讀 背 而 之 注 意 事 項 -fb 填 裝 訂 線 經濟部屮央標準局负工消合作杜印製 7 . 7 8 (1 Η, d), 7 . 5 6 (1 Η, t ) 7 . 4 7 (1 Η, t)( 7 . 4 1 (1 Η, d) 7 . 0 7 (2 Η, d), 6 . 8 0 (2 Η, d) 5 . 5 2 (2 Η, s ), 5 . 4 3 (1 Η, s ) 3 · 1 5 (3 Η, S), 2 . 6 3 (2 Η, t ) 1 · 7 5 (3 Η, S ), 1 . 6 4 - 1 . 7 5 ( 1 . 6 0 (3 Η, S ), 0 . 9 1 (3 Η, t ) 質譜(FAB) :m/z 5 0 0 (ΜΗ + ) 5 2- 81. 7. 20.000ik(H) 本紙ft尺度遑用中明國家«準(CNS)T4規格(210X297公址) 五、發明説明(51) 實施例3 3 Λ 6 η 6 0Η With 4- [N-methyl-N- (3-methylbutenalyl) amino] -2-n-propyl-1-[[2,-(tetrazol-5-yl) biphenyl- 4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester as raw material, treated as in Example 3 1 to give 4- [N-methyl-N- (3-methylbutenyl) amine Yl-2-n-propyl-1- [[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid. Physical and chemical properties of 'H-NMR (CDC13): &lt; 5 (ppm) Ml read back to the precautions -fb filling and binding line Ministry of Economic Affairs, Bureau of Standards, the Ministry of Economic Affairs, the negative work and elimination cooperation printing 7. 7 8 (1 Η, d), 7.5 6 (1 Η, t) 7. 4 7 (1 Η, t) (7.4 1 (1 Η, d) 7. 0 7 (2 Η, d), 6.8 0 (2 Η, d) 5. 5 2 (2 Η, s), 5. 4 3 (1 Η, s) 3 · 1 5 (3 Η, S), 2. 6 3 (2 Η, t) 1 · 7 5 (3 Η, S), 1. 6 4-1. 7 5 (1. 6 0 (3 Η, S), 0.9 1 (3 Η, t) mass spectrometry (FAB): m / z 5 0 0 (ΜΗ +) 5 2- 81. 7. 20.000ik (H) ft scale of this paper instead of Zhongming National Standard (CNS) T4 specification (210X297 public address) V. Description of invention (51) Example 3 3 Λ 6 η 6 0

Η 以4 - ( 2 -氯-1 -吡咯啶基)-2 -正丙基-:[-〔〔2 ’ -(四唑-5 -基)聯苯-4-基〕甲基〕-1Η -咪唑-5-羧酸乙酯為原料, 仿實施例3 1處理,得4 - ( 2 -氣-卜吡咯啶基)-2 -正丙基-1 -〔〔2'-(四唑-5-基)聯苯-4-基〕甲基〕-1Η-眯唑-5-羧酸》 理化學的性狀 'Η - NMR (C D C 1 3); δ (ppm) 先 閲 背 而 之 事 填 % 本 經濟部中央櫺準局IS:工消合作社印製 7 . 8 9 (1 Η, d) t 7 . 5 6 (1 H, t ), 7 . 4 9 (1 Η, t) » 7 . 4 0 (1 H, d), 7 . 0 5 (2 Η, d) t 6 . 9 3 (2 H( d ), 5 . 4 8 (2 Η, s ) t 4 . 0 1 (2 H, t ), 2 . 5 5 -2 • 6 4 (4 H, m ) 2 . 2 1 -2 .2 6 (2 H, m ) 1 _ 6 8 -1 .7 6 (2 H, m ) 0 .9 6( 質譜(FAB) : m/z 4 7 2 (ΜΗ -53 本紙Λ尺度遑用中困家樣準(CNS)甲4規格(210X297公:in 81. 7. 20,000^(11) 五、發明説明(52) 實施例 34 Λ 6 Η 6Η With 4-(2 -chloro-1 -pyrrolidinyl) -2 -n-propyl-: [-[[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1Η -Ethyl imidazole-5-carboxylate is used as the raw material and treated as in Example 31 to obtain 4- (2-gas-pyrrolidinyl) -2-n-propyl-1-[[2 '-(tetrazole- 5-yl) biphenyl-4-yl] methyl] -1Η- 簯 azole-5-carboxylic acid》 Physical and chemical properties of 'Η-NMR (CDC 1 3); δ (ppm) % The Central Bureau of the Ministry of Economic Affairs IS: printed by the industrial and consumer cooperatives 7. 8 9 (1 Η, d) t 7. 5 6 (1 H, t), 7. 4 9 (1 Η, t) »7. 4 0 (1 H, d), 7. 0 5 (2 Η, d) t 6. 9 3 (2 H (d), 5. 4 8 (2 Η, s) t 4. 0 1 (2 H, t), 2. 5 5 -2 • 6 4 (4 H, m) 2. 2 1 -2 .2 6 (2 H, m) 1 _ 6 8 -1 .7 6 (2 H, m) 0. 9 6 (mass spectrometry (FAB): m / z 4 7 2 (ΜΗ -53 paper Λ scale and using the middle-sleepy home standard (CNS) A 4 specifications (210X297 g: in 81. 7. 20,000 ^ (11) Description of the invention (52) Example 34 Λ 6 Η 6

三苯甲基 用4 -胺基-2-正丁基-1-〔 〔2‘-U-三苯甲基-四唑- 5- 基)聯苯-4-基〕甲基〕眯唑-5-羧酸乙酯及3, 3 -二甲基 丙烯醯氣,仿實施例1處理,得2 -正丁基- 4-ί:Ν-(3 -甲 基丁烯醯基)胺基〕-1-〔 〔2'-(Ν-三苯甲基-四唑-5-基) 聯苯-4-基]甲基〕-1Η-眯唑-5-羧酸乙酯。 理化學的性狀 'H-NMRCCDCla): 先 閲 »n 背 而 之 注 意 事 碩 再 填For trityl 4-amino-2-n-butyl-1- [[2'-U-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] mazole 5-Carboxylic acid ethyl ester and 3, 3-dimethylacrylic acid gas, treated as in Example 1, to obtain 2-n-butyl-4-4-: N- (3-methylbutenyl) amino group] -1- [[2 '-(Ν-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties' H-NMRCCDCla): Read first »n Contrary to Note Matters Master Refill

F 經濟部屮央榣準局员工消&quot;合作社印製 (P P m ) 8. 8 7 (1 H, s ), 6. 7 2- 7. 9 2 (2 3H, m) 6 . 0 0 -6 . 1 1( 1 H, m), 5. 3 5 (2 H, s ) 4 . 1 5 (2 H, q) ,2 6 1 (2 H, t ), 2 . 2 5 (3 H, d) ,1 9 2 (3 H, d), 1 . 3 1 -1 . 8 2( 4 H, m), 1 . 1 6 ( 3 H, t ) 0 . 8 6 (3 H, t ) 質譜(F A B) m/ z : 7 7 0 (MH + ) 5 4 本紙Λ尺度遑用中《«家樣準(CNS)T4規格(210X297公tf) 81. 7. 20.000i|c (1!)F Printed by the Employee Consumers of the Central Bureau of Economics and Trademark of the Ministry of Economic Affairs (PP m) 8. 8 7 (1 H, s), 6. 7 2- 7. 9 2 (2 3H, m) 6. 0 0- 6. 1 1 (1 H, m), 5. 3 5 (2 H, s) 4. 1 5 (2 H, q), 2 6 1 (2 H, t), 2. 2 5 (3 H, d), 1 9 2 (3 H, d), 1. 3 1 -1. 8 2 (4 H, m), 1. 1 6 (3 H, t) 0. 8 6 (3 H, t) (FAB) m / z: 7 7 0 (MH +) 5 4 This paper is used in «Standard (CNS) T4 specification (210X297 male tf) 81. 7. 20.000i | c (1!)

ο -X ...1 C;}ο CW 66 ΛΠ 五、發明説明(53) 實施例 3 5 /Meο -X ... 1 C;} ο CW 66 ΛΠ V. Description of the invention (53) Example 3 5 / Me

用2 -正丁基-4-〔N -甲基-N- (3 -甲基丁烯醯基)胺基〕 -l-〔 [2'-(N-三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕 -1H -咪唑-5-羧酸乙酯及溴化甲基,彷實施例12處理, 得2 -正丁基-4-〔M -甲基- N- (3 -甲基丁烯醯基)胺基〕-1-〔〔2'-(N -三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕-1H -眯唑-5-羧酸乙酯。 理化學的性狀 丨 Η - NMR (C D C 1 3): δ (ppm) 先 IW] 背 而 之 注 意 事 項 再 填 寫 本 頁一 装 丁 經濟部屮央楳準局EX工消费合作杜印製 6 . 7 1 _ 8 .0 0(2 3 H, m) t 5 . 4 1 -5 .5 0 (3 H, m), 4 . 1 4 (2 Η, q). 3 . 2 4 (3 H, s ) 2 . 4 9 (2 Η, t), 2 . 0 7 (3 H, d) 1 . 6 5 (3 Η, d), 1 · 3 1 -1 .7 5 (4 H, m), 1. 23 (3 H, t ) , 0. 86 (3 H, t ) 質諸(FAB) : m/ z 7 8 4 (MH+) -5 5 - 本紙Λ尺度遍用中《«家樣準(CNS)甲4規格(210x297公釐) 81. 7. 20,U00ik(!l) 五、發明説明(54) 實施例;)6With 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino]]-l- [[2 '-(N-trityl-tetrazole-5 -Yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester and methyl bromide, treated as in Example 12, to give 2-n-butyl-4- [M-methyl -N- (3-methylbutenyl) amino] -1-[[2 '-(N-trityl-tetrazol-5-yl) biphenyl-4-yl] methyl]- 1H-Fenazole-5-carboxylic acid ethyl ester. Physical and chemical properties 丨 Η-NMR (CDC 1 3): δ (ppm) IW] Contrary to the precautions and then fill out this page a package Ding printed by the Ministry of Economic Affairs, Biyang, Bureau of Industry and Commerce, Co., Ltd. Du printed 6. 7 1 _ 8 .0 0 (2 3 H, m) t 5. 4 1 -5 .5 0 (3 H, m), 4. 1 4 (2 Η, q). 3. 2 4 (3 H, s) 2. 4 9 (2 Η, t), 2.0 7 (3 H, d) 1. 6 5 (3 Η, d), 1. 3 1 -1 .7 5 (4 H, m), 1. 23 (3 H, t), 0.86 (3 H, t) Quality (FAB): m / z 7 8 4 (MH +) -5 5-This paper is widely used in the «Home Sample Standard (CNS) A 4 specifications (210x297 mm) 81. 7. 20, U00ik (! L) V. Description of the invention (54) Examples;) 6

MeMe

Η 用2 -正丁基-4-〔 Ν -甲基- Ν- (3 -甲基丁烯醯蕋)胺基-卜 〔〔2'-(N -三苯甲基-四唑-5-基)聯苯-4 -基〕甲基〕咪 唑-5-羧酸乙酯仿實施例19處理,得2-正丁基-4-〔N-甲基-N-(3. -甲基丁烯醯基)胺基〕-;1 -〔 〔 2 '-(四唑-5 -基)聯苯-4- 基〕甲基〕-1H-眯唑-5-羧酸乙酯。 理化學的性狀 元素分析値(C3eH35N7〇3 ) C (°/〇) Η {%) 計算値 6 6.5 2 6.5 1 實測値 6 6.5 0 6.5 1 Ν (°/〇) 8 · 10 8 . 0 5 先 閲 讀 背 而 之 注 意 事 5 填 % 本 Μ 經濟部屮央槛準局β工消&quot;合作杜印製 熔點:1 8 4 - 1 8 5 °C 質譜(F A B) : m/ z 5 4 2 (MH+) -56- 本紙ft尺度遑用中《國家楳毕(CNS)T4規格(210X297公放) 81. 7. 20,00()¾ (II) :;:V- 五、發明説明(55) 實施例3 7 Λ 6 Π 6Η With 2-n-butyl-4- [Ν -methyl- Ν- (3-methylbutene acryloside) amino-bu [[2 '-(N-trityl-tetrazole-5- Group) Biphenyl-4-yl] methyl] imidazole-5-carboxylic acid ethyl ester was treated as in Example 19 to obtain 2-n-butyl-4- [N-methyl-N- (3. -Methylbutyl Alkenyl) amino]]-; 1-[[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties element analysis value (C3eH35N7〇3) C (° / 〇) Η (%) Calculated value 6 6.5 2 6.5 1 Actual measured value 6 6.5 0 6.5 1 Ν (° / 〇) 8 · 10 8. 0 5 first Read the notes on the contrary 5 fill in the content of this ・ Ministry of Economic Affairs, the Central Bureau of Quorum βWork Consumer &quot; Cooperative Du Printing Melting Point: 1 8 4-1 8 5 ° C Mass Spectrometry (FAB): m / z 5 4 2 ( MH +) -56- The ft scale of this paper is used in the "National Standard (CNS) T4 specification (210X297 public release) 81. 7. 20,00 () ¾ (II):;: V- V. Description of the invention (55) Example 3 7 Λ 6 Π 6

MeMe

Η 用2 -正丁基-4-〔 Ν -甲基- Ν- (3 -甲基丁烯醯基)胺基-1 〔〔2’-(N-三苯甲基四唑-5_基)聯苯-4-基〕甲基〕眯 唑-5-羧酸乙酯仿實施例31處理,得2 -正丁基-4-〔N-(3 -甲基丁烯醯基)胺基〕-l-〔 〔2'-(四唑-5-基〉聯苯- 4- 基〕甲基〕-1H -眯唑-5-羧酸乙酯。 理化學的性狀 元素分析値(C28H3, N7〇3 · 0. 3H20) C (%) Η (%) N (%) 計算値 64.80 6 . 1 3 1 8.89 實測値 64.93 6.16 1 8.81Η With 2-n-butyl-4- [Ν-methyl-Ν- (3-methylbutenyl) amino] -1 [〔2 '-(N-trityltetrazole-5-yl ) Biphenyl-4-yl] methyl] benzoazole-5-carboxylic acid ethyl ester was treated as in Example 31 to give 2-n-butyl-4- [N- (3-methylbutenyl) amino 〕 -L- 〔[2 '-(tetrazol-5-yl> biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester. Physical and chemical properties element analysis value (C28H3, N7〇3 · 0.3H20) C (%) Η (%) N (%) calculated value 64.80 6.1 3 1 8.89 measured value 64.93 6.16 1 8.81

Tk 閲 讀 背 而 之 注 意 事 項 再 填 % 术 頁一 裝 玎 經濟部屮央梂準局CS:工消赀合作社印Μ 熔點:1 5 6 - 1 5 8 -C 質譜 (F A B) : m/ z 5 1 4 (ΜίΤ) 57 本《张疋度边用中《«家«準(CN5) «Ρ4規格(2丨0X297公ft)Tk Read the notes on the back and fill in%. The page is filled with the quasi-bureau of the Central Committee of the Ministry of Economic Affairs CS: printed by the Cooperative Society. Melting point: 1 5 6-1 5 8 -C Mass Spectrometry (FAB): m / z 5 1 4 (ΜίΤ) 57 This book "Zhang Deng Duan Zhongzhong" «Home« Quasi (CN5) «P4 Specification (2 丨 0X297 ft)

Bl. 7. 2U.U00ik(ll) 五、發明説明(56) 實施例 38 Λ 6 Η 6 ,MeBl. 7. 2U.U00ik (ll) 5. Description of the invention (56) Example 38 Λ 6 Η 6, Me

Me η - BuMe η-Bu

經濟部屮央榣準局tax消炽合作社印製 於2-正丁基-4-〔 N -甲基- N- (3 -甲基丁烯醯基)胺基- ΙΕ 〔2'-( 三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕 -1H-眯唑-5-羧酸5·0克之乙醇溶液20Qml,在冰冷下以 20分滴加O.lmol/ JI乙醇性KOH溶液69.5ml。在冰冷下 攪拌10分後,減壓蒸除溶劑。殘渣溶在丙_20Qml,而 在冰冷下依序加1 0 % N a I水溶液2 G m U待戊酸氣甲酯1 . 5 4 克。加熱回流7 . 5小時後,減壓蒸除溶劑。 殘渣以乙酸乙酯萃取而水洗2次後,予以乾燥,減壓 蒸發。殘渣在矽膠柱層析(己烷:乙酸乙酯=2: 1),得 2 -正丁基-4 -〔 N -甲基-N - ( 3 -甲基丁烯醯基)胺基〕-1 -〔〔2'-(三苯甲基四唑-5-基)聯苯-4-基〕甲基〕-1H-眯唑-5-羧酸待戊醯氣甲酯3.80克,泡狀。 理化學的性狀 1 H-NMR (CDC13):&lt;5 (ppm) 5 8- 本紙ft尺度遑用t « β家«準(CHS) f 4規格(210x297公货) 81. 7. 20.000^ (II) (請先閲請背而之注意事項再堝寫本頁) 裝. 五、發明説明(57) Λ 6η 6 6. 7 1 - 7. 9 3 (2 3 H, m) , 5. 75 (2 H, s) 5. 4 6 (3 Η, s ) , 3 . 22 (3 Η, s ), 2. 5 1-2. 59 (2 Η, m) , 2 1. 48-1. 72 (5Η, m), 1. 25-1. 3 2 ( 2 Η, m) , 1 Ο . 8 6 ( 3 Η, t ) 0 6 (3 Η, s) 15 (9 Η, s ) 質譜(FAB) :m/z 870 (Μ + ) 實施例3 9 η - Bu-Printed by the Ministry of Economic Affairs, the Central Bureau of Taxation, the Tax Consumers Cooperative on 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino] -ΙΕ 〔2 '-(三Benzyl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid 5.0 g ethanol solution 20Qml, under ice-cooling was added O.lmol dropwise in 20 minutes / JI alcoholic KOH solution 69.5ml. After stirring for 10 minutes under ice cooling, the solvent was distilled off under reduced pressure. The residue was dissolved in C_20Qml, and 10% NaI aqueous solution 2 G m U was added in sequence under ice-cooling to prepare 1.54 g of valeric acid gas methyl ester. After heating to reflux for 7.5 hours, the solvent was distilled off under reduced pressure. The residue was extracted with ethyl acetate and washed twice with water, dried, and evaporated under reduced pressure. The residue was chromatographed on a silica gel column (hexane: ethyl acetate = 2: 1) to obtain 2-n-butyl-4-[N-methyl-N- (3-methylbutenyl) amino]]- 1-[[2 '-(trityltetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid to be pentafluoromethyl methyl ester 3.80 g, foam . Physical and chemical properties 1 H-NMR (CDC13): &lt; 5 (ppm) 5 8- ft scale of the paper, using t «β 家« quasi (CHS) f 4 specifications (210x297 public goods) 81. 7. 20.000 ^ ( II) (Please read the precautions before writing this page) Install. V. Description of the invention (57) Λ 6η 6 6. 7 1-7. 9 3 (2 3 H, m), 5. 75 (2 H, s) 5. 4 6 (3 Η, s), 3. 22 (3 Η, s), 2. 5 1-2. 59 (2 Η, m), 2 1. 48-1. 72 (5Η, m), 1. 25-1. 3 2 (2 Η, m), 1 Ο. 8 6 (3 Η, t) 0 6 (3 Η, s) 15 (9 Η, s) mass spectrometry (FAB ): m / z 870 (Μ +) Example 3 9 η-Bu-

Me 1 /Me /NCOCH= C \Me 、co2ch2 、 ,MeMe 1 / Me / NCOCH = C \ Me, co2ch2,, Me

CC

基 甲 苯 三 閲 背 而 之 注 意 事 項 填 寫 本 頁 例 施 實 仿 經濟部中央標準局貝工消费合作社印製 基 烯 茂 ffi 二 以 之 代 酯 甲 氯 酸 戊 待 惟基 得 氨 基 甲 基 丁 正 氣基 2 甲 i -, sr 基c 甲 -Note on the back of the third reading of the base toluene Fill in the example on this page to implement the imitation of iminomethyl butane based on the printing of the base dimethine ffi bis-pentyl methacrylate by the Pengong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 2 A i-, sr base c A-

酸 羧 f 5 I C 唑 1-咪 ~ I ο 31H酯 基一甲 胺 3 } )r基基 基甲4-酸 Dfcs 烯基 $ 狀 了-4-S 性 基苯--IB的 聯 C 甲 學 化 ίιι 理 本紙張尺度遑用中困β家楳毕(CNS) «Τ4規格(2Κ1Χ297公釐) 唑 四 一 基 甲 苯 三 '—\ - 2 氣 1 2 I 基 甲 81. 7. 20,000¾ (II) i 五、發明説明(58) Η - NMR (C D C δ (ppm) 6 . 7 3 -7 9 2 .( 2 3 H 5 · 4 4 (2 Η, s ) 4 . 3 . 2 1 (3 Η, s ) 2 . 2 . 0 5 -2 .1 0 (6 H, 1 · 5 2 -1 .7 2 (5 H, 1 . 2 1 -1 .3 2 (2 H, (F A B) :m / z 8 實施例4 〇 η — BuAcid carboxylic acid f 5 IC azole 1-imid ~ I ο 31H Ester monomethylamine 3}) r-yl-yl-methyl 4-acid Dfcs alkenyl-like 4-S-based benzene-IB's bicarbonate Chemicals and paper-based papers for use in the middle of troubled β- 揳 戳 Bi (CNS) «Τ4 specifications (2Κ1Χ297 mm) azole tetrakisyltoluene 3 '-\-2 gas 1 2 I base methyl 81. 7. 20,000¾ (II ) i 5. Description of the invention (58) H-NMR (CDC δ (ppm) 6.7 3 -7 9 2. (2 3 H 5 · 4 4 (2 Η, s) 4. 3. 2 1 (3 Η , s) 2. 2. 0 5 -2 .1 0 (6 H, 1 · 5 2 -1 .7 2 (5 H, 1. 2 1 -1 .3 2 (2 H, (FAB): m / z 8 Example 4 〇η — Bu

Λ 6 Η 6 2 H, s),Λ 6 Η 6 2 H, s),

Me Me -NCOCH= =C \]vie C02CH0C02EtMe Me -NCOCH = = C \] vie C02CH0C02Et

Me 閲 讀 背 而 之 注 意 事 再 塡 寫 本 π- 裝 玎 經濟部中央橾準局员工消伢合作杜印製 例得 C 施 ’-[ 實氯-1 仿基1 乙基 8 3Me Read the back of the notes, and then write a copy π- pretend that the Central Ministry of Economic Affairs of the Ministry of Economic Affairs employees cooperated with the du printing to make an example of C Shi ’-[actual chlorine-1 imitation 1 ethyl 8 3

2 Η C2 Η C

基 甲 苯 三 以 之 代 酯 甲 氣 酸CN 戊-4 特-惟基 ,丁 基 甲 唑 四 I 基 甲 笨 三 }按 基}甲 氣基1 羰醯基 氧嫌4 乙丁 -(基 甲 3 基 苯 聯 ο 6 本紙張尺度遑用中《«家«準(CNS)肀4規怙(210X297公;it) 81. 7. 20.000¾ (II) Λ 6 Η 6 五、發明説明(59) 基〕-1 Η -眯唑-5 -羧酸 I 1 -乙氣羰氣乙酯 理化學的性狀 ^-NMR (CDC13): 5 (ppm) 6 . 7 0 - 7. 95 (24 H, m). 5. 3 9 - 5. 57 (3 H, m), 4, 17 (2 H, q), 3. 23 (3 H, s) , 2. 4 2 - 2. 6 7 ( 2 H, m), 2. 86 (3 H, d) , 1. 4 2 - 1. 7 6 ( 1 0 H, m), 1. 17-1. 34 (3 H, m) , 0. 85 ( 3 H, t ) 質譜(FAB) : να/ z 8 7 2 . (ΜΗ + ) 實施例4 1 η - Bu.Substituted by methyl tolyl formate Methanoic acid CN Pent-4 Tetra-Butyl, Butyl Metrazole Tetramethyl Idibenzyl} Methyl} Methyl 1 Carbonyloxycarbonyl 4 Ethyl- (Methyl 3 ylbenzene Joint ο 6 This paper is used in the "《家« 准 (CNS) 言 4 訙 悙 (210X297 public; it) 81. 7. 20.000¾ (II) Λ 6 Η 6 V. Description of invention (59) base]- 1 Η-簯 azole-5 -carboxylic acid I 1 -ethane gas carbonyl gas physicochemical properties ^ -NMR (CDC13): 5 (ppm) 6.7 0-7. 95 (24 H, m). 5 . 3 9-5. 57 (3 H, m), 4, 17 (2 H, q), 3. 23 (3 H, s), 2. 4 2-2. 6 7 (2 H, m), 2. 86 (3 H, d), 1. 4 2-1. 7 6 (1 0 H, m), 1. 17-1. 34 (3 H, m), 0. 85 (3 H, t) Mass spectrometry (FAB): να / z 8 7 2. (ΜΗ +) Example 4 1 η-Bu.

Me .Me NCOCH =C 〇 ^Me •CO〆 VoMe .Me NCOCH = C 〇 ^ Me • CO〆 Vo

Tk 先 閲 讀 背 而 之 注 意 事 項 填 % 枣 % 經濟部中央楳準局κι工消伢合作杜印3i 基 8 3 例 施 實 仿 基 甲Tk first read the background and pay attention to the items. Fill in% Date% Central Bureau of Economics of the Ministry of Economic Affairs, Industry and Consumers Cooperation, Duyin 3i base, 8 cases, implementation of imitation base

CC

基 甲 苯 三 氣- 基 3 酞基 以胺 之丨 代 酯 甲 氣 酸 戊 待 隹 丁 I 2 得 基 醯 烯 I~* 基 甲 本紙張尺度遑用中《«家楳準(CNS)甲4規怙(210X297公龙) 81. 7. 2U.00Ui(t (11) f.i-2 9 ο £ ο G Λli 五、發明説明(ϋ0) (三苯甲基-四唑-5 -基)聯苯-4 -基〕甲基〕-1 Η -眯唑-5 羧酸酞酯。 理化學的性狀 ^I-NMRCCDClg): δ (ppm) 6. 7 7 - 7. 93 (28 H, m), 5. 35-5. 4 8 ( 3 Η, m), 3. 0 3 (3 H, s) . 2. 5 2 - 2. 6 2 ( 2 H, m), 1 . 9 1 ( 3 H, d), 1. 6 6 (3 H, d), 先 閱 ill 背 而 之 注 意 項 再 5 2-1. 7 2 H, m), 1. 25-1. 30 ( 2 H, m), 0· 88 (3 H, t ) 質譜(FAB) :m/z 8 8 8 (MH + ) 實施例4 2 η - Bu- nN-Benzene toluene gas-base 3 phthaloyl esters with amine esters, methanoic acid, pentylpyridinium, I 2, and acetylenes I ~ *怙 (210X297 公 龙) 81. 7. 2U.00Ui (t (11) fi-2 9 ο £ ο G Λli V. Description of invention (ϋ0) (trityl-tetrazol-5-yl) biphenyl- 4-yl] methyl] -1H-quinazol-5carboxylic acid phthalate. Physical and chemical properties ^ I-NMRCCDClg): δ (ppm) 6. 7 7-7. 93 (28 H, m), 5 . 35-5. 4 8 (3 Η, m), 3. 0 3 (3 H, s). 2. 5 2-2. 6 2 (2 H, m), 1. 9 1 (3 H, d ), 1. 6 6 (3 H, d), first read the notes on the back of ill and then 5 2-1. 7 2 H, m), 1. 25-1. 30 (2 H, m), 0 · 88 (3 H, t) Mass spectrometry (FAB): m / z 8 8 8 (MH +) Example 4 2 η-Bu- nN-

Me I /Me ,NCOCH = C XMe 、C02CH20C0CMe3 裝 η 經濟部屮央標準局员工消伢合作社印製 2 Η cMe I / Me, NCOCH = C XMe, C02CH20C0CMe3 installed η Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 2 Η c

Η 81. 7. 20,000^ (II) 本紙ft尺度边用中困家«準(CNS) f 4規格(210X297公;tt)Η 81. 7. 20,000 ^ (II) The ft scale of this paper is used in the sleepy home «quasi (CNS) f 4 specifications (210X297 public; tt)

Λ (i M G 五、發明説明(bl) 將2-]基- 4-〔N-甲基- N- (3-甲基丁嫌酿基)胺基〕-ΐ-ί 〔 2 ' - (三 笨甲基 -四唑 - 5 - 基) 聯笨 - 4 - 基〕 甲基〕-1[]-眯唑-5 -羧酸特戊醯氣甲酯3 . 6 Q克溶在5 %乙酸-乙醇1 5 0 ΙΗ 1 ,而加熱回流一夜後,減壓蒸除溶劑,而與甲苯3 0 in 1 共沸2次。 殘渣從乙酸結晶,得2 -丁基-4-〔 N -甲基- N- (3 -甲基 丁烯醯基)胺基〕-1-〔 〔2^(四唑-5-基)聯苯-4-基〕 甲基〕-1H -眯唑-5-羧酸待戊醯氧甲酯2.0克,白色結晶。 理化學的性狀 熔點:1 4〗-1 4 2 °C元素分析値(C34H4〇N7〇5 . 〇. 2H2〇) C (%) Η (%) Ν (%)計算値 64.79 6.46 15.55分析値 64.59 6.60 1 5. 4 0 實施例4 3 (請先間讀背而之注意事頊孙填-[&gt;?本頁} 經濟部屮央櫺準扃Α工消伢合作杜印製Λ (i MG V. Description of the invention (bl) 2- (4-)-N-methyl-N- (3-methylbutanoyl) amino group]-Ι-ί 〔2 ′-(三Benzomethyl-tetrazol-5-yl) biben-4-yl] methyl] methyl] -1 []-myrazole-5-carboxylic acid pivaloyl gas methyl ester 3. 6 Q g dissolved in 5% acetic acid- Ethanol 1 5 0 ΙΗ 1, and after heating to reflux overnight, the solvent was distilled off under reduced pressure, and azeotrope with toluene 3 0 in 2 times. The residue was crystallized from acetic acid to give 2-butyl-4- [N-methyl- N- (3 -methylbutenyl) amino] -1- [[2 ^ (tetrazol-5-yl) biphenyl-4-yl] methyl] -1H -quinazol-5-carboxylic acid To be 2.0 grams of pentamethylene oxide, white crystals. Physical and chemical properties Melting point: 1 4〗 -1 4 2 ° C elemental analysis value (C34H4〇N7〇5. 〇. 2H2〇) C (%) Η (%) Ν (%) calculation value 64.79 6.46 15.55 analysis value 64.59 6.60 1 5. 4 0 Example 4 3 (please read back and forth and pay attention to the matter first Sun Sun fill-[&gt;? This page} Ministry of Economic Affairs 殮 央 棂 准 扃Alpha Engineering Consumer Cooperative Du Print

-63- 本紙ft尺度边用中國國家«率(CNS) f 4規格(210X297公:«:) 91. 7. 20,000¾ (II) 209^^° Λ () Π (i 五、發明説明(b2) 仿實施例4 2,惟2 - 丁基-4 -〔 N -甲基-N - ( 3 -甲基丁烯 醯基)胺基]-1-〔 〔2'-(三苯甲基-四唑-5-基)聯苯- 4- 基〕甲基〕-1 Η -眯唑-5 -羧酸待戊醛氧甲酯代之以實施 例3 9之化合物2 - 丁基-4 -〔 Ν -甲基-Ν - ( 3 -甲基丁烯醛基) 胺基〕-1-〔 〔2、(三苯甲基-四唑-5-基)聯苯-4-基〕 甲基〕-1H -眯唑-5-羧酸(5 -甲基-2-氧-1,3 -二II号茂烯- 4-基)甲酯,得2-ΪΓ基-4-〔Ν -甲基- Ν- (3 -甲基丁烯醯基) 胺基〕-l-〔 四唑-5-基)聯苯-4-基〕甲基〕-1Η- 眯唑-5-羧酸- (5 -甲基-2-氣-1,3 -二B琴茂烯-4-基)甲酯。 理化學的性狀-63- This paper uses the Chinese national «rate (CNS) f 4 specification (210X297:« :) 91. 7. 20,000¾ (II) 209 ^^ ° Λ () Π (i V. Invention description (b2 ) Example 4 2, but 2-butyl-4- [N-methyl-N- (3-methylbutenyl) amino] -1-[[2 '-(trityl- Tetrazol-5-yl) biphenyl-4-yl] methyl] -1 Η- 篯 azole-5 -carboxylic acid to be replaced by valeraldehyde methyl ester Example 2 9 Compound 2 -Butyl-4- [Ν -methyl-Ν-(3 -methylbutenalyl) amino] -1- [[2, (trityl-tetrazol-5-yl) biphenyl-4-yl] methyl 〕 -1H-Pyrazole-5-carboxylic acid (5-methyl-2-oxo-1,3-diII No. II-carboene-4-yl) methyl ester, to give 2-ΪΓ group-4- [Ν- 甲Group-Ν- (3-methylbutenyl) amino] -l- [tetrazol-5-yl) biphenyl-4-yl] methyl] -1H- quinazol-5-carboxylic acid- ( 5-methyl-2-gas-1,3-di-B-phenocenen-4-yl) methyl ester. Physical and chemical properties

熔點:1 3 9 - 1 4 0 °C 元素分析値(CuH^N^Oe ) C (%) H (%) N {%) 計算値 63.35 5.64 15.6 7 分析値 63.16 5.65 15.67 實施例44 „ (請先閱讀背而之注意事項外填寫本頁) 經濟部中央榀準局A工消费合作社印製Melting point: 1 3 9-1 4 0 ° C Elemental analysis value (CuH ^ N ^ Oe) C (%) H (%) N (%) Calculation value 63.35 5.64 15.6 7 Analysis value 63.16 5.65 15.67 Example 44 "(Please (Read the back-to-back precautions and fill out this page) Printed by the Ministry of Economic Affairs, Central Bureau of Industry and Commerce, A Industrial Consumer Cooperative

81. 7. 20,000張(11) 本紙張尺度逍用中國《家楳準(CNS) T4規怙(210X297公龙) Μ 經濟部中央櫺準Λ;β工消费合作社印製2 - μ Λ Π 6 五、發明説明(6今81. 7. 20,000 sheets (11) of this paper are used in China ’s “China Family Standard (CNS) T4 regulation (210X297 male dragon) Μ Central Ministry of Economic Affairs Standard Λ; β Industrial Consumer Cooperative Printed 2-μ Λ Π 6 V. Description of the invention (6 present

仿實施例42,惟2-正丁基-4-〔 N-甲基- N- (3-甲基丁 烯醯基)胺基〕-1 -〔〔 2 '-(三苯甲基-四唑-5 -基)聯苯 -4 -基〕甲基〕-1 Η -咪唑-5 -羧酸持戊醯氣甲酯代之以實 施例40之化合物2-丁基-4-〔 Ν -甲基- Ν- (3 -甲基丁烯醯 基)胺基〕-卜〔〔2^(三苯甲基-四唑-5-基)聯苯-4-基 〕甲基〕-1Η -眯唑-5-羧酸- ;Τ -乙氣羰氧乙酯,得-2-正 丁基- 4- (N -甲基- N- (3 -甲基丁嫌醒基)胺基〕—1-〔 〔2' -(四唑-5-基)聯苯-4-基〕甲基〕-1H -咪唑-5-羧酸1'-乙氧羰氧乙酯。 理化學的性狀 熔點:1 1 2 - 1 1 4 °C 元素分析値(C33H39N7〇6*0. 6H2〇) C {%) Η (°/〇) 計算値 6 1.8 8 6.3 3 分析値 6 1.7 0 6 . 1 7 實施例4 5Imitating Example 42, except 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino] -1-[[2 '-(trityl-tetra Oxazol-5-yl) biphenyl-4-yl] methyl] -1 Η-imidazole-5-carboxylic acid with methyl ester of pentane gas and the compound of Example 40 2-butyl-4- [Ν- Methyl-Ν- (3-methylbutenyl) amino] -Bu [[2 ^ (trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H- Pyrazole-5-carboxylic acid-; Τ-ethoxycarbonyloxyethyl ester, to give 2-n-butyl-4- (N-methyl-N- (3-methylbutanoyl) amino]] — 1- [[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid 1'-ethoxycarbonyloxyethyl. Physical and chemical properties Melting point: 1 1 2-1 1 4 ° C Elemental analysis value (C33H39N7〇6 * 0.6H2〇) C (%) Η (° / 〇) Calculation value 6 1.8 8 6.3 3 Analysis value 6 1.7 0 6.1.7 Examples 4 5

Η -NΗ -N

JLL t紙張尺度遑用中《家«準(CNS) &gt;F4規怙(210X297公;it) 先 閱 th 背 而 之 注 意 事 再 填 % 本 頁一 裝 玎 N (%) 5 . 3 1 5 . 3 2 線 81. 7. 20,0()0¾ (II)JLL t paper standard is used in "Home" (CNS) &gt; F4 regulations (210X297 public; it) First read th and pay attention to the matter before filling in% This page is a decoration N (%) 5. 3 1 5 . 3 2 lines 81. 7. 20,0 () 0¾ (II)

C Λ (i l\ (iC Λ (i l \ (i

五、發明説明(64) 仿實施例4 2,惟2 -正丁基-4 -〔 N -甲基-N - ( 3 -甲基丁 烯醯基)胺基〕-卜〔〔2 ’ -(三苯甲基-四唑-5 -基)聯苯 -4 -基〕甲基〕-1 Η -眯唑-5 -羧酸待戊醯氧甲酯代之以實 施例41之化合物2 -正丁基-4-〔 Ν -甲基- Ν- (3 -甲基丁烯 醯基)胺基〕-1-〔 〔2^(三苯甲基四脞-5-基)聯苯-4-基 〕甲基〕-1Η -眯唑-5-羧酸酞酸,得 2 -正丁基-4 -( Ν-甲基-Ν-(3-甲基丁烯醯基)胺基〕-1-〔 〔2'-(四唑-5 -基)聯苯-4-基〕甲基〕-1Η-眯唑-5-羧酸酞酯。 理化學的性狀 熔點:2 ϋ 2 - 2 0 3 °C 元素分析値(C36H35N7〇5)c (°/〇) 計算値 66.96 分析値 6 6.82 Η (%) 5 . 4 6 5 . 4 7 Ν (%) 5 . 18 4 . 9 9 (請先間讀背而之注意事項典蜞寫本頁} 實施例4 6 經濟部中央櫺準局A工消费合作社印奴V. Description of the invention (64) Imitating Example 4 2, except that 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino]]-Bu [[2'- (Trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1 Η- 眯 azole-5-carboxylic acid is replaced by the compound 2 of Example 41 by pentyloxymethyl N-Butyl-4- [Ν -methyl- Ν- (3-methylbutenyl) amino] -1- [〔2 ^ (trityltetrahydro-5-yl) biphenyl-4 -Yl] methyl] -1H-quinazol-5-carboxylic acid phthalic acid to give 2-n-butyl-4-(Ν-methyl-Ν- (3-methylbutenyl) amino]]- 1- [[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid phthalate. Physical and chemical properties Melting point: 2 ϋ 2-2 0 3 ° C Elemental analysis value (C36H35N7〇5) c (° / 〇) Calculation value 66.96 Analysis value 6 6.82 Η (%) 5. 4 6 5. 4 7 Ν (%) 5. 18 4. 9 9 (please first Read the back-to-back precautions and write a code on this page} Example 4 6 Central Slave Bureau of the Ministry of Economic Affairs A Industrial Consumer Cooperative Indo

MeMe

仿實施例38,惟持戊酸氣甲酯代之以1-環己氣羰氣乙 -66- 本紙張尺度遑用中《國家標準(CNS) T4規格(210X297公;it) 81. 7. 20,000¾ (II) 00 01 3 e.L 飞.- 6 ο ΛΠ 五、發明説明(6ί;) 基氯,得2 -正丁基-4 -〔 N -甲基-N - ( 3 -甲基丁烯醯基)胺 基〕-1-〔 〔2'-(三苯甲基-四唑-5-基)聯苯-4-基〕甲 基〕-1H-眯唑-5-羧酸 1’-環己羰氣酯。 理化學的性狀 ^-NMR (CDClg): δ (ppm) 6. 72-8. 0 8 ( 2 4 H, m), 5· 30-5. 6 4 ( 3 Η, m), 5. 53-5. 60 ( 1 Η, m) , 3. 23 (3 Η, s), 2. 5 4 - 2. 6 7 (2 Η, m) , 2. 09 (3 Η, s), 1· 15-1. 92 (20H-m), 〇. 86 (3Η, t ) ) 質譜(FAB) : m/ z 9 2 6 (M + ) 實施例4 7 閱 讀 背 而 之 注 意 事 項 再 堝 % 术 經濟部中央梂準局E:工消佾合作杜印製Imitate Example 38, except that methyl valerate is replaced by 1-cyclohexyl carbonyl gas B-66- The paper standard is used in "National Standard (CNS) T4 Specification (210X297; it) 81. 7. 20,000¾ (II) 00 01 3 eL 飞 .- 6 ο ΛΠ V. Description of the invention (6ί;) Based on chlorine, 2-N-butyl-4- [N-methyl-N- (3-methylbutene Acetyl) amino] -1- [[2 '-(trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid 1'- Cyclohexyl carbonyl ester. Physical and chemical properties ^ -NMR (CDClg): δ (ppm) 6. 72-8. 0 8 (2 4 H, m), 5.30-5. 6 4 (3 Η, m), 5. 53- 5. 60 (1 Η, m), 3. 23 (3 Η, s), 2. 5 4-2. 6 7 (2 Η, m), 2. 09 (3 Η, s), 1.15- 1. 92 (20H-m), 0.86 (3Η, t)) Mass Spectrometry (FAB): m / z 9 2 6 (M +) Example 4 7 Read the notes on the contrary and re-% of the Ministry of Economics and Trade Center Enclosure E: Co-operation with the Consumer Council

仿實施例42,惟2 -正丁基-4-〔 N -甲基- N- (3 -甲基丁 -6 7 - 81. 7. 20,000^(11) 本紙ft尺度遑用中«國家楳準(CNS)T4規格(210x297公Λ)Imitate Example 42, except that 2-n-butyl-4- [N-methyl-N- (3-methylbutan-6 7-81. 7. 20,000 ^ (11) is used on the ft scale of this paper. «国 楳Standard (CNS) T4 specifications (210x297 g)

,^ 經濟部中央榣準局A工消赀合作杜印製 CO ο 五、發明説明6 ) 烯醯基)胺基〕-1-〔 〔2‘-(三苯甲基-四唑-5-基)聯苯 -4 -基〕甲基〕-1 Η -眯唑-5 -羧酸持戊醯氣甲酯代之以實 施例46之化合物2 -正丁基-4-〔 Ν -甲基- Ν- (3 -甲基丁烯 醯基)胺基〕-1-〔 〔2_-(三苯甲基-四唑-5-基)聯苯- 4- 基〕甲基〕-1Η-眯唑-5-羧酸-1'-環己羰氣乙酯,得-2-正丁基- 4- (Ν -甲基- Ν- (3 -甲基丁烯醯基)胺基〕-ΐ-〔〔 2’-(四唑-5-基)甲基〕-1Η -眯唑-5-羧酸1,-環己羧 氧乙酯。 1理化學的性狀 ih 先 閲 請 背 而 之 注 意 事 項 再 填 % 术 頁一 熔點:1 7 7 - 1 7 8 °C k 元素分析値(匚37只45^?〇6 C (%) Η (°/〇) Ν (%) 訂 計算値 6 4.99 6 . 6 3 1 4 . 3 4 分析値 6 4.79 6 . 6 8 1 14. 26 線 實施例4 8, ^ The Ministry of Economic Affairs, Central Bureau of Industry and Commerce, Co., Ltd. cooperates in the production of CO. Ο V. Description of the invention 6) Enilyl) amino] -1- [[2 '-(trityl-tetrazole-5- Group) biphenyl-4 -yl] methyl] -1 Η-?-Azole-5-carboxylic acid methyl ester of pentane gas was replaced by the compound of Example 46 2-n-butyl-4- [N-methyl -Ν- (3-methylbutenyl) amino] -1- [[2 -_ (trityl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1Η- 眯Azole-5-carboxylic acid-1'-cyclohexyl carbonyl gas ethyl ester to give-2-n-butyl-4- (Ν-methyl-Ν- (3-methylbutenyl) amino] -l -[[2 '-(tetrazol-5-yl) methyl] -1H-quinazol-5-carboxylic acid 1, -cyclohexyl carboxyethyl ester. 1 Physical and chemical properties ih Please read beforehand Fill in the items again.% Page 1 Melting point: 1 7 7-1 7 8 ° C k Elemental analysis value (37 only 45 ^? 〇6 C (%) Η (° / 〇) Ν (%) Calculated value 6 4.99 6. 6 3 1 4. 3 4 Analysis value 6 4.79 6. 6 8 1 14. 26 Line example 4 8

MeMe

將2 -正丁基- 4-〔N -甲基- N- (3 -甲基丁烯醯基)胺基〕 6 8- 本紙ft尺度遑用中《國家«準(CNS)^規格(210X297公:Jt) 8!. 7. 20,000¾ (II) Λ (i W (i 五、發明説明(G7) -1 -〔〔 2 '-(四唑-5 -基)聯苯-4 -基〕甲基]-1 Η -眯唑-5 -袋酸5 ϋ 0 in g溶在乙醇1 m 1 ,而在冰冷下滴加〇 .〖m 〇 1 /义 乙醇性Κ Ο Η溶液9 . 7 4 m ]。攪拌1 Q分後,不加熱而減壓蒸 除溶劑。將殘渣作成粉狀,得2_正丁基-4-〔N -甲基-N-(3 -甲基丁烯醯基)胺基〕-1-〔 〔2'-(四唑-5-基)聯笨- 4 -基〕甲基〕-1H -眯唑-5-羧酸鉀鹽430mg。理化學的性狀'Η - NMR (DM S Ο) .δ (ppm): 7 . 5 4 (1 Η, d), 7. 3 5- •7. 4 1 (2 Η, m) 7 . 3 0 (1 Η, ά) ,7 . 0 6 (2 Η, d ), 6 . 8 3 (2 Η, d) ,5. 6 1 (2 Η, S ), 5 . 4 4 (1 Η, s ) ,3. 0 6 (3 Η, s ) 2 . 5 7 (2 Η, t) ,1 · 9 4 (3 Η, s ), 1 . 6 1 (3 Η, S ), 1 . 5 0- 1 . 5 6 (2 Η, m) 1 . 2 3 -1 .2 7( 2 Η, m), 0 . 8 0 (3 Η, t ) (請先閱誚背而之注意,項具填寫本頁、 經濟部中央標準局只工消仲合作社印製 質譜(FAB) : m/ z 5 5 0 (M—H)-,5 13 (Μ- K)- 本紙張尺度遑用中《«家標準(CNS)f 4規怙(210X297公tf) 81. 7. 20,000ilt (II) &quot; X 9 ο ri it. Γ\ Λπ 五、發明説明(68) 實施例4 9Use 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino] 6 8- on the ft scale of this paper in the "National Standards (CNS) ^ Specification (210X297 Male: Jt) 8 !. 7. 20,000¾ (II) Λ (i W (i V. Description of the invention (G7) -1-[[2 '-(tetrazole-5-yl) biphenyl-4-yl] Methyl] -1 Η-簯 azole-5-bag acid 5 ϋ 0 in g was dissolved in ethanol 1 m 1, and was added dropwise under ice cooling 〇. 〖M 〇1 / sense ethanolic K Ο Η solution 9. 7 4 m]. After stirring for 1 Q minutes, the solvent was distilled off under reduced pressure without heating. The residue was powdered to give 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) ) Amino] -1- [[2 '-(tetrazol-5-yl) biben-4-yl] methyl] -1H-quinazol-5-carboxylic acid potassium salt 430mg. Physical and chemical properties' Η -NMR (DM S Ο) .δ (ppm): 7. 5 4 (1 Η, d), 7. 3 5- • 7. 4 1 (2 Η, m) 7. 3 0 (1 Η, ά) , 7. 0 6 (2 Η, d), 6.8 3 (2 Η, d), 5. 6 1 (2 Η, S), 5. 4 4 (1 Η, s), 3. 0 6 ( 3 Η, s) 2.5 7 (2 Η, t), 1. 9 4 (3 Η, s), 1. 6 1 (3 Η, S), 1.5 0- 1. 5 6 (2 Η , m) 1. 2 3 -1 .2 7 (2 Η, m), 0. 8 0 (3 Η, t) (please read the note on the back first To fill out this page, the Central Standards Bureau of the Ministry of Economic Affairs prints a mass spectrometer (FAB) printed by only the Zhongzhong Cooperative Society: m / z 5 5 0 (M—H)-, 5 13 (Μ-K)- In use, "« Family Standard (CNS) f 4 regulations (210X297 public tf) 81. 7. 20,000ilt (II) &quot; X 9 ο ri it. Γ \ Λπ V. Description of invention (68) Example 4 9

MeMe

將2-正丁基-4-〔N-甲基- N-(3-甲基丁烯醯基)胺基〕 (請先閲讀背而之注意事項#填Κ采頁j -1-〔 〔2’-(四唑-5-基)聯苯-4-基〕甲基〕-1H-眯唑-5 -羧酸1'-乙氣羰氣乙酯990mg溶在乙醇20ml,而在冰冷 下滴加O.lmol/Jl乙醇性Κ0Η溶液15.8ml。在5。0以下攪 拌10分後,減壓蒸除溶劑,得2 -正丁基-4-〔N -甲基- N-(3 -甲基丁烯醯基)胺基〕-1-〔 〔2'-(四唑-5 -基)聯苯- 4 -基〕甲基〕-1H -眯唑-5-羧酸I1-乙氣羰氣乙酯鉀鹽1.〇 克,泡狀。 理化學的性狀 Ή-NMR (DMSO) δ (ppm): 7 · 54 (1H, d) , 7. 36-7. 41 (2 H, m), 7. 2 9 ( 1 H, d) , 7. 0 7 (2 Η, d), 6. 83 (2 Η, d) , 6 . 6 6 ( 1 Η, t ) 5. 54 (2 Η, dd). 5 . 38 ( 1 Η, s ), -70- 本紙張足度遑用中鷗《家«準(CNS) Ή規格(210x297公:tfr) 裝· 線· 經濟部屮央櫺準局εχ工消费合作杜印製 81. 7. 20r000ifc (II)Put 2-n-butyl-4- [N-methyl-N- (3-methylbutenyl) amino]] (please read the back-end notes first #fill Κ 采 页 j -1- [〔 2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5 -carboxylic acid 1'-ethane carbonyl gas ethyl ester 990mg dissolved in ethanol 20ml, and under ice cooling Add 0.18ml / Jl ethanolic KOH solution 15.8ml dropwise. After stirring for 10 minutes below 5.0, evaporate the solvent under reduced pressure to obtain 2-n-butyl-4- [N-methyl-N- (3- Methylbutenylamino) amino] -1- [[2 '-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid I1-ethane Carbonate ethyl ester potassium salt 1.0 g, foamy. Physical and chemical properties Ή-NMR (DMSO) δ (ppm): 7. 54 (1H, d), 7. 36-7. 41 (2 H, m ), 7. 2 9 (1 H, d), 7. 0 7 (2 Η, d), 6. 83 (2 Η, d), 6.6 6 (1 Η, t) 5. 54 (2 Η , dd). 5. 38 (1 Η, s), -70- This paper is fully equipped with Zhongou's "Home« Standard (CNS) Ή Specification (210x297 g: tfr) installed · line · Ministry of Economic Affairs Bureau εχIndustry and Consumer Cooperation Du Printing 81. 7. 20r000ifc (II)

·、.r .L Λ (i H () 五、發明説明 4. 10 ( 2 Η, q) , 3 . 0 4 ( 3 Η, s ), 2. 63-2. 6 6 ( 2 Η, m) , 1· 96 (3 Η, s ) 1. 61 (3Η, s), 1. 53—1. 59 (2Η, m) 1 . 2 4 - 1. 2 8 ( 2 Η, m), 1 - 1 7 (3 Η, d) , 0. 82 ( 3 Η, t ) 質譜(F A Β) : m/ ζ 6 2 8 (Μ — Κ) 一 實施例5 0 η - Bu·, .R .L Λ (i H () V. Description of the invention 4. 10 (2 Η, q), 3.0 4 (3 Η, s), 2. 63-2. 6 6 (2 Η, m ), 1.96 (3 Η, s) 1. 61 (3Η, s), 1. 53-1. 59 (2Η, m) 1.2 4-1. 2 8 (2 Η, m), 1- 1 7 (3 Η, d), 0.82 (3 Η, t) mass spectrometry (FA Β): m / ζ 6 2 8 (Μ — Κ) Example 5 0 η-Bu

(請先閲讀背而之注意事項洱填寫术頁』 將 苯 聯 Η NCOCH = CHC02Et CO,Et 基基而 胺4-,(Please read the precautions for filling in Er's page first) Benzene Η NCOCH = CHC02Et CO, Et base and amine 4-,

基吡 拌洗 攪水 P 而 5 指 1 S 在乙 〇 酸 氯乙 醯在 之溶 製渣 ,調殘 IB1氯將 10醯, 啶草劑 經濟部屮央榀準,知员工消伢合作杜印製 乙 : -烷順 己3- 酯 乙 酸 乙 狀 。性 狀的 -5泡學 唑,化 8 四 m 理 基 0 4 烯-丙苯 羰聯 氣&gt; 基 基 溶析 I - 7 除層CN基酯 蒸柱,甲乙 壓膠-4苯酸 減矽基三羧 ,r±l—115 後,正nl-時後2-&quot; 小次得&quot; 唑 咪 本紙張尺度遑用中困國家楳準(CNS)T4規格(210X297公幻 81. 7. 20(000ifc(H)Kylpyridine mixed with water P and 5 refers to 1 S in acetic acid chloroacetate dissolved in slag, adjusted residual IB1 chlorine will be 10 amide, chlorpyrifos Ministry of Economics, quasi-accurate, know employees to cooperate with Du Yin Production of B: -Alkane cis-hexyl 3-ester acetate ethyl. Characters: -5 blezozole, chemistry 8 4 m, base 0 4 ene-propylbenzene carbonyl gas> base group leaching I-7 delamination CN base ester steam column, methyl ethyl pressure gel-4 benzoic acid minus silicon base After tricarboxylic acid, r ± l—115, after nl-hour, 2- &quot; small order is &quot; Zomibene paper standard is used in the middle-sleepy national standard (CNS) T4 specification (210X297 public phantom 81. 7. 20 (000ifc (H)

Ο 經濟部中央櫺準局Α工消费合作杜印製 ο - CM Λ (i Π () 五、發明説明(7〇) 'H-NMR (CDC13) .&lt;5 (ppm): 6. 7 0 - 7. 9 4 (2 5 H, m) , 5. 5 7 (2 H, s) 4 · 08-4. 41 (4 H, m) , 2. 56 (2 H, t ) 1. 12-1. 90 (10H, m), 0. 86 (3H, t 質譜 實施例5 1Ο Du-printed by the Ministry of Economic Affairs, Central Bureau of Industry and Commerce ο-CM Λ (i Π () V. Description of invention (7〇) 'H-NMR (CDC13). &Lt; 5 (ppm): 6. 7 0 -7. 9 4 (2 5 H, m), 5. 5 7 (2 H, s) 4 · 08-4. 41 (4 H, m), 2. 56 (2 H, t) 1. 12- 1. 90 (10H, m), 0.86 (3H, t MS Example 5 1

MeMe

三苯甲基 將2-正丁基-4-〔N-(3-順-乙氧羰丙烯醯基)胺基〕-1 〔〔2'-(三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕-1H-眯唑-5-羧酸乙酯1.61克溶在DMF 2Gml,而在冰冷下加 碘化甲基3 2 0 m g , N a Η 9 0 m g。在5 °C攪拌5小時後,減壓 蒸除溶劑。殘渣溶在乙酸乙酯而水洗2次後,予以乾燥 ,減壓蒸除溶劑,在矽膠柱層析(己烷:乙酸乙酯=5 : 1 ),得2 -正丁基-4 -〔 N -甲基-N - ( 3 -順-乙氣羰丙烯醯基 )胺基]--〔〔 2 1 -(三苯甲基-四脞-5 -基)聯苯-4 -基] 甲基〕-1H -眯唑-5-羧酸乙酯1.40克,泡狀。 理化學的性狀 本紙張尺度遑用中國國家«準(CNS)T4規怙(210X297公龙) HI. 7. 20,000¾ (I!) (請先閲讀背而之注意事項再填寫本頁」 裝- £03心 Λ (i Κ6 五、發明説明( 1 II - N M R ( C D C 1 3) δ (ppm):6. 7 4 - 7. 9 2 (2 5 H, m) , 5. 48 (2 H, s), 4 · 12 (4 H, q ) , 3. 3 1 (3 H, s ), 2. 54 (2 H, t ) , 1. 4 5 — 1. 82 ( 2 H, m), 1. 0 5 - 1. 40 ( 8 H, m) , 0. 86 (3 H, t ) 質譜 實施例5 2 NCOCH = CHC02Et n - BuTrityl will 2-n-butyl-4- [N- (3-cis-ethoxycarbonylpropenyl acetyl) amino] -1 [〔2 '-(trityl-tetrazol-5-yl ) Biphenyl-4-yl] methyl] -1H-quinazole-5-carboxylic acid ethyl ester 1.61 g was dissolved in DMF 2Gml, and methyl iodide 3 20 mg, Na Η 90 mg were added under ice cooling . After stirring at 5 ° C for 5 hours, the solvent was distilled off under reduced pressure. The residue was dissolved in ethyl acetate and washed twice with water, dried, and the solvent was distilled off under reduced pressure, and the silica gel column chromatography (hexane: ethyl acetate = 5: 1), to give 2-n-butyl-4-[N -Methyl-N-(3 -cis-ethoxycarbonylpropenyl amidyl) amino]-[〔2 1-(trityl-tetramin-5-yl) biphenyl-4-yl] methyl 〕 -1H-Fuzole-5-carboxylic acid ethyl ester 1.40 g, foam. The physical and chemical properties of this paper are based on the Chinese National Standard "CNS" T4 (210X297 male dragon) HI. 7. 20,000¾ (I!) (Please read the precautions before filling in this page " £ 03 Λ (i Κ6 V. Description of the invention (1 II-NMR (CDC 1 3) δ (ppm): 6. 7 4-7. 9 2 (2 5 H, m), 5. 48 (2 H, s), 4 · 12 (4 H, q), 3. 3 1 (3 H, s), 2. 54 (2 H, t), 1. 4 5 — 1. 82 (2 H, m), 1 . 0 5-1. 40 (8 H, m), 0.86 (3 H, t) Mass Spec Example 5 2 NCOCH = CHC02Et n-Bu

MeMe

(請先閲讀背而之注意节項#填寫术頁; 裝· 訂_ 線. 2 J J 將基基 胺甲 基 丁 正 唑 眯 _ 基醋 基甲乙 甲苯酸 N-三羧 順 唑 四 經濟部屮央榣準历=5工消伢合作社印製 20苯 液甲 溶與 J 享 基3自 g基乙 醯 -_ 烯-4酸 丙苯乙 羰聯 % 氧丨5 乙 基 在 溶 克 減層 -柱 後 _ 時矽 小在卩v、 3itI 拌殘-4 攪。基 °c次丁 9 2 正 在沸2-而共得 基 甲 基 胺 基 - 5 I ο 起 g 唑 m 四60 ( 9 2 C乙 C酸 - 羧 1 -* 5 —唑狀 咪性 H-的 基-1學 醯1化 烯基理 丙 羰 劑 氣 容 \1 i 仿 7 4 除M a -氯li 蒸¢-)苯 壓析(3聯 S子 酉 甲 基 甲 本紙張疋度遑用中《 B家標準(CNS) Ή規怙(210x297公:jfc) 81. 7· 20,0(ΧΜΜΠ) 9 ο ,0,0 ΛΠ 2 (7 明 發 五 Η - NMR (C D C 1 3)δ (ppm): 8 . 0 3 (1 H, d), 7 . 5 : 3 - 7 . 6 1 (2 7 . 4 3 (1 H, d) ,7. 1 9 (2 H, d ), 7 . 0 3 (2 H. d) .6 . 8 6 (1 H, d ), 6 . 7 4 (1 H, d) ,5. 5 7 (2 H, s ) r 4 . 1 9 (2 H, q) ,4. 0 1 (2 H, q), 3 . 3 2 (3 H, s ), ,2. 8 0 (2 H, t ), 1 . 7 4 - 1· 8 0 (2 H, m), 1 . 4 0 - 1 . 4 7 (2 H, m), 1. 23 (3 H, t), 1. 18 (3 H, t ), 0. 9 5 (3 H, t ) 質譜(FAB) : m/ z 5 8 6 (MH + ) 實施例5 3 (請先閲請背而之注意事項孙碣寫术頁』 經濟部屮央櫺準局员工消#合作社印51(Please read the back first of the section #Fill in the surgery page; Binding · Bookmark _ Line. 2 JJ will be based on the aminobutyrazole _ ethyl acetate methyl ethyl toluic acid N-tricarboxyl cisazole four Ministry of Economic Affairs Central calendar = 5 printed by the industrial and commercial cooperatives. 20 benzene solution was dissolved with J. estriol. 3 g g acetyl-_en-4 propylene phenyl ethyl carbonyl% oxygen. 5 ethyl group in the dissolution layer- Behind the column _ when Si Xiaozai is mixed in the v, 3itI residue-4 stirring. The base ° c times butadiene 9 2 is boiling 2- and a total of methyl methylamino group-5 I ο g gazole m four 60 (9 2 C Acetic acid-carboxyl 1-* 5-azole-like imidic H-based-1-carboxylic acid 1 alkenyl propyl carbonyl reagent gas capacity \ 1 i imitation 7 4 except for Ma-chloroli steam ¢-) benzene pressure Analysis of the use of 3-fold S-sub-methyl methyl paper in the "B home standard (CNS) Ή regulation (210x297 public: jfc) 81.7.20,0 (ΧΜΜΠ) 9 ο, 0,0 ΛΠ 2 (7 Mingfa five H-NMR (CDC 1 3) δ (ppm): 8.0 3 (1 H, d), 7.5: 3-7.6 1 (2 7. 4 3 (1 H, d), 7. 1 9 (2 H, d), 7. 0 3 (2 H. d) .6. 8 6 (1 H, d), 6. 7 4 (1 H, d), 5. 5 7 (2 H, s) r 4. 1 9 (2 H, q), 4. 0 1 (2 H, q), 3. 3 2 (3 H, s ),, 2. 8 0 (2 H, t), 1. 7 4-1 · 8 0 (2 H, m), 1. 4 0-1. 4 7 (2 H, m), 1. 23 ( 3 H, t), 1. 18 (3 H, t), 0.9 5 (3 H, t) Mass Spectrometry (FAB): m / z 5 8 6 (MH +) Example 5 3 (Please read first Contrary to note, Sun Jie writes the art page 』Ministry of Economic Affairs 汮 央 擂 准 局 Employee # Cooperative seal 51

MeMe

將2 -正丁基-4 -〔 N -甲基-N - ( 3 -順-乙氣羰丙烯醯基) 胺基〕-1 -〔 〔 2 ’ -(四唑-5 -基)聯苯-4 -基]甲基〕-1}1- 咪唑-5 -羧酸乙酯8 5 0 m g溶在乙醇2 0 m 1 ,而在冰冷下滴加 7 4 - 本紙ft尺度遑用中《國家«準(CNS) 規怙(210x297公:«:) 81. 7. 20,000張(II) 09^:13 Λ (i II Γ, 經濟部中央標準局Α工消费合作社印¾ 五、發明説明(73) 1 N N a ϋ Η 7 · 3 m 昇至室溫而攪拌1 8小時後,減壓蒸除 溶劑。殘渣溶在水5 in 1 ,而· 1 N鹽酸7 · 3 ra 1作成p Η 2〜3。 次以乙酸乙酯2 0 m 1萃取2次而予以水洗,乾燥,減壓蒸 發。殘渣從丙酮-乙_結晶,得2-正丁基- 4-〔N -甲基-N -(3 -順-乙氧羰丙烯醯基)胺基〕-1 -〔〔 2 1 -(四唑-5 -基 )聯苯-4-基〕甲基〕-1H-眯唑-5-羧酸3 6 0 mg,白色結晶。 理化學的性狀 元素分析値(C27H2TN7Os · 1 H2〇 &gt; C {%) Η (%) Ν (%) 計算値 59.22 5 . 3 4 1 7.9 1 理論値 59.09 5.23 17.80 'Η - NMR (DMS Ο) δ (ppm): 7. 5 2 - 7. 70 (2 Η, m) , 7. 08 (2 Η, d), 6. 92 (2 Η, d) , 6. 7 4 (1 Η, d), 6. 46 ( 1 Η, d), 5. 63 (2 Η, s ), 3. 17 (3 Η, s ) , 2. 59 ( 2 Η, t), 1. 49-1. 5 4 ( 2 Η, m), 1. 23-1. 27 ( 2 Η, m) , 0. 80 ( 3 Η, t ) 質譜(FAB):m/z 5 3 0 (ΜΗ + ) 7 5 本紙ft尺度遑用中《國家«準(CNS) Ή規怙(2】0X297公;《:) 81. 7. 20,_ίΜΗ) 先 間 讀 背 而 之 意 事 項 填 术 頁1 五、發明説明(74) 實施例5 4 ΗPut 2-n-butyl-4- [N-methyl-N- (3-cis-ethoxycarbonylpropenylamide) amino] -1-[[2 '-(tetrazole-5-yl) biphenyl -4 -yl] methyl] -1} 1-imidazole-5-carboxylic acid ethyl ester 8 5 0 mg dissolved in ethanol 2 0 m 1, and add 7 4 dropwise under ice-cooling «Standard (CNS) regulations (210x297:« :) 81. 7. 20,000 sheets (II) 09 ^: 13 Λ (i II Γ, printed by the Central Bureau of Standards, Ministry of Economic Affairs, A Industrial Consumer Cooperative Society ¾ V. Description of Invention (73 ) 1 NN a ϋ Η 7 · 3 m was raised to room temperature and stirred for 18 hours, then the solvent was distilled off under reduced pressure. The residue was dissolved in water 5 in 1, and · 1 N hydrochloric acid 7.3 ra 1 made p Η 2 ~ 3. Extract twice with ethyl acetate 2 0 m 1 and wash with water, dry and evaporate under reduced pressure. The residue is crystallized from acetone-B_ to give 2-n-butyl-4- [N-methyl-N- ( 3 -cis-ethoxycarbonylpropenylamino) amino] -1-[[2 1-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid 3 60 mg, white crystals. Physical and chemical properties Element analysis value (C27H2TN7Os · 1 H2〇> C {%) Η (%) Ν (%) Calculation value 59.22 5. 3 4 1 7.9 1 Theoretical value 59.09 5.23 17.80 'Η-NM R (DMS Ο) δ (ppm): 7. 5 2-7. 70 (2 Η, m), 7. 08 (2 Η, d), 6. 92 (2 Η, d), 6. 7 4 ( 1 Η, d), 6. 46 (1 Η, d), 5. 63 (2 Η, s), 3. 17 (3 Η, s), 2. 59 (2 Η, t), 1. 49- 1. 5 4 (2 Η, m), 1. 23-1. 27 (2 Η, m), 0.80 (3 Η, t) mass spectrometry (FAB): m / z 5 3 0 (ΜΗ +) 7 5 The ft scale of this paper is used in the "National Standards (CNS) Ή Regulations (2) 0X297 public;" :) 81. 7. 20, _ίΜΗ) Read the meaning of the matter in advance and fill in the page 1 V. Description of the invention (74) Example 5 4 Η

Λ 6η 6 先 閱 讀 背 而 之 注 意 填 寫 本 頁 經濟部屮央橾準局貝工消伢合作杜印製 將4 -胺基-2-正丁基-1-〔〔 2'-(.二苯甲基-四唑-5-基 )聯苯-4-基〕甲基〕-1Η -眯唑-5-羧酸乙酯1.(!克溶在吡 啶1 0 m 1 ,而在冰冷下加由(Ε ) - ( 3 -二甲胺甲基)丙烯酸2 8 5 mg及草醒氮420mg調製之醒氣之二氛甲院溶液IQml。在 1 5 °C攪拌4小時後,減壓蒸除溶劑。於殘渣加氣仿及水 。分取有機層而以硫酸鎂乾燥後,減壓蒸除溶劑。殘渣 在矽膠柱層析(己烷:乙酸乙酯=1: 1〜1: 2),得2 -正 丁基- 4-〔N-(E)-(3 -二甲胺甲基)丙烯醯胺基:-1-〔〔 2’-(三苯甲基-四唑-5-基)聯苯-4-基〕甲基〕-1H -眯唑 -5 -羧酸1'-乙氣羰氧乙酯450mg,泡狀。 理化學的性狀 1H-NMR(CDC13): 6 (ppm) 9. 12 (1 H, brs), 6. 71-7. 9 6 (2 8 H, m) , 5. 37 (2 H, s), 7 6 本紙ΛΛ度遑用中國《家楳準(CNS)甲4規怙(210X297公釐) 81. 7. 2〇.υ〇ϋίΜϋ) Λ 6η 6 五、發明説明(7 5) 4. 19 (2 H, q) . 3. 6 2 - 3. 7 5 ( 2 H, m), 2. 6 6 (6 H, s ) , 2. 4 6 - 2. 6 5 ( 2 H, m), 1 . 4 5 - 1 . 6 6 ( 2 H, m) , 1. 18 ( 3 Η, t), 1. 10-1. 34 (2H, m), 0. 88 (3H, t) 質譜(FAB) 7 9 9 (MH +) 實施例5 5Λ 6η 6 Read it first and pay attention to it. Fill out this page. The Ministry of Economic Affairs, the Central Bureau of Industry and Fisheries Co., Ltd. cooperates with Dugong to produce 4-amino-2-n-butyl-1- [〔2 '-(. Diphenyl Methyl-tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid ethyl ester 1. (! G dissolved in pyridine 10 m 1, and added under ice cooling IQml of Dioxin Nail Salon Solution prepared by (Ε)-(3-Dimethylaminemethyl) acrylic acid 285 mg and chlortetracycline 420 mg. After stirring at 15 ° C for 4 hours, it was distilled off under reduced pressure Solvent. Aerated imitation and water were added to the residue. The organic layer was separated and dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel column (hexane: ethyl acetate = 1: 1 ~ 1: 2), To give 2-n-butyl-4- [N- (E)-(3-dimethylaminomethyl) acrylamido: -1- [〔2 '-(trityl-tetrazol-5-yl ) Biphenyl-4-yl] methyl] -1H-quinazol-5-carboxylic acid 1'-ethoxycarbonyloxyethyl 450mg, foamy. Physicochemical properties 1H-NMR (CDC13): 6 (ppm) 9. 12 (1 H, brs), 6. 71-7. 9 6 (2 8 H, m), 5. 37 (2 H, s), 7 6 The paper ΛΛ degree is used in China ’s ) A4 gauge (210X297 mm) 81. 7. 2〇.υ〇ϋίΜϋ) Λ 6η 6 Description of the invention (7 5) 4. 19 (2 H, q). 3. 6 2-3. 7 5 (2 H, m), 2. 6 6 (6 H, s), 2. 4 6-2 . 6 5 (2 H, m), 1. 4 5-1. 6 6 (2 H, m), 1. 18 (3 Η, t), 1. 10-1. 34 (2H, m), 0 . 88 (3H, t) Mass Spectrometry (FAB) 7 9 9 (MH +) Example 5 5

MeMe

將2 -正丁基-4-〔N-(E)-(3 -二甲胺甲基)丙烯醯胺基〕 -l-〔 〔2,-(三苯甲基-四唑-5-基)聯苯-4-基]甲基] 唑 咪 胺碘 醯基 甲甲 基加 甲 , 二 後 在分 溶20 mg拌 20攪 4 醋 g J ffl z3 2 氣 羰aH 氧&quot;酸二 羧 slΜ -- 昇 5 而 劑 溶 除 蒸 壓 減 後 時 小 5 拌 if 經濟部中央榣準局员工消费合作杜印製 減 後 燥 乾 0 酸 硫 以 層析 機層 有柱 取膠 分矽 〇 在 水渣 及殘 仿 〇 氨劑 加溶 渣除 殘蒸 於壓 醇 甲 仿 氣 正 2-基基 得胺甲 基 基 _ 甲乙 苯酸 三羧 ( ~ 一 5 2唑 V_. 眯 基 5 甲 -胺唑 甲四 甲 - Ν I 基 0 烯 丙 基 得 4 - 苯 聯 基 狀 泡 81. 7. 20,U00ii|c (II) 本紙张尺度遑用中《 家樣毕(CNS)甲4規怙(210X297公;¢) 203沿 Λ 6 Β 6 五、發明説明(76) 理化學的性狀 1H-NMR (CDC13):δ (ppm) 6 . 7 0 - 7. 9 2 ( 2 7 H , m), 5. 9 5-6. 16 ( 1 Η, m) , 5 . 4 7 ( 2 Η, s ), 4. 1 1 (2 Η, q) , 3. 4 3-3. 5 1 (2 Η, m), 3 . 29 ( 3 Η, s), 2. 52 (6 Η, s ), 2. 50-2. 71 (2Η, m), 1. 4 5 - 1. 6 5 (2 Η, m) , 1. 20 (3 Η, t ), 1. 12-1. 31 ( 2 Η, m) , 0. 88 ( 3 Η, t ) 質譜(F A Β) 8 1 5 (ΜΗ +) 實施例5 6 Me2-N-butyl-4- [N- (E)-(3-dimethylaminomethyl) acrylamido] -l- [[2,-(trityl-tetrazole-5-yl ) Biphenyl-4-yl] methyl] oxamidine iodide methyl methyl plus methyl, then dissolve in 20 mg and mix 20 mg and stir 4 vinegar g J ffl z3 2 gas carbonyl aH oxygen &quot; acid dicarboxyl slM -Up to 5 and the agent is dissolved and the autoclave is reduced and the time is reduced to 5 times. If the consumer cooperation of the Central Bureau of Economy and Economy of the Ministry of Economic Affairs is printed and dried, the acid is dried and dried. Residues and residual imitation amines are added with dissolved residues to remove residues and vaporize in the alcohol 2-methyl group of methylformaldehyde gas to obtain amine methyl group-tosylate tricarboxylate (~ 5 2 azole V_. Succinyl 5 methyl-amine azole A tetramethyl-Ν I group 0 allyl to 4-benzyl-like bubble 81. 7. 20, U00ii | c (II) This paper is not used in the "Home Sample Bi (CNS) A 4 regulation (210X297 ¢; 203 along Λ 6 Β 6 5. Description of the invention (76) Physical and chemical properties 1H-NMR (CDC13): δ (ppm) 6. 7 0-7. 9 2 (2 7 H, m), 5 . 9 5-6. 16 (1 Η, m), 5. 4 7 (2 Η, s), 4. 1 1 (2 Η, q), 3. 4 3-3. 5 1 (2 Η, m ), 3.29 (3 Η, s), 2. 52 (6 Η, s), 2. 50-2. 71 (2Η, m), 1. 4 5-1. 6 5 (2 Η, m), 1. 20 (3 Η, t), 1 . 12-1. 31 (2 Η, m), 0.88 (3 Η, t) mass spectrometry (FA Β) 8 1 5 (ΜΗ +) Example 5 6 Me

N^NCOCH = CHCH2NMe2 n — Bu -《IT 、入 C〇2EtN ^ NCOCH = CHCH2NMe2 n — Bu-《IT 、 入 C〇2Et

(請先閲讀背而之注意事項杯塡寫本頁; 裝· *?τ_ 線- 經濟部中央標準局貝工消&quot;合作杜印製 基醇與 基 丁 正 - 2 將 基 胺 甲 基 甲 在一 -J 由沸 ,共 ral苯 10甲 基 甲 胺 甲基 二甲 3-苯 /IV- 三 \)/ /V E - //V *. 1 2 唑 四 基 τ 胺苯 醯聯 烯丨 丙 基 酯後 乙時 酸小 羧5 在 溶 -B而 Ξ 酸 --1 乙劑醇 %溶甲 -ί—1 除 : 蒸仿 壓氣 /IV 咸 析 層 柱 膠 矽 在 -5半渣 唑m殘 眯 Ρ ο H-90次 本妹張尺度遑用中《«家楳率(CNS)T4規格(210X297公:») 81. 7. (1!)(Please read the notes on the back of the cup first to write this page; install · *? Τ_ line-Ministry of Economic Affairs Central Standards Bureau Beigong &quot; cooperation du printing base alcohol and Kebutane-2 will be amino amine methyl In a-J by boiling, co-ral benzene 10 methyl methylamine methyl dimethyl 3-benzene / IV- tri \) / / VE-// V *. 1 2 oxazolyl τ amine phenyl acetylene allyl After the base ester, the acetic acid carboxyl 5 is dissolved in -B and the Ξ acid--1 ethyl alcohol is dissolved in methyl alcohol-ί-1.眯 Ρ ο H-90 times, this girl's Zhang scales are used in the "« Carbon rate (CNS) T4 specification (210X297 public: ») 81. 7. (1!)

ί、 (J Λ 6 Η 6 五、發明説明( Π) :卜5 :〖),得2 - 丁遷 烯醯基-Ν-甲胺基〕-ί 卜〔Ν - ( Ε ) - ( 3 -二甲胺甲基)丙 〔〔2 1 -(四唑-5 -基)聯苯-4 -基〕 甲基]-1Η -咪唑-5-羧酸乙酯80rag,泡狀 理化學的性狀 1H-NMR (CDC13): δ (ppm) 6. 5 0 - 7. 7 8 ( 9 H, m), 5· 85 — 6. 09 ( 1 Η, m) , 5 4. 15 (2 Η, q) , 3. 3 0-3 3. 26 (3 Η, s). 2. 6 3-2 2. 26 ( 3 Η, s ) , 2. 3 7 (6 Η, s ),1. 5 6 - 1. 8 7 ( 2 Η, m) , 1. 22 (3 Η, t ) 1. 15-1. 38 (2 Η, m) , 0 . 88 (3 Η, t 質譜(FAB) 5 7 1 (ΜΗ +) 4 7 (2 Η, s ) 3 5 ( 2 Η, τη) 8 2 (2 Η, m) \ 請 閲 背 而 之 注 意 事 項 填 寫 尽 裝 π 線 經濟部屮央梂準局貝工消合作社印製 本紙張尺度遑用中《國家楳毕(CNS) Ή規格(2丨0父297公|) 81. 7. 20.00Uik(ll) Λ 6 Β 6 五、發明説明(78) 處方例 Η舉本發明化合物當作翳藥之處方例。 錠劑 組成 1 ΰ in g錠 實施例3 7之化合物 1〇 乳糖 83.4 玉米澱粉 18 羥丙基纖雒素 4 羧甲基纖維素鈣 4 硬脂酸鎂 0.6 共計 1 2 0 ( m g ) 將實施例3 7之化合物5 Q克,乳糖4 1 7克,玉米澱粉9 0 克以流動造粒被覆裝置(大川原製作所)均勻混合後,對 此噴霧10 %羥丙基纖維素溶液2QQ克來造粒。乾燥後, 0 X 素 7 維)¾ 纖&gt; 基 甲 矮 加 ,機 選錠 筛打 孔轉 篩回 20在 經’ 所 Η 鐵 畑 克片 3 每 鎂成 酸作 旨 仵 ΗΠ —不- 硬臼 及之 R 克 經濟部中央標準局K3:工消ί\ν合作杜印製 劑 錠 之 本紙》尺度逡用中《國家《毕(CHS) T 4規怙(210X297公;¢) 81. 7. 20.000¾ (II)ί, (J Λ 6 Η 6 Fifth, the description of the invention (Π): Bu 5: 〖), get 2-butanenyl-N-methylamino] -ί Bu 〔Ν-(Ε)-(3- Dimethylaminomethyl) propane [〔2 1-(tetrazol-5-yl) biphenyl-4-yl] methyl] -1H-imidazole-5-carboxylic acid ethyl ester 80rag, bubble physical and chemical properties 1H -NMR (CDC13): δ (ppm) 6. 5 0-7. 7 8 (9 H, m), 5.85 — 6. 09 (1 Η, m), 5 4. 15 (2 Η, q) , 3. 3 0-3 3. 26 (3 Η, s). 2. 6 3-2 2. 26 (3 Η, s), 2. 3 7 (6 Η, s), 1. 5 6-1 . 8 7 (2 Η, m), 1. 22 (3 Η, t) 1. 15-1. 38 (2 Η, m), 0.88 (3 Η, t mass spectrometry (FAB) 5 7 1 (ΜΗ +) 4 7 (2 Η, s) 3 5 (2 Η, τη) 8 2 (2 Η, m) \ Please read the precautions and fill in the complete π line, the Ministry of Economic Affairs, the Central Bureau of the Ministry of Economic Affairs, Beigong Consumer Cooperative The standard of the printed paper is used in the "National Standards (CNS) Ή Specification (2 丨 0 father 297 public |) 81. 7. 20.00Uik (ll) Λ 6 Β 6 5. Description of the invention (78) Prescription examples The compound of the present invention is used as a prescription for panacea. Tablet composition 1 ΰ in g tablet Example 3 Compound 7 7 10 Lactose 83.4 Corn starch 18 Hydroxypropylcellulose 4 Calcium carboxymethylcellulose 4 Magnesium stearate 0.6 Total 1 2 0 (mg) The compound of Example 3 7 5 Q g, lactose 4 1 7 g, corn starch 90 g are flowed into a granulation coating device (Ogawara After being uniformly mixed, spray 10% hydroxypropyl cellulose solution with 2QQ grams for granulation. After drying, 0 X element 7 dimensional) ¾ fiber> base plus short, machine-selected ingot sieve punching and sieve back 20 在 经 '所 Η Tiehatake tablets 3 Each magnesium is made into an acid for the purpose of ΗΠ —No-hard mortar and R grams of the Ministry of Economic Affairs Central Standards Bureau K3: industrial consumption ί \ ν cooperation du printing preparation of the original paper of the ingots "scale In use "National" Bi (CHS) T 4 regulations (210X297; ¢) 81. 7. 20.000¾ (II)

Claims (1)

六、申請專利範園 A: 本; η :7 VJ 个 ¢)7 第8 1 1 06539「4-醯胺基眯唑衍生物」專利案 (82年5月修正) 1. 一種如下式(I)新顆之咪唑衍生物或其製_容許鹽Sixth, the application for patent Fan Garden A: this; η: 7 VJ ¢) 7 No. 8 1 1 06539 patent case of "4-aminoamidoazole derivative" (amended in May 82) 1. One of the following formula (I ) New imidazole derivatives or their preparation Rs為可被羧基,胺基,Ci - β烷胺基,Ci - 3烷 氣羰基或Cm 〇硪琛芳基任意取代之C2 - a烯基;被 Ci - 3烷氱基或C6-!。硪琛芳氧基任意取代之(^ - 9 院基;Ci - a烷氣羰基,或式- (請先«1請背面之注意事項再堪寫本頁 •裝. 經濟部屮央標準局貝工消贽合作社印製 C 或 氫 為 9 R C 被 可 為 1 A 基 烷 2 C 之 代 取 基 基 烷 7 ] R -1 I cT之 o MHC 氣 I 含-10 或可C6 基或或 氰氫氳 為為為 3 7 4 R R R 基 殘 酯 C 基 芳 琛 磺 基 烷 本紙張尺度適用中B鼸家櫺準(CNS)甲4規格(210x297公嫠) % 09 Λ 3 Α7 Β7 C7 D7 六、申請專利範園 2^如申^專利範園第1項之新類咪唑衍生物或其裂藥容 許鹽,其中 之酯殘基為C i 烷基 -A2 - 0- C- X- R 或如下式基: —CH-Rs is a C2-a alkenyl group which can be optionally substituted by a carboxyl group, an amine group, a Ci-β alkylamino group, a Ci-3 alkane carbonyl group or a Cm 〇 桪 chen aryl group; a Ci-3 alkynyl group or C6- !. The aryloxy radicals are optionally substituted (^-9 courtyard; Ci-a alkyl carbonyl, or formula-(please first «1 please note the back of the page before writing this page • outfit. Ministry of Economic Affairs Printed by Cooperative Society of Co., Ltd. C or hydrogen is 9 RC can be substituted for 1 A alkyl alkane 2 C alkane alkane 7] R -1 I cT o MHC gas I contains -10 or may be C6 group or hydrogen cyanide It is 3 7 4 RRR group residue ester C group aryl sulfonane. This paper standard is applicable to the B Lujia Family Standard (CNS) A 4 specification (210x297 public daughter)% 09 Λ 3 Α7 Β7 C7 D7 VI. Application Patent Fanyuan 2 ^ If the application is a new class of imidazole derivatives or their cleavage-tolerant salts of Patent Fanyuan Item 1, the ester residue is C i alkyl-A2-0-C-X-R or the following formula Base: —CH- Y R8Y R8 A2為Ci - β伸烷基,X為氧或單鍵,Re為(:丄-3 烷基或C 3_1β琢烷基。 .2-正丁基-4-〔Ν-甲基-Ν- (3-甲基丁烯醯基)胺基〕-ΙΕ 〔2'-( 1Η-四唑 -5-基) 聯苯 -4-基〕 甲基] -1Η-咪唑 -5 -羧酸或其製藥容許鹽。 • 2-正丁基-4-〔Ν-甲基- Ν-(3-甲基丁烯醯基)胺基〕-1-〔〔2^( 1Η-四唑-5-基)聯苯-4-基〕甲基〕-1Η-眯唑 -5-羧酸1-乙氣羧氣乙酯或其製藥容許鹽。 .2-正丁基-4-〔Ν-甲基- Ν-(3-甲基丁烯Μ基)胺基〕-1-〔〔2’-( 1Η-四唑-5-基)聯苯-4-基〕甲基〕-1Η-咪唑 -5 -羧酸1-(環己氧羰氣基乙酯或其製藥容許鹽。 .一種如下式新穎咪唑衍生物之製法: --------------^ --------裝------.玎---^ —0 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局3工消費合作社印製A2 is Ci-β alkylene, X is oxygen or single bond, and Re is (: 丄 -3 alkyl or C 3_1β alkyl. .2-n-butyl-4- [Ν-methyl-Ν- ( 3-methylbutenyl) amino] -ΙΕ [2 '-(1Η-tetrazol-5-yl) biphenyl-4-yl] methyl] -1Η-imidazole-5 -carboxylic acid or its pharmaceutical Salts are allowed. • 2-n-Butyl-4- [Ν-methyl-Ν- (3-methylbutenyl) amino] -1-[[2 ^ (1Η-tetrazol-5-yl) Biphenyl-4-yl] methyl] -1H-quinazole-5-carboxylic acid 1-ethyl gas carboxy gas ethyl ester or its pharmaceutically acceptable salt. .2-n-butyl-4- [Ν-methyl- Ν -(3-methylbutenylamino) amino] -1-[[2 '-(1Η-tetrazol-5-yl) biphenyl-4-yl] methyl] -1Η-imidazole-5 -carboxy Acid 1- (cyclohexyloxycarbonyl ethyl ester or its pharmaceutically acceptable salts.... A method for preparing novel imidazole derivatives of the following formula: -------------- ^ ------ -装 ------. 玎 --- ^ —0 (Please read the precautions on the back before filling this page) Printed by the Ministry of Economic Affairs, Bureau of Standards, 3 Industrial and Consumer Cooperatives 4 R 2 本紙張尺度適用中國國家標準(CN’S)甲4规格(210 X 297公H 六、申請專利.苑·圊 此製法乃令如下式胺 AT B7 C7 D74 R 2 The size of this paper is in accordance with the Chinese National Standard (CN ’S) A 4 specifications (210 X 297 g H. 6. Apply for a patent. Yuan · Ji This method of making is as follows: amine AT B7 C7 D7 R4 與呈式Rs _C〇2 Η之羧酸或其反應性衍生物反應 (以上式中符號如申請專利範圍第1項之定義)。 一種如下式新穎眯唑衍生物之製法: //°R4 reacts with the carboxylic acid or its reactive derivative of the formula Rs _C〇2 Η (the symbol in the above formula is as defined in item 1 of the patent application scope). A method for preparing novel azole derivatives as follows: // ° R ‘ 此製法乃令如下式胺R ‘This method of making the following formula amine 經 濟 部 t 央 檫 準 局 消 费 合 作 杜 印 製 與呈式Y-A1 -C〇2 Η之羧酸或其反應性衍生物反應, 而製成如下式咪唑衍生物, ...........................(....................¾..............................ίτ.ί .......................Φ (請先閲讀背面之注意事項再填筇本頁) 本紙張尺度適用中囤國家櫺準(CNS) Τ4規格(210x297公發) 3 A 7 巳7 C7 D7 六、申請專利範圍The Ministry of Economic Affairs t Central Sassafras Bureau of Consumer Cooperation Du Yin made with the carboxylic acid or its reactive derivatives of the formula Y-A1 -C〇2 Η to produce imidazole derivatives of the following formula, ... .................... (.................... ¾ ........ ..................... ίτ.ί ....................... Φ ( Please read the precautions on the back before filling in this page) This paper size is applicable to the China National Standard (CNS) Τ4 specifications (210x297 public) 3 A 7 巳 7 C7 D7 6. Scope of patent application 00 {請先聞讀背面之注意事項再堪穹本百) 发. .訂&lt; •綠. 經 濟 部 中 央 橾 準 局 貝 工 消 費 合 作 杜 印 製 與呈式-Y (Y為鹵素)之烷化劑反應 (以上諸式中RV為Cl - 3烷基,其他符號如申誚專 利範園第1項之定義)。 — 4 本紙張尺度適用中因國家樑準(CNS) T4規格(2’1〇父297公贽) 六、申請專利範圊 9. 一種如下式新穎眯唑衍生物之製法 A7 B7 C7 D7 κι R(Please read the precautions on the back first, and then be able to make a hundred copies). .. Order &lt; • Green. The Ministry of Economic Affairs Central Bureau of Industry and Fisheries Cooperative Printing and Printing-Y (Y is halogen) alkylation Reagent reaction (in the above formulas, RV is Cl-3 alkyl, other symbols are as defined in item 1 of Shenzhuang Patent Fan Garden). — 4 The size of this paper is applicable to China National Standard (CNS) T4 (2’10 father 297 gong) 6. Patent application Fan Ji 9. A method for preparing novel azole derivatives of the following formula A7 B7 C7 D7 κι R Η 此製法乃令如下式化合物予以脱保護反應Η This preparation method is to deprotect the compound of the following formula R‘ (以上式中R+ ,為Ce—1()硪琿芳基Ci - a烷基,其他符 號如申諳專利範園第1項之定義)。 10.—種如下式新穎眯唑衍生物之製法: M RR ‘(In the above formula, R + is Ce-1 () 硪 珲 aryl group Ci-a alkyl group, other symbols are as defined in the first paragraph of the application for patent model garden). 10. A method for preparing novel azole derivatives of the following formula: MR R4 此製法乃將如下式酯化合物以酸或鹼處理 (請先聞讀背面之注意事項再填穽本頁) •装, •訂·-*· 經 部 中 央 榉 準 局 貝 X 消 费 合 作 杜 印 製R4 This preparation method is to treat the ester compound of the following formula with acid or alkali (please read the precautions on the back and then fill in this page) • Install, • Order system R4 .線. 本紙張尺度適用中困國家楳準(CNS) Ψ4規格(210x297公釐) A7 B7 C7 D: 六、申請專利範園 (以上式中RP為以可含氣之C,_17酯殘基酯化之羧基 ,其他符號如申謫專利範國第1項之定義)。 11 —種作為血管緊縮素II拮抗劑之蕖學組成物•内含如 申誚專利範園第1項之新穎眯唑衍生物或其製藥容許 鹽及賦形劑。 12如申讅專利範圃第11項之藥學組成物,偽用以治療离 血壓或慢性心臓衰竭。 --------------ί---------裝------’玎---产 孤嫁 (請先閲讀背面之注意事項再填寫本頁) 經濟部t央樣準爲貝工消費合作社印製 衣紙張尺度遘用中國國家標準(CNS)甲4规格(210 2&lt; 297公货)R4 .Line. This paper scale is suitable for CNS Ψ4 specifications (210x297 mm) A7 B7 C7 D: Six. Patent application (RP in the above formula is a gaseous C, _17 ester residue Carboxyl group of esterification, other symbols are as defined in Item 1 of the patent application country). 11-An angiotensin II antagonist as a antagonistic composition • Contains novel azole derivatives or pharmaceutical acceptable salts and excipients such as No. 1 of Shenzhao Patent Fanyuan. 12 For example, the pharmaceutical composition of item 11 of the patent application is used to treat blood pressure or chronic heart failure. -------------- ί --------- Pretend ------ '玎 --- Lonely Marriage (Please read the notes on the back before filling in this Page) The Ministry of Economic Affairs has printed the paper standard for the Beigong Consumer Cooperative to use the Chinese National Standard (CNS) A 4 specifications (210 2 &lt; 297 public goods)
TW81106539A 1991-08-21 1992-08-18 TW209213B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23417391 1991-08-21
JP27342191 1991-09-25
JP32522491 1991-11-13
JP8808092 1992-03-12

Publications (1)

Publication Number Publication Date
TW209213B true TW209213B (en) 1993-07-11

Family

ID=27467473

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81106539A TW209213B (en) 1991-08-21 1992-08-18

Country Status (3)

Country Link
AU (1) AU2449592A (en)
TW (1) TW209213B (en)
WO (1) WO1993004059A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
TW259786B (en) * 1992-12-17 1995-10-11 Sankyo Co
FR2711367B1 (en) * 1993-10-19 1995-12-01 Roussel Uclaf New process for the preparation of sulfur derivatives of imidazole and the new intermediates obtained.
DK0668272T3 (en) * 1994-01-28 2000-09-18 Takeda Chemical Industries Ltd Process for the preparation of tetrazolyl compounds
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
EP3323809A4 (en) * 2015-06-22 2019-01-02 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic heterocyclic amide derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists

Also Published As

Publication number Publication date
WO1993004059A1 (en) 1993-03-04
AU2449592A (en) 1993-03-16

Similar Documents

Publication Publication Date Title
TWI344955B (en) Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
TWI300066B (en) Pharmaceutically active compounds
TWI254047B (en) Triazaspiro[5,5]undecane compounds and pharmaceutical agents containing the same as effective ingredient
BRPI0110955B1 (en) tropane derivatives pharmaceutical composition, use thereof in the manufacture of a medicament as well as a process for the preparation thereof.
TW200825058A (en) Cysteine protease inhibitors
US7649002B2 (en) (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
TW234717B (en) 1-[2-(arylsulfonylamine)-1-oxoethyl]piperidine derivatives, their preparation and therapeutic applications
UA72750C2 (en) Azabicycloalcanes as ccr5 modulators and pharmaceutical composition
TW200838515A (en) Fused ring compound
CA2617654A1 (en) Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
JP2009532454A (en) Novel dipeptidyl peptidase IV inhibitor, method for preparing the same, and pharmaceutical composition containing the inhibitor
WO2017131156A1 (en) Cyclic amine derivative and pharmaceutical use thereof
TW200838508A (en) Chemical compounds
TW472054B (en) Azetidines
WO2007042668A1 (en) Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1
AU2008284746A1 (en) Aminopyrazole amide derivative
JP6476175B2 (en) Diarylalkylamine REV-ERB antagonists and their use as pharmaceuticals
TW209213B (en)
JP6673932B2 (en) Indole and azaindole derivatives and their use in neurodegenerative diseases
KR20210039417A (en) Substituted tetrahydrocyclopenta[c]pyrrole, substituted dihydropyrrolysine, analogs thereof, and methods of use thereof
KR20100095439A (en) 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
CN101087757B (en) Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
BRPI0709894A2 (en) dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical composition containing them
KR20200033224A (en) Treatment or prevention of alopecia areata
TW201038562A (en) Azetidines as histamine H3 receptor antagonists